| GO Type | GO Category | GO Term | No. of Plants | No. of Medicinal Plants | No. of Food Plants | No. of Human Edible Plants | No. of Agricultural Plants | No. of Garden Plants | No. of Drug-producing Plants |
|---|---|---|---|---|---|---|---|---|---|
| BP | GO:0051179;localization | GO:0015908;fatty acid transport | 333 | 182 | 61 | 115 | 1 | 11 | 85 |
| BP | GO:0008152;metabolic process | GO:0019433;triglyceride catabolic process | 318 | 169 | 52 | 111 | 1 | 8 | 79 |
| BP | GO:0051179;localization | GO:0015909;long-chain fatty acid transport | 288 | 143 | 42 | 97 | 1 | 8 | 74 |
| BP | GO:0008152;metabolic process | GO:0046464;acylglycerol catabolic process | 284 | 139 | 38 | 97 | 1 | 9 | 72 |
| BP | GO:0008152;metabolic process | GO:0006641;triglyceride metabolic process | 248 | 106 | 20 | 81 | 1 | 6 | 67 |
| BP | GO:0065007;biological regulation | GO:0050727;regulation of inflammatory response | 713 | 342 | 123 | 214 | 1 | 19 | 188 |
| BP | GO:0008152;metabolic process | GO:0019369;arachidonic acid metabolic process | 2303 | 956 | 208 | 657 | 2 | 60 | 558 |
| BP | GO:0008152;metabolic process | GO:0019371;cyclooxygenase pathway | 270 | 113 | 14 | 79 | 0 | 4 | 72 |
| BP | GO:0065007;biological regulation | GO:0120162;positive regulation of cold-induced thermogenesis | 745 | 385 | 108 | 241 | 0 | 22 | 183 |
| BP | GO:0065007;biological regulation | GO:0009893;positive regulation of metabolic process | 634 | 345 | 98 | 215 | 0 | 21 | 159 |
| BP | GO:0008152;metabolic process | GO:0019372;lipoxygenase pathway | 539 | 217 | 41 | 150 | 0 | 10 | 127 |
| BP | GO:0065007;biological regulation | GO:0046320;regulation of fatty acid oxidation | 229 | 103 | 33 | 73 | 1 | 3 | 61 |
| BP | GO:0008152;metabolic process | GO:0006631;fatty acid metabolic process | 816 | 319 | 63 | 239 | 0 | 18 | 205 |
| BP | GO:0065007;biological regulation | GO:0019217;regulation of fatty acid metabolic process | 245 | 112 | 37 | 75 | 1 | 4 | 64 |
| BP | GO:0008152;metabolic process | GO:0001516;prostaglandin biosynthetic process | 180 | 75 | 13 | 55 | 0 | 3 | 48 |
| BP | GO:0065007;biological regulation | GO:0032691;negative regulation of interleukin-1 beta production | 417 | 208 | 111 | 123 | 1 | 10 | 106 |
| BP | GO:0065007;biological regulation | GO:0062012;regulation of small molecule metabolic process | 505 | 184 | 22 | 150 | 0 | 11 | 119 |
| BP | GO:0008152;metabolic process | GO:0042759;long-chain fatty acid biosynthetic process | 2138 | 877 | 206 | 622 | 1 | 51 | 529 |
| BP | GO:0065007;biological regulation | GO:0032692;negative regulation of interleukin-1 production | 410 | 202 | 105 | 123 | 1 | 10 | 104 |
| BP | GO:0008152;metabolic process | GO:0006693;prostaglandin metabolic process | 194 | 99 | 44 | 56 | 0 | 4 | 43 |
| BP | GO:0065007;biological regulation | GO:0046889;positive regulation of lipid biosynthetic process | 180 | 78 | 19 | 60 | 1 | 3 | 50 |
| BP | GO:0008152;metabolic process | GO:1901617;organic hydroxy compound biosynthetic process | 1225 | 508 | 128 | 360 | 1 | 35 | 312 |
| BP | GO:0008152;metabolic process | GO:0006690;icosanoid metabolic process | 1400 | 570 | 102 | 395 | 1 | 32 | 330 |
| BP | GO:0009987;cellular process | GO:0031669;cellular response to nutrient levels | 156 | 59 | 11 | 51 | 1 | 3 | 41 |
| BP | GO:0009987;cellular process | GO:0071277;cellular response to calcium ion | 241 | 87 | 18 | 74 | 1 | 7 | 59 |
| BP | GO:0009987;cellular process | GO:0036294;cellular response to decreased oxygen levels | 329 | 160 | 22 | 101 | 1 | 14 | 96 |
| BP | GO:0008152;metabolic process | GO:0006633;fatty acid biosynthetic process | 1882 | 755 | 174 | 539 | 1 | 44 | 454 |
| BP | GO:0065007;biological regulation | GO:0051240;positive regulation of multicellular organismal process | 266 | 160 | 60 | 101 | 0 | 14 | 63 |
| BP | GO:0008152;metabolic process | GO:0001676;long-chain fatty acid metabolic process | 2322 | 951 | 209 | 659 | 2 | 57 | 568 |
| BP | GO:0065007;biological regulation | GO:0032651;regulation of interleukin-1 beta production | 349 | 167 | 92 | 99 | 0 | 8 | 90 |
| BP | GO:0065007;biological regulation | GO:0031347;regulation of defense response | 60 | 29 | 3 | 24 | 0 | 2 | 9 |
| BP | GO:0065007;biological regulation | GO:0031348;negative regulation of defense response | 249 | 102 | 16 | 76 | 0 | 4 | 66 |
| BP | GO:0065007;biological regulation | GO:0019216;regulation of lipid metabolic process | 86 | 27 | 3 | 21 | 0 | 1 | 18 |
| BP | GO:0065007;biological regulation | GO:0031325;positive regulation of cellular metabolic process | 430 | 208 | 83 | 136 | 1 | 10 | 114 |
| BP | GO:0050896;response to stimulus | GO:0051592;response to calcium ion | 152 | 56 | 10 | 47 | 0 | 4 | 41 |
| BP | GO:0051179;localization | GO:0006869;lipid transport | 281 | 125 | 31 | 85 | 0 | 3 | 68 |
| BP | GO:0050896;response to stimulus | GO:0033993;response to lipid | 502 | 251 | 120 | 149 | 0 | 17 | 119 |
| BP | GO:0065007;biological regulation | GO:0032102;negative regulation of response to external stimulus | 323 | 155 | 27 | 101 | 0 | 5 | 89 |
| BP | GO:0009987;cellular process | GO:0071345;cellular response to cytokine stimulus | 1157 | 526 | 108 | 349 | 1 | 31 | 289 |
| BP | GO:0065007;biological regulation | GO:0032101;regulation of response to external stimulus | 49 | 21 | 1 | 17 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0071456;cellular response to hypoxia | 584 | 261 | 24 | 176 | 1 | 17 | 159 |
| BP | GO:0009987;cellular process | GO:0071248;cellular response to metal ion | 340 | 214 | 119 | 103 | 0 | 11 | 82 |
| BP | GO:0008152;metabolic process | GO:0006367;transcription initiation from RNA polymerase II promoter | 574 | 237 | 63 | 175 | 1 | 15 | 116 |
| BP | GO:0065007;biological regulation | GO:0032096;negative regulation of response to food | 221 | 78 | 10 | 62 | 0 | 2 | 55 |
| BP | GO:0065007;biological regulation | GO:0031620;regulation of fever generation | 96 | 42 | 1 | 29 | 0 | 1 | 24 |
| BP | GO:0032501;multicellular organismal process | GO:1990379;lipid transport across blood-brain barrier | 207 | 73 | 9 | 61 | 0 | 2 | 52 |
| BP | GO:0065007;biological regulation | GO:0031394;positive regulation of prostaglandin biosynthetic process | 86 | 36 | 0 | 23 | 0 | 1 | 23 |
| BP | GO:0065007;biological regulation | GO:0031652;positive regulation of heat generation | 86 | 36 | 0 | 23 | 0 | 1 | 23 |
| BP | GO:0050896;response to stimulus | GO:0034694;response to prostaglandin | 188 | 71 | 15 | 60 | 0 | 5 | 51 |
| BP | GO:0065007;biological regulation | GO:0002820;negative regulation of adaptive immune response | 234 | 94 | 14 | 77 | 0 | 5 | 65 |
| BP | GO:0009987;cellular process | GO:0009267;cellular response to starvation | 121 | 54 | 12 | 33 | 1 | 3 | 33 |
| BP | GO:0065007;biological regulation | GO:0010891;negative regulation of sequestering of triglyceride | 228 | 88 | 5 | 67 | 0 | 2 | 59 |
| BP | GO:0065007;biological regulation | GO:0070092;regulation of glucagon secretion | 160 | 54 | 5 | 53 | 0 | 4 | 45 |
| BP | GO:0065007;biological regulation | GO:0046137;negative regulation of vitamin metabolic process | 575 | 268 | 108 | 162 | 1 | 16 | 156 |
| BP | GO:0065007;biological regulation | GO:1903242;regulation of cardiac muscle hypertrophy in response to stress | 574 | 254 | 26 | 167 | 2 | 15 | 163 |
| BP | GO:0065007;biological regulation | GO:0031622;positive regulation of fever generation | 85 | 35 | 0 | 22 | 0 | 1 | 23 |
| BP | GO:0008152;metabolic process | GO:0006352;DNA-templated transcription, initiation | 485 | 202 | 53 | 151 | 1 | 14 | 99 |
| BP | GO:0065007;biological regulation | GO:0070374;positive regulation of ERK1 and ERK2 cascade | 449 | 222 | 89 | 133 | 0 | 14 | 116 |
| BP | GO:0065007;biological regulation | GO:0043950;positive regulation of cAMP-mediated signaling | 131 | 44 | 4 | 44 | 0 | 3 | 36 |
| BP | GO:0065007;biological regulation | GO:0071073;positive regulation of phospholipid biosynthetic process | 741 | 296 | 50 | 221 | 0 | 24 | 186 |
| BP | GO:0008152;metabolic process | GO:2001301;lipoxin biosynthetic process | 834 | 346 | 80 | 257 | 0 | 18 | 205 |
| BP | GO:0065007;biological regulation | GO:0010566;regulation of ketone biosynthetic process | 129 | 42 | 3 | 43 | 0 | 3 | 35 |
| BP | GO:0032501;multicellular organismal process | GO:0072539;T-helper 17 cell differentiation | 227 | 71 | 3 | 70 | 0 | 4 | 56 |
| BP | GO:0065007;biological regulation | GO:2001280;positive regulation of unsaturated fatty acid biosynthetic process | 75 | 31 | 0 | 20 | 0 | 0 | 18 |
| BP | GO:0009987;cellular process | GO:0050872;white fat cell differentiation | 137 | 49 | 3 | 47 | 0 | 3 | 38 |
| BP | GO:0065007;biological regulation | GO:0031392;regulation of prostaglandin biosynthetic process | 74 | 30 | 0 | 19 | 0 | 0 | 17 |
| BP | GO:0009987;cellular process | GO:0019221;cytokine-mediated signaling pathway | 922 | 404 | 78 | 269 | 1 | 23 | 232 |
| BP | GO:0065007;biological regulation | GO:0031328;positive regulation of cellular biosynthetic process | 162 | 61 | 9 | 40 | 0 | 4 | 55 |
| BP | GO:0065007;biological regulation | GO:0001818;negative regulation of cytokine production | 246 | 91 | 7 | 84 | 0 | 6 | 56 |
| BP | GO:0065007;biological regulation | GO:0032099;negative regulation of appetite | 163 | 53 | 1 | 47 | 0 | 1 | 43 |
| BP | GO:0009987;cellular process | GO:0050873;brown fat cell differentiation | 124 | 38 | 2 | 39 | 0 | 3 | 34 |
| BP | GO:0008152;metabolic process | GO:0042181;ketone biosynthetic process | 388 | 152 | 19 | 114 | 0 | 9 | 104 |
| BP | GO:0065007;biological regulation | GO:2001171;positive regulation of ATP biosynthetic process | 160 | 51 | 1 | 45 | 0 | 1 | 42 |
| BP | GO:0065007;biological regulation | GO:0032368;regulation of lipid transport | 156 | 48 | 1 | 44 | 0 | 1 | 41 |
| BP | GO:0065007;biological regulation | GO:0032000;positive regulation of fatty acid beta-oxidation | 157 | 50 | 1 | 45 | 0 | 1 | 42 |
| BP | GO:0008152;metabolic process | GO:0006636;unsaturated fatty acid biosynthetic process | 352 | 149 | 39 | 116 | 0 | 7 | 94 |
| BP | GO:0008152;metabolic process | GO:0051122;hepoxilin biosynthetic process | 583 | 293 | 134 | 169 | 0 | 13 | 143 |
| BP | GO:0008152;metabolic process | GO:0051121;hepoxilin metabolic process | 582 | 292 | 134 | 169 | 0 | 13 | 143 |
| BP | GO:0008152;metabolic process | GO:0042448;progesterone metabolic process | 81 | 27 | 1 | 28 | 0 | 1 | 19 |
| BP | GO:0065007;biological regulation | GO:0009914;hormone transport | 115 | 35 | 2 | 35 | 0 | 3 | 31 |
| BP | GO:0065007;biological regulation | GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway | 94 | 36 | 1 | 32 | 0 | 1 | 25 |
| BP | GO:0065007;biological regulation | GO:0009966;regulation of signal transduction | 112 | 57 | 28 | 42 | 0 | 3 | 24 |
| BP | GO:0009987;cellular process | GO:0071379;cellular response to prostaglandin stimulus | 51 | 17 | 1 | 18 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:0010887;negative regulation of cholesterol storage | 429 | 160 | 18 | 135 | 0 | 7 | 98 |
| BP | GO:0065007;biological regulation | GO:0042753;positive regulation of circadian rhythm | 175 | 50 | 2 | 55 | 0 | 4 | 46 |
| BP | GO:0065007;biological regulation | GO:0045820;negative regulation of glycolytic process | 92 | 32 | 0 | 27 | 0 | 0 | 21 |
| BP | GO:0008152;metabolic process | GO:0034310;primary alcohol catabolic process | 119 | 55 | 20 | 36 | 0 | 2 | 37 |
| BP | GO:0065007;biological regulation | GO:0060099;regulation of phagocytosis, engulfment | 90 | 34 | 0 | 30 | 0 | 1 | 25 |
| BP | GO:0065007;biological regulation | GO:1900543;negative regulation of purine nucleotide metabolic process | 91 | 31 | 0 | 26 | 0 | 0 | 21 |
| BP | GO:0065007;biological regulation | GO:0051896;regulation of protein kinase B signaling | 1840 | 763 | 159 | 529 | 2 | 42 | 429 |
| BP | GO:0065007;biological regulation | GO:0050728;negative regulation of inflammatory response | 939 | 467 | 140 | 295 | 0 | 25 | 209 |
| BP | GO:0065007;biological regulation | GO:0071636;positive regulation of transforming growth factor beta production | 58 | 23 | 0 | 13 | 0 | 0 | 14 |
| BP | GO:0050896;response to stimulus | GO:0031960;response to corticosteroid | 36 | 12 | 0 | 13 | 0 | 0 | 6 |
| BP | GO:0050896;response to stimulus | GO:0036314;response to sterol | 133 | 38 | 2 | 39 | 0 | 4 | 34 |
| BP | GO:0065007;biological regulation | GO:0010614;negative regulation of cardiac muscle hypertrophy | 285 | 122 | 9 | 75 | 2 | 5 | 79 |
| BP | GO:0032502;developmental process | GO:0060612;adipose tissue development | 149 | 41 | 2 | 39 | 0 | 4 | 43 |
| BP | GO:0065007;biological regulation | GO:1903037;regulation of leukocyte cell-cell adhesion | 194 | 68 | 7 | 52 | 0 | 3 | 46 |
| BP | GO:0065007;biological regulation | GO:0046321;positive regulation of fatty acid oxidation | 83 | 27 | 0 | 23 | 0 | 0 | 21 |
| BP | GO:0042592;homeostatic process | GO:0055091;phospholipid homeostasis | 35 | 13 | 0 | 12 | 0 | 0 | 8 |
| BP | GO:0008152;metabolic process | GO:0034440;lipid oxidation | 325 | 141 | 31 | 101 | 0 | 6 | 77 |
| BP | GO:0009987;cellular process | GO:0090399;replicative senescence | 71 | 30 | 0 | 17 | 0 | 2 | 21 |
| BP | GO:0009987;cellular process | GO:0043618;regulation of transcription from RNA polymerase II promoter in response to stress | 240 | 91 | 5 | 70 | 1 | 7 | 65 |
| BP | GO:0008152;metabolic process | GO:0006259;DNA metabolic process | 677 | 287 | 69 | 198 | 0 | 19 | 155 |
| BP | GO:0008152;metabolic process | GO:0006281;DNA repair | 616 | 240 | 33 | 188 | 0 | 13 | 151 |
| BP | GO:0065007;biological regulation | GO:0051000;positive regulation of nitric-oxide synthase activity | 95 | 51 | 3 | 26 | 0 | 2 | 22 |
| BP | GO:0065007;biological regulation | GO:0048522;positive regulation of cellular process | 1438 | 598 | 88 | 421 | 1 | 38 | 359 |
| BP | GO:0009987;cellular process | GO:0036003;positive regulation of transcription from RNA polymerase II promoter in response to stress | 67 | 35 | 2 | 15 | 1 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:0032770;positive regulation of monooxygenase activity | 54 | 32 | 0 | 14 | 0 | 2 | 12 |
| BP | GO:0008152;metabolic process | GO:0016310;phosphorylation | 1019 | 412 | 71 | 308 | 0 | 24 | 241 |
| BP | GO:0065007;biological regulation | GO:1901796;regulation of signal transduction by p53 class mediator | 582 | 237 | 29 | 184 | 0 | 14 | 141 |
| BP | GO:0065007;biological regulation | GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II | 210 | 96 | 11 | 71 | 1 | 5 | 59 |
| BP | GO:0065007;biological regulation | GO:0045639;positive regulation of myeloid cell differentiation | 312 | 120 | 6 | 86 | 0 | 6 | 86 |
| BP | GO:0065007;biological regulation | GO:0050999;regulation of nitric-oxide synthase activity | 62 | 31 | 3 | 11 | 0 | 1 | 16 |
| BP | GO:0009987;cellular process | GO:0048863;stem cell differentiation | 27 | 18 | 0 | 6 | 0 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:0010628;positive regulation of gene expression | 41 | 31 | 5 | 23 | 0 | 3 | 6 |
| BP | GO:0065007;biological regulation | GO:1902893;regulation of pri-miRNA transcription by RNA polymerase II | 288 | 130 | 26 | 91 | 1 | 5 | 82 |
| BP | GO:0009987;cellular process | GO:0006796;phosphate-containing compound metabolic process | 68 | 29 | 0 | 18 | 0 | 1 | 17 |
| BP | GO:0009987;cellular process | GO:0048762;mesenchymal cell differentiation | 19 | 11 | 0 | 2 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0042770;signal transduction in response to DNA damage | 12 | 8 | 0 | 4 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0048523;negative regulation of cellular process | 407 | 194 | 37 | 130 | 2 | 14 | 102 |
| BP | GO:0065007;biological regulation | GO:0010507;negative regulation of autophagy | 159 | 67 | 9 | 44 | 0 | 5 | 34 |
| BP | GO:0050896;response to stimulus | GO:0000302;response to reactive oxygen species | 467 | 282 | 160 | 135 | 1 | 21 | 114 |
| BP | GO:0009987;cellular process | GO:0044773;mitotic DNA damage checkpoint signaling | 79 | 46 | 3 | 29 | 0 | 2 | 25 |
| BP | GO:0065007;biological regulation | GO:0031330;negative regulation of cellular catabolic process | 29 | 18 | 0 | 7 | 0 | 2 | 6 |
| BP | GO:0065007;biological regulation | GO:0051726;regulation of cell cycle | 45 | 18 | 1 | 14 | 0 | 2 | 13 |
| BP | GO:0065007;biological regulation | GO:0001938;positive regulation of endothelial cell proliferation | 174 | 70 | 6 | 60 | 0 | 4 | 43 |
| BP | GO:0009987;cellular process | GO:0034644;cellular response to UV | 458 | 261 | 75 | 150 | 0 | 16 | 126 |
| BP | GO:0065007;biological regulation | GO:0001936;regulation of endothelial cell proliferation | 244 | 101 | 7 | 76 | 0 | 8 | 61 |
| BP | GO:0050896;response to stimulus | GO:0006974;cellular response to DNA damage stimulus | 668 | 264 | 52 | 200 | 0 | 15 | 154 |
| BP | GO:0065007;biological regulation | GO:0010634;positive regulation of epithelial cell migration | 342 | 143 | 16 | 100 | 0 | 6 | 99 |
| BP | GO:0065007;biological regulation | GO:0042127;regulation of cell population proliferation | 2208 | 933 | 187 | 623 | 2 | 60 | 542 |
| BP | GO:0065007;biological regulation | GO:0010941;regulation of cell death | 59 | 23 | 6 | 19 | 0 | 2 | 18 |
| BP | GO:0065007;biological regulation | GO:0010604;positive regulation of macromolecule metabolic process | 117 | 67 | 29 | 49 | 0 | 4 | 25 |
| BP | GO:0008152;metabolic process | GO:0006260;DNA replication | 363 | 123 | 3 | 80 | 0 | 7 | 79 |
| BP | GO:0032501;multicellular organismal process | GO:0014831;gastro-intestinal system smooth muscle contraction | 92 | 45 | 5 | 27 | 0 | 5 | 23 |
| BP | GO:0032502;developmental process | GO:0048539;bone marrow development | 345 | 146 | 15 | 97 | 0 | 8 | 89 |
| BP | GO:0065007;biological regulation | GO:1903377;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 312 | 104 | 8 | 75 | 0 | 4 | 80 |
| BP | GO:0009987;cellular process | GO:0071236;cellular response to antibiotic | 109 | 58 | 5 | 30 | 0 | 4 | 36 |
| BP | GO:0009987;cellular process | GO:0061419;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia | 306 | 102 | 9 | 76 | 1 | 5 | 77 |
| BP | GO:0065007;biological regulation | GO:0010511;regulation of phosphatidylinositol biosynthetic process | 118 | 68 | 23 | 29 | 0 | 8 | 32 |
| BP | GO:0065007;biological regulation | GO:0050679;positive regulation of epithelial cell proliferation | 584 | 221 | 24 | 160 | 0 | 10 | 151 |
| BP | GO:0009987;cellular process | GO:0034599;cellular response to oxidative stress | 931 | 482 | 197 | 281 | 1 | 30 | 234 |
| BP | GO:0065007;biological regulation | GO:1902531;regulation of intracellular signal transduction | 250 | 114 | 8 | 85 | 0 | 3 | 46 |
| BP | GO:0065007;biological regulation | GO:0070243;regulation of thymocyte apoptotic process | 73 | 42 | 4 | 18 | 0 | 3 | 24 |
| BP | GO:0065007;biological regulation | GO:1902033;regulation of hematopoietic stem cell proliferation | 276 | 98 | 4 | 62 | 0 | 6 | 77 |
| BP | GO:0065007;biological regulation | GO:0046885;regulation of hormone biosynthetic process | 256 | 86 | 7 | 60 | 0 | 4 | 66 |
| BP | GO:0032501;multicellular organismal process | GO:0014897;striated muscle hypertrophy | 58 | 26 | 0 | 18 | 0 | 3 | 17 |
| BP | GO:0009987;cellular process | GO:0035855;megakaryocyte development | 237 | 86 | 4 | 53 | 0 | 6 | 68 |
| BP | GO:0042592;homeostatic process | GO:0032364;oxygen homeostasis | 255 | 85 | 7 | 59 | 0 | 4 | 66 |
| BP | GO:0042592;homeostatic process | GO:0033483;gas homeostasis | 236 | 81 | 7 | 54 | 0 | 4 | 60 |
| BP | GO:0065007;biological regulation | GO:0032909;regulation of transforming growth factor beta2 production | 280 | 103 | 8 | 79 | 0 | 5 | 73 |
| BP | GO:0009987;cellular process | GO:0032060;bleb assembly | 30 | 18 | 0 | 6 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:0032352;positive regulation of hormone metabolic process | 251 | 89 | 11 | 58 | 0 | 3 | 66 |
| BP | GO:0065007;biological regulation | GO:0045899;positive regulation of RNA polymerase II transcription preinitiation complex assembly | 191 | 105 | 26 | 50 | 1 | 2 | 43 |
| BP | GO:0051179;localization | GO:0015671;oxygen transport | 12 | 8 | 0 | 4 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:1903376;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | 232 | 80 | 7 | 52 | 0 | 4 | 60 |
| BP | GO:0065007;biological regulation | GO:2000112;regulation of cellular macromolecule biosynthetic process | 136 | 59 | 10 | 35 | 1 | 3 | 22 |
| BP | GO:0065007;biological regulation | GO:0006983;ER overload response | 64 | 33 | 0 | 15 | 0 | 1 | 21 |
| BP | GO:0009987;cellular process | GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 183 | 65 | 6 | 41 | 0 | 3 | 51 |
| BP | GO:0065007;biological regulation | GO:1903689;regulation of wound healing, spreading of epidermal cells | 29 | 18 | 0 | 6 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:1900119;positive regulation of execution phase of apoptosis | 58 | 29 | 0 | 12 | 0 | 1 | 21 |
| BP | GO:0065007;biological regulation | GO:0045839;negative regulation of mitotic nuclear division | 7 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0070099;regulation of chemokine-mediated signaling pathway | 183 | 65 | 6 | 41 | 0 | 3 | 51 |
| BP | GO:0032501;multicellular organismal process | GO:0003300;cardiac muscle hypertrophy | 18 | 14 | 0 | 4 | 0 | 1 | 4 |
| BP | GO:0008152;metabolic process | GO:0000012;single strand break repair | 173 | 85 | 2 | 48 | 1 | 4 | 41 |
| BP | GO:0009987;cellular process | GO:0090400;stress-induced premature senescence | 86 | 42 | 0 | 21 | 0 | 2 | 24 |
| BP | GO:0065007;biological regulation | GO:0038202;TORC1 signaling | 29 | 18 | 0 | 6 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0002761;regulation of myeloid leukocyte differentiation | 29 | 18 | 0 | 6 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0006975;DNA damage induced protein phosphorylation | 9 | 5 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0006468;protein phosphorylation | 1766 | 714 | 142 | 503 | 1 | 47 | 422 |
| BP | GO:0008152;metabolic process | GO:0018105;peptidyl-serine phosphorylation | 642 | 272 | 30 | 194 | 1 | 15 | 162 |
| BP | GO:0009987;cellular process | GO:0043276;anoikis | 65 | 36 | 0 | 13 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0035563;positive regulation of chromatin binding | 25 | 12 | 0 | 3 | 0 | 0 | 10 |
| BP | GO:0009987;cellular process | GO:0098751;bone cell development | 185 | 77 | 4 | 45 | 0 | 6 | 51 |
| BP | GO:0065007;biological regulation | GO:0045654;positive regulation of megakaryocyte differentiation | 154 | 64 | 4 | 35 | 0 | 5 | 40 |
| BP | GO:0065007;biological regulation | GO:0051095;regulation of helicase activity | 53 | 26 | 0 | 9 | 0 | 1 | 18 |
| BP | GO:0065007;biological regulation | GO:0046602;regulation of mitotic centrosome separation | 7 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0006265;DNA topological change | 30 | 19 | 0 | 6 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:0006302;double-strand break repair | 369 | 137 | 10 | 106 | 1 | 8 | 83 |
| BP | GO:0008152;metabolic process | GO:0018209;peptidyl-serine modification | 623 | 258 | 26 | 183 | 1 | 15 | 159 |
| BP | GO:0065007;biological regulation | GO:0045898;regulation of RNA polymerase II transcription preinitiation complex assembly | 166 | 88 | 20 | 42 | 1 | 2 | 34 |
| BP | GO:0065007;biological regulation | GO:0098664;G protein-coupled serotonin receptor signaling pathway | 118 | 69 | 25 | 31 | 0 | 7 | 32 |
| BP | GO:0009987;cellular process | GO:0060218;hematopoietic stem cell differentiation | 52 | 26 | 0 | 9 | 0 | 1 | 17 |
| BP | GO:0050896;response to stimulus | GO:0043201;response to leucine | 27 | 17 | 0 | 5 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0051549;positive regulation of keratinocyte migration | 47 | 34 | 2 | 10 | 0 | 0 | 13 |
| BP | GO:0009987;cellular process | GO:0071233;cellular response to leucine | 27 | 17 | 0 | 5 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:1990253;cellular response to leucine starvation | 27 | 17 | 0 | 5 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0051974;negative regulation of telomerase activity | 53 | 25 | 1 | 8 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0070234;positive regulation of T cell apoptotic process | 48 | 22 | 0 | 6 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0045945;positive regulation of transcription by RNA polymerase III | 38 | 19 | 0 | 5 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:1901838;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I | 26 | 16 | 0 | 4 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0030949;positive regulation of vascular endothelial growth factor receptor signaling pathway | 132 | 49 | 6 | 29 | 0 | 2 | 35 |
| BP | GO:0009987;cellular process | GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 40 | 15 | 0 | 6 | 0 | 1 | 13 |
| BP | GO:0032502;developmental process | GO:0032288;myelin assembly | 22 | 13 | 0 | 4 | 0 | 0 | 8 |
| BP | GO:0009987;cellular process | GO:0007167;enzyme linked receptor protein signaling pathway | 1503 | 619 | 139 | 431 | 0 | 37 | 359 |
| BP | GO:0065007;biological regulation | GO:0051347;positive regulation of transferase activity | 1527 | 629 | 141 | 444 | 0 | 40 | 371 |
| BP | GO:0065007;biological regulation | GO:0043549;regulation of kinase activity | 1500 | 618 | 140 | 434 | 0 | 38 | 361 |
| BP | GO:0065007;biological regulation | GO:0043069;negative regulation of programmed cell death | 1778 | 753 | 185 | 512 | 0 | 48 | 430 |
| BP | GO:0065007;biological regulation | GO:0033674;positive regulation of kinase activity | 1519 | 625 | 140 | 436 | 0 | 39 | 363 |
| BP | GO:0065007;biological regulation | GO:0043066;negative regulation of apoptotic process | 1809 | 782 | 202 | 530 | 0 | 51 | 430 |
| BP | GO:0065007;biological regulation | GO:0042981;regulation of apoptotic process | 1809 | 743 | 170 | 516 | 1 | 47 | 436 |
| BP | GO:0008152;metabolic process | GO:0046777;protein autophosphorylation | 1818 | 728 | 143 | 515 | 1 | 46 | 438 |
| BP | GO:0065007;biological regulation | GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway | 1493 | 607 | 132 | 431 | 0 | 35 | 359 |
| BP | GO:0065007;biological regulation | GO:0042327;positive regulation of phosphorylation | 1699 | 687 | 147 | 482 | 0 | 42 | 408 |
| BP | GO:0051179;localization | GO:0015701;bicarbonate transport | 2264 | 919 | 158 | 659 | 3 | 59 | 549 |
| BP | GO:0009987;cellular process | GO:0000165;MAPK cascade | 1286 | 519 | 101 | 365 | 0 | 29 | 296 |
| BP | GO:0065007;biological regulation | GO:0051897;positive regulation of protein kinase B signaling | 1697 | 698 | 141 | 484 | 1 | 43 | 392 |
| BP | GO:0008152;metabolic process | GO:0018108;peptidyl-tyrosine phosphorylation | 1390 | 541 | 85 | 402 | 0 | 34 | 323 |
| BP | GO:0009987;cellular process | GO:1903083;protein localization to condensed chromosome | 1193 | 445 | 56 | 343 | 0 | 28 | 279 |
| BP | GO:0065007;biological regulation | GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling | 1393 | 534 | 64 | 404 | 0 | 32 | 331 |
| BP | GO:0009987;cellular process | GO:0034501;protein localization to kinetochore | 1165 | 422 | 45 | 330 | 0 | 28 | 268 |
| BP | GO:0065007;biological regulation | GO:2001028;positive regulation of endothelial cell chemotaxis | 1282 | 461 | 48 | 358 | 0 | 29 | 307 |
| BP | GO:0008152;metabolic process | GO:0042554;superoxide anion generation | 1189 | 433 | 43 | 335 | 0 | 29 | 273 |
| BP | GO:0008152;metabolic process | GO:0038083;peptidyl-tyrosine autophosphorylation | 1443 | 560 | 87 | 418 | 1 | 36 | 339 |
| BP | GO:0009987;cellular process | GO:0071459;protein localization to chromosome, centromeric region | 1104 | 388 | 36 | 311 | 0 | 27 | 257 |
| BP | GO:0051179;localization | GO:0015711;organic anion transport | 2250 | 902 | 159 | 649 | 3 | 58 | 554 |
| BP | GO:0032502;developmental process | GO:0061436;establishment of skin barrier | 1031 | 373 | 34 | 294 | 0 | 26 | 244 |
| BP | GO:0032502;developmental process | GO:0033561;regulation of water loss via skin | 1028 | 371 | 32 | 291 | 0 | 26 | 244 |
| BP | GO:0065007;biological regulation | GO:0014066;regulation of phosphatidylinositol 3-kinase signaling | 1425 | 563 | 108 | 408 | 0 | 33 | 337 |
| BP | GO:0065007;biological regulation | GO:1902533;positive regulation of intracellular signal transduction | 1752 | 726 | 174 | 498 | 1 | 48 | 412 |
| BP | GO:0065007;biological regulation | GO:0070371;ERK1 and ERK2 cascade | 1138 | 477 | 121 | 314 | 0 | 31 | 271 |
| BP | GO:0009987;cellular process | GO:0097028;dendritic cell differentiation | 947 | 339 | 25 | 265 | 0 | 25 | 222 |
| BP | GO:0009987;cellular process | GO:1903131;mononuclear cell differentiation | 938 | 333 | 24 | 262 | 0 | 25 | 220 |
| BP | GO:0008152;metabolic process | GO:0008210;estrogen metabolic process | 2221 | 936 | 198 | 626 | 1 | 59 | 542 |
| BP | GO:0009987;cellular process | GO:0002244;hematopoietic progenitor cell differentiation | 1097 | 419 | 51 | 316 | 1 | 31 | 263 |
| BP | GO:0009987;cellular process | GO:0006801;superoxide metabolic process | 873 | 300 | 19 | 241 | 0 | 23 | 212 |
| BP | GO:0065007;biological regulation | GO:0043408;regulation of MAPK cascade | 1441 | 604 | 164 | 408 | 0 | 41 | 345 |
| BP | GO:0032501;multicellular organismal process | GO:0048754;branching morphogenesis of an epithelial tube | 700 | 238 | 18 | 182 | 0 | 19 | 172 |
| BP | GO:0065007;biological regulation | GO:0050921;positive regulation of chemotaxis | 832 | 299 | 22 | 226 | 0 | 23 | 197 |
| BP | GO:0065007;biological regulation | GO:0008284;positive regulation of cell population proliferation | 1950 | 773 | 116 | 548 | 1 | 51 | 469 |
| BP | GO:0008152;metabolic process | GO:0033559;unsaturated fatty acid metabolic process | 1161 | 480 | 127 | 322 | 2 | 29 | 292 |
| BP | GO:0032502;developmental process | GO:0048514;blood vessel morphogenesis | 651 | 212 | 11 | 162 | 0 | 18 | 169 |
| BP | GO:0008152;metabolic process | GO:0018212;peptidyl-tyrosine modification | 998 | 356 | 45 | 265 | 0 | 26 | 247 |
| BP | GO:0008152;metabolic process | GO:0019395;fatty acid oxidation | 672 | 246 | 40 | 175 | 0 | 18 | 171 |
| BP | GO:0050896;response to stimulus | GO:0014070;response to organic cyclic compound | 1676 | 664 | 128 | 455 | 1 | 45 | 425 |
| BP | GO:0065007;biological regulation | GO:2000142;regulation of DNA-templated transcription, initiation | 363 | 151 | 12 | 110 | 1 | 9 | 93 |
| BP | GO:0065007;biological regulation | GO:0060260;regulation of transcription initiation from RNA polymerase II promoter | 324 | 134 | 11 | 98 | 1 | 9 | 79 |
| BP | GO:0065007;biological regulation | GO:0048010;vascular endothelial growth factor receptor signaling pathway | 775 | 275 | 18 | 188 | 0 | 15 | 180 |
| BP | GO:0065007;biological regulation | GO:0043410;positive regulation of MAPK cascade | 1297 | 565 | 164 | 377 | 1 | 37 | 314 |
| BP | GO:0032502;developmental process | GO:0043588;skin development | 441 | 158 | 13 | 109 | 0 | 13 | 103 |
| BP | GO:0008152;metabolic process | GO:0031145;anaphase-promoting complex-dependent catabolic process | 494 | 167 | 10 | 121 | 0 | 14 | 120 |
| BP | GO:0032501;multicellular organismal process | GO:0030098;lymphocyte differentiation | 422 | 150 | 6 | 103 | 0 | 12 | 89 |
| BP | GO:0065007;biological regulation | GO:0010595;positive regulation of endothelial cell migration | 901 | 322 | 19 | 251 | 0 | 18 | 235 |
| BP | GO:0009987;cellular process | GO:0030097;hemopoiesis | 1387 | 528 | 62 | 393 | 1 | 31 | 336 |
| BP | GO:0009987;cellular process | GO:0030855;epithelial cell differentiation | 652 | 218 | 13 | 173 | 0 | 16 | 148 |
| BP | GO:0065007;biological regulation | GO:1904018;positive regulation of vasculature development | 1097 | 407 | 30 | 303 | 0 | 27 | 289 |
| BP | GO:0065007;biological regulation | GO:2000138;positive regulation of cell proliferation involved in heart morphogenesis | 394 | 138 | 4 | 88 | 0 | 9 | 95 |
| BP | GO:0009987;cellular process | GO:0038033;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway | 422 | 141 | 5 | 95 | 0 | 11 | 112 |
| BP | GO:0065007;biological regulation | GO:0051901;positive regulation of mitochondrial depolarization | 422 | 141 | 5 | 95 | 0 | 11 | 112 |
| BP | GO:0009987;cellular process | GO:0071316;cellular response to nicotine | 700 | 267 | 44 | 193 | 0 | 16 | 175 |
| BP | GO:0065007;biological regulation | GO:1905097;regulation of guanyl-nucleotide exchange factor activity | 358 | 120 | 3 | 81 | 0 | 9 | 85 |
| BP | GO:0009987;cellular process | GO:0071305;cellular response to vitamin D | 390 | 136 | 3 | 88 | 0 | 9 | 93 |
| BP | GO:0065007;biological regulation | GO:0010957;negative regulation of vitamin D biosynthetic process | 325 | 123 | 19 | 86 | 0 | 7 | 93 |
| BP | GO:0065007;biological regulation | GO:2000628;regulation of miRNA metabolic process | 662 | 257 | 44 | 187 | 0 | 15 | 161 |
| BP | GO:0008152;metabolic process | GO:0000965;mitochondrial RNA 3'-end processing | 437 | 165 | 8 | 107 | 0 | 12 | 102 |
| BP | GO:0008152;metabolic process | GO:0070901;mitochondrial tRNA methylation | 409 | 156 | 8 | 100 | 0 | 12 | 92 |
| BP | GO:0065007;biological regulation | GO:0032823;regulation of natural killer cell differentiation | 314 | 106 | 3 | 70 | 0 | 9 | 71 |
| BP | GO:0065007;biological regulation | GO:0036324;vascular endothelial growth factor receptor-2 signaling pathway | 335 | 112 | 4 | 76 | 0 | 10 | 80 |
| BP | GO:0008152;metabolic process | GO:0051103;DNA ligation involved in DNA repair | 370 | 132 | 4 | 85 | 0 | 10 | 82 |
| BP | GO:0008152;metabolic process | GO:0008202;steroid metabolic process | 2216 | 918 | 203 | 624 | 1 | 57 | 539 |
| BP | GO:0065007;biological regulation | GO:0032466;negative regulation of cytokinesis | 285 | 95 | 4 | 69 | 0 | 9 | 73 |
| BP | GO:0065007;biological regulation | GO:0060556;regulation of vitamin D biosynthetic process | 259 | 99 | 12 | 72 | 0 | 7 | 74 |
| BP | GO:0050896;response to stimulus | GO:1990776;response to angiotensin | 576 | 229 | 35 | 168 | 0 | 16 | 140 |
| BP | GO:0050896;response to stimulus | GO:0035404;histone-serine phosphorylation | 283 | 93 | 3 | 69 | 0 | 8 | 73 |
| BP | GO:0008152;metabolic process | GO:0006549;isoleucine metabolic process | 324 | 123 | 5 | 81 | 0 | 10 | 77 |
| BP | GO:0008152;metabolic process | GO:2001300;lipoxin metabolic process | 518 | 188 | 9 | 152 | 0 | 11 | 117 |
| BP | GO:0065007;biological regulation | GO:1900125;regulation of hyaluronan biosynthetic process | 246 | 93 | 12 | 67 | 0 | 7 | 72 |
| BP | GO:0008152;metabolic process | GO:0042780;tRNA 3'-end processing | 312 | 117 | 5 | 79 | 0 | 10 | 72 |
| BP | GO:0009987;cellular process | GO:0071219;cellular response to molecule of bacterial origin | 131 | 49 | 5 | 34 | 0 | 3 | 35 |
| BP | GO:0065007;biological regulation | GO:0045766;positive regulation of angiogenesis | 963 | 363 | 27 | 280 | 0 | 25 | 259 |
| BP | GO:0009987;cellular process | GO:0071222;cellular response to lipopolysaccharide | 123 | 44 | 4 | 33 | 0 | 3 | 31 |
| BP | GO:0032502;developmental process | GO:0060429;epithelium development | 402 | 132 | 8 | 105 | 0 | 12 | 87 |
| BP | GO:0009987;cellular process | GO:0071310;cellular response to organic substance | 1734 | 617 | 48 | 479 | 1 | 39 | 421 |
| BP | GO:0065007;biological regulation | GO:2000669;negative regulation of dendritic cell apoptotic process | 217 | 70 | 1 | 52 | 0 | 5 | 49 |
| BP | GO:0065007;biological regulation | GO:0060558;regulation of calcidiol 1-monooxygenase activity | 219 | 84 | 10 | 64 | 0 | 6 | 63 |
| BP | GO:0009987;cellular process | GO:0090166;Golgi disassembly | 215 | 67 | 1 | 51 | 0 | 5 | 48 |
| BP | GO:0065007;biological regulation | GO:1904181;positive regulation of membrane depolarization | 225 | 72 | 2 | 58 | 0 | 6 | 55 |
| BP | GO:0065007;biological regulation | GO:2000630;positive regulation of miRNA metabolic process | 496 | 195 | 31 | 147 | 0 | 14 | 118 |
| BP | GO:0065007;biological regulation | GO:0045685;regulation of glial cell differentiation | 187 | 59 | 1 | 45 | 0 | 5 | 43 |
| BP | GO:0065007;biological regulation | GO:0048549;positive regulation of pinocytosis | 181 | 55 | 1 | 44 | 0 | 4 | 42 |
| BP | GO:0009987;cellular process | GO:0002320;lymphoid progenitor cell differentiation | 261 | 91 | 5 | 56 | 0 | 5 | 59 |
| BP | GO:0008152;metabolic process | GO:0097267;omega-hydroxylase P450 pathway | 1980 | 819 | 166 | 561 | 2 | 48 | 479 |
| BP | GO:0008152;metabolic process | GO:0019373;epoxygenase P450 pathway | 1923 | 787 | 165 | 540 | 1 | 49 | 471 |
| BP | GO:0008152;metabolic process | GO:0042572;retinol metabolic process | 1942 | 801 | 162 | 551 | 1 | 46 | 472 |
| BP | GO:0008152;metabolic process | GO:0034308;primary alcohol metabolic process | 1906 | 773 | 156 | 539 | 1 | 45 | 462 |
| BP | GO:0065007;biological regulation | GO:0001819;positive regulation of cytokine production | 631 | 273 | 39 | 197 | 0 | 19 | 141 |
| BP | GO:0008152;metabolic process | GO:0042420;dopamine catabolic process | 222 | 104 | 7 | 71 | 0 | 4 | 56 |
| BP | GO:0008152;metabolic process | GO:0016098;monoterpenoid metabolic process | 1294 | 545 | 131 | 362 | 2 | 32 | 307 |
| BP | GO:0065007;biological regulation | GO:1904251;regulation of bile acid metabolic process | 878 | 333 | 40 | 260 | 0 | 20 | 201 |
| BP | GO:0008152;metabolic process | GO:0042424;catecholamine catabolic process | 198 | 90 | 6 | 62 | 0 | 3 | 52 |
| BP | GO:0008152;metabolic process | GO:0006721;terpenoid metabolic process | 1195 | 505 | 123 | 331 | 2 | 28 | 289 |
| BP | GO:0065007;biological regulation | GO:0070857;regulation of bile acid biosynthetic process | 813 | 299 | 32 | 237 | 0 | 16 | 184 |
| BP | GO:0008152;metabolic process | GO:0001523;retinoid metabolic process | 1964 | 791 | 166 | 555 | 1 | 51 | 484 |
| BP | GO:0065007;biological regulation | GO:0050810;regulation of steroid biosynthetic process | 747 | 282 | 40 | 215 | 0 | 16 | 172 |
| BP | GO:0008152;metabolic process | GO:0042417;dopamine metabolic process | 388 | 192 | 50 | 122 | 0 | 14 | 97 |
| BP | GO:0065007;biological regulation | GO:0090181;regulation of cholesterol metabolic process | 633 | 229 | 20 | 179 | 0 | 13 | 149 |
| BP | GO:0008152;metabolic process | GO:0042738;exogenous drug catabolic process | 804 | 350 | 96 | 220 | 1 | 20 | 202 |
| BP | GO:0008152;metabolic process | GO:0042737;drug catabolic process | 756 | 344 | 95 | 204 | 1 | 19 | 189 |
| BP | GO:0009987;cellular process | GO:0071407;cellular response to organic cyclic compound | 1813 | 747 | 148 | 522 | 2 | 45 | 414 |
| BP | GO:0065007;biological regulation | GO:0010575;positive regulation of vascular endothelial growth factor production | 828 | 306 | 34 | 225 | 2 | 16 | 220 |
| BP | GO:0065007;biological regulation | GO:0010574;regulation of vascular endothelial growth factor production | 815 | 297 | 31 | 219 | 2 | 15 | 217 |
| BP | GO:0008152;metabolic process | GO:0016042;lipid catabolic process | 658 | 245 | 32 | 183 | 1 | 10 | 145 |
| BP | GO:0065007;biological regulation | GO:0031326;regulation of cellular biosynthetic process | 524 | 194 | 17 | 151 | 0 | 11 | 127 |
| BP | GO:0065007;biological regulation | GO:0045765;regulation of angiogenesis | 284 | 109 | 9 | 78 | 0 | 9 | 82 |
| BP | GO:0065007;biological regulation | GO:0046425;regulation of receptor signaling pathway via JAK-STAT | 271 | 85 | 8 | 73 | 1 | 7 | 67 |
| BP | GO:0065007;biological regulation | GO:0009967;positive regulation of signal transduction | 287 | 101 | 6 | 81 | 0 | 5 | 83 |
| BP | GO:0065007;biological regulation | GO:0030335;positive regulation of cell migration | 682 | 274 | 32 | 208 | 0 | 12 | 172 |
| BP | GO:0065007;biological regulation | GO:0010565;regulation of cellular ketone metabolic process | 572 | 207 | 17 | 164 | 0 | 10 | 130 |
| BP | GO:0008152;metabolic process | GO:0016125;sterol metabolic process | 621 | 217 | 17 | 165 | 0 | 14 | 163 |
| BP | GO:0065007;biological regulation | GO:0007162;negative regulation of cell adhesion | 110 | 36 | 4 | 28 | 0 | 2 | 28 |
| BP | GO:0065007;biological regulation | GO:0032677;regulation of interleukin-8 production | 359 | 141 | 12 | 104 | 0 | 9 | 85 |
| BP | GO:0065007;biological regulation | GO:0032680;regulation of tumor necrosis factor production | 233 | 93 | 15 | 62 | 0 | 6 | 56 |
| BP | GO:0008152;metabolic process | GO:0009820;alkaloid metabolic process | 1141 | 467 | 110 | 310 | 1 | 22 | 275 |
| BP | GO:0065007;biological regulation | GO:1905449;regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 225 | 78 | 4 | 61 | 0 | 4 | 53 |
| BP | GO:0009987;cellular process | GO:0031580;membrane raft distribution | 218 | 76 | 3 | 60 | 0 | 4 | 53 |
| BP | GO:0008152;metabolic process | GO:0006464;cellular protein modification process | 564 | 232 | 19 | 184 | 0 | 9 | 140 |
| BP | GO:0008152;metabolic process | GO:0032787;monocarboxylic acid metabolic process | 1368 | 529 | 120 | 372 | 1 | 30 | 319 |
| BP | GO:0065007;biological regulation | GO:0090205;positive regulation of cholesterol metabolic process | 352 | 123 | 4 | 99 | 0 | 4 | 89 |
| BP | GO:0065007;biological regulation | GO:0010901;regulation of very-low-density lipoprotein particle remodeling | 418 | 146 | 5 | 124 | 0 | 9 | 100 |
| BP | GO:0008152;metabolic process | GO:0050665;hydrogen peroxide biosynthetic process | 79 | 33 | 2 | 25 | 0 | 0 | 16 |
| BP | GO:0042592;homeostatic process | GO:0035356;cellular triglyceride homeostasis | 432 | 145 | 5 | 124 | 0 | 9 | 109 |
| BP | GO:0008152;metabolic process | GO:0002933;lipid hydroxylation | 861 | 335 | 81 | 224 | 1 | 19 | 203 |
| BP | GO:0065007;biological regulation | GO:0044070;regulation of anion transport | 869 | 317 | 34 | 244 | 1 | 18 | 214 |
| BP | GO:0065007;biological regulation | GO:1903979;negative regulation of microglial cell activation | 196 | 67 | 2 | 49 | 0 | 3 | 52 |
| BP | GO:0065007;biological regulation | GO:0001915;negative regulation of T cell mediated cytotoxicity | 193 | 65 | 2 | 49 | 0 | 3 | 51 |
| BP | GO:0065007;biological regulation | GO:0050926;regulation of positive chemotaxis | 418 | 165 | 14 | 131 | 0 | 9 | 101 |
| BP | GO:0032501;multicellular organismal process | GO:0001779;natural killer cell differentiation | 285 | 116 | 8 | 92 | 0 | 7 | 58 |
| BP | GO:0008152;metabolic process | GO:0034969;histone arginine methylation | 262 | 90 | 3 | 83 | 0 | 6 | 61 |
| BP | GO:0065007;biological regulation | GO:2000258;negative regulation of protein activation cascade | 199 | 72 | 4 | 62 | 0 | 5 | 45 |
| BP | GO:0008152;metabolic process | GO:1901361;organic cyclic compound catabolic process | 739 | 289 | 63 | 202 | 1 | 13 | 164 |
| BP | GO:0065007;biological regulation | GO:0033629;negative regulation of cell adhesion mediated by integrin | 402 | 145 | 13 | 101 | 1 | 10 | 107 |
| BP | GO:0065007;biological regulation | GO:0010988;regulation of low-density lipoprotein particle clearance | 252 | 85 | 2 | 80 | 0 | 6 | 58 |
| BP | GO:0008152;metabolic process | GO:0046466;membrane lipid catabolic process | 376 | 131 | 11 | 91 | 1 | 8 | 103 |
| BP | GO:0065007;biological regulation | GO:2000434;regulation of protein neddylation | 123 | 43 | 6 | 26 | 0 | 2 | 33 |
| BP | GO:0051179;localization | GO:0019896;axonal transport of mitochondrion | 129 | 58 | 12 | 31 | 0 | 2 | 27 |
| BP | GO:0051179;localization | GO:1903204;negative regulation of oxidative stress-induced neuron death | 103 | 37 | 6 | 20 | 0 | 2 | 24 |
| BP | GO:0009987;cellular process | GO:0071397;cellular response to cholesterol | 168 | 57 | 2 | 51 | 0 | 4 | 40 |
| BP | GO:0065007;biological regulation | GO:0060761;negative regulation of response to cytokine stimulus | 108 | 36 | 2 | 26 | 0 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:0060255;regulation of macromolecule metabolic process | 14 | 3 | 0 | 5 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0002003;angiotensin maturation | 161 | 52 | 2 | 49 | 0 | 4 | 40 |
| BP | GO:0065007;biological regulation | GO:0002002;regulation of angiotensin levels in blood | 159 | 50 | 2 | 48 | 0 | 4 | 40 |
| BP | GO:0065007;biological regulation | GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress | 320 | 108 | 11 | 73 | 1 | 7 | 81 |
| BP | GO:0065007;biological regulation | GO:1904892;regulation of receptor signaling pathway via STAT | 105 | 32 | 2 | 24 | 0 | 3 | 26 |
| BP | GO:0065007;biological regulation | GO:0050854;regulation of antigen receptor-mediated signaling pathway | 78 | 24 | 0 | 22 | 0 | 1 | 19 |
| BP | GO:0050896;response to stimulus | GO:0010039;response to iron ion | 283 | 124 | 38 | 86 | 0 | 10 | 71 |
| BP | GO:0008152;metabolic process | GO:0006576;cellular biogenic amine metabolic process | 75 | 30 | 1 | 18 | 0 | 0 | 19 |
| BP | GO:0065007;biological regulation | GO:0045940;positive regulation of steroid metabolic process | 129 | 41 | 0 | 44 | 0 | 2 | 32 |
| BP | GO:0009987;cellular process | GO:0047497;mitochondrion transport along microtubule | 94 | 45 | 10 | 25 | 0 | 2 | 16 |
| BP | GO:0065007;biological regulation | GO:0010640;regulation of platelet-derived growth factor receptor signaling pathway | 194 | 75 | 14 | 63 | 0 | 5 | 43 |
| BP | GO:0065007;biological regulation | GO:0150079;negative regulation of neuroinflammatory response | 67 | 18 | 0 | 17 | 0 | 1 | 16 |
| BP | GO:0065007;biological regulation | GO:0051584;regulation of dopamine uptake involved in synaptic transmission | 352 | 194 | 64 | 110 | 0 | 12 | 99 |
| BP | GO:0065007;biological regulation | GO:0060158;phospholipase C-activating dopamine receptor signaling pathway | 269 | 128 | 27 | 79 | 0 | 7 | 75 |
| BP | GO:0008152;metabolic process | GO:0006584;catecholamine metabolic process | 81 | 54 | 20 | 25 | 0 | 3 | 23 |
| BP | GO:0065007;biological regulation | GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway | 175 | 105 | 36 | 57 | 0 | 7 | 51 |
| BP | GO:0009987;cellular process | GO:0071875;adrenergic receptor signaling pathway | 173 | 104 | 37 | 55 | 0 | 7 | 51 |
| BP | GO:0065007;biological regulation | GO:0043269;regulation of ion transport | 297 | 152 | 38 | 90 | 0 | 11 | 87 |
| BP | GO:0065007;biological regulation | GO:0051940;regulation of catecholamine uptake involved in synaptic transmission | 320 | 148 | 30 | 90 | 0 | 8 | 95 |
| BP | GO:0065007;biological regulation | GO:0060134;prepulse inhibition | 280 | 132 | 27 | 81 | 0 | 7 | 80 |
| BP | GO:0009987;cellular process | GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway | 240 | 113 | 21 | 74 | 0 | 3 | 69 |
| BP | GO:0065007;biological regulation | GO:1903531;negative regulation of secretion by cell | 88 | 62 | 23 | 20 | 0 | 4 | 21 |
| BP | GO:0051179;localization | GO:1903963;arachidonate transport | 71 | 45 | 15 | 19 | 0 | 3 | 20 |
| BP | GO:0051179;localization | GO:0050482;arachidonic acid secretion | 71 | 45 | 15 | 19 | 0 | 3 | 20 |
| BP | GO:0050896;response to stimulus | GO:0034776;response to histamine | 72 | 46 | 15 | 19 | 0 | 3 | 20 |
| BP | GO:0065007;biological regulation | GO:1901386;negative regulation of voltage-gated calcium channel activity | 76 | 50 | 20 | 20 | 0 | 6 | 20 |
| BP | GO:0051179;localization | GO:0032309;icosanoid secretion | 64 | 39 | 13 | 17 | 0 | 2 | 18 |
| BP | GO:0009987;cellular process | GO:0007200;phospholipase C-activating G protein-coupled receptor signaling pathway | 207 | 129 | 45 | 61 | 0 | 9 | 56 |
| BP | GO:0065007;biological regulation | GO:0045761;regulation of adenylate cyclase activity | 65 | 41 | 10 | 19 | 0 | 2 | 17 |
| BP | GO:0065007;biological regulation | GO:1901385;regulation of voltage-gated calcium channel activity | 59 | 35 | 10 | 17 | 0 | 2 | 16 |
| BP | GO:0042592;homeostatic process | GO:0055074;calcium ion homeostasis | 126 | 75 | 19 | 37 | 0 | 5 | 35 |
| BP | GO:0009987;cellular process | GO:0071870;cellular response to catecholamine stimulus | 295 | 176 | 101 | 96 | 0 | 7 | 72 |
| BP | GO:0065007;biological regulation | GO:0050805;negative regulation of synaptic transmission | 172 | 104 | 32 | 36 | 0 | 6 | 46 |
| BP | GO:0065007;biological regulation | GO:0014059;regulation of dopamine secretion | 63 | 40 | 8 | 19 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:0051224;negative regulation of protein transport | 52 | 30 | 6 | 14 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:2001258;negative regulation of cation channel activity | 77 | 53 | 21 | 20 | 0 | 6 | 19 |
| BP | GO:0065007;biological regulation | GO:1901020;negative regulation of calcium ion transmembrane transporter activity | 72 | 47 | 10 | 24 | 0 | 3 | 23 |
| BP | GO:0065007;biological regulation | GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway | 126 | 78 | 34 | 35 | 0 | 8 | 32 |
| BP | GO:0065007;biological regulation | GO:0050433;regulation of catecholamine secretion | 67 | 44 | 10 | 19 | 0 | 3 | 15 |
| BP | GO:0065007;biological regulation | GO:0007189;adenylate cyclase-activating G protein-coupled receptor signaling pathway | 268 | 148 | 41 | 85 | 0 | 9 | 77 |
| BP | GO:0065007;biological regulation | GO:0043266;regulation of potassium ion transport | 75 | 49 | 11 | 24 | 0 | 3 | 24 |
| BP | GO:0065007;biological regulation | GO:0050708;regulation of protein secretion | 359 | 168 | 25 | 100 | 0 | 10 | 107 |
| BP | GO:0009987;cellular process | GO:0050808;synapse organization | 258 | 126 | 30 | 83 | 0 | 4 | 81 |
| BP | GO:0065007;biological regulation | GO:0050709;negative regulation of protein secretion | 70 | 40 | 4 | 21 | 0 | 3 | 25 |
| BP | GO:0050896;response to stimulus | GO:0010243;response to organonitrogen compound | 56 | 43 | 7 | 20 | 0 | 3 | 17 |
| BP | GO:0065007;biological regulation | GO:0051966;regulation of synaptic transmission, glutamatergic | 178 | 137 | 128 | 40 | 0 | 8 | 33 |
| BP | GO:0050896;response to stimulus | GO:0042220;response to cocaine | 107 | 60 | 11 | 26 | 0 | 4 | 35 |
| BP | GO:0050896;response to stimulus | GO:0043278;response to morphine | 111 | 64 | 11 | 30 | 0 | 5 | 37 |
| BP | GO:0065007;biological regulation | GO:0043270;positive regulation of ion transport | 67 | 46 | 13 | 23 | 0 | 0 | 20 |
| BP | GO:0065007;biological regulation | GO:0051481;negative regulation of cytosolic calcium ion concentration | 81 | 56 | 15 | 25 | 0 | 5 | 20 |
| BP | GO:0050896;response to stimulus | GO:0071869;response to catecholamine | 233 | 102 | 7 | 72 | 0 | 1 | 69 |
| BP | GO:0065007;biological regulation | GO:0007193;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 172 | 106 | 29 | 52 | 0 | 8 | 53 |
| BP | GO:0050896;response to stimulus | GO:0043279;response to alkaloid | 96 | 70 | 20 | 24 | 0 | 6 | 25 |
| BP | GO:0009987;cellular process | GO:0071868;cellular response to monoamine stimulus | 213 | 90 | 4 | 66 | 0 | 1 | 64 |
| BP | GO:0065007;biological regulation | GO:0001963;synaptic transmission, dopaminergic | 185 | 117 | 81 | 48 | 0 | 7 | 41 |
| BP | GO:0065007;biological regulation | GO:0060159;regulation of dopamine receptor signaling pathway | 66 | 42 | 5 | 21 | 0 | 3 | 19 |
| BP | GO:0009987;cellular process | GO:0007416;synapse assembly | 106 | 51 | 2 | 27 | 0 | 1 | 37 |
| BP | GO:0065007;biological regulation | GO:0051354;negative regulation of oxidoreductase activity | 81 | 30 | 2 | 28 | 0 | 1 | 22 |
| BP | GO:0065007;biological regulation | GO:0007194;negative regulation of adenylate cyclase activity | 51 | 28 | 2 | 16 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:0031280;negative regulation of cyclase activity | 51 | 28 | 2 | 16 | 0 | 2 | 15 |
| BP | GO:0009987;cellular process | GO:0034329;cell junction assembly | 87 | 42 | 0 | 22 | 0 | 0 | 32 |
| BP | GO:0065007;biological regulation | GO:0045776;negative regulation of blood pressure | 54 | 30 | 2 | 17 | 0 | 3 | 15 |
| BP | GO:0065007;biological regulation | GO:0007268;chemical synaptic transmission | 276 | 190 | 128 | 67 | 0 | 13 | 61 |
| BP | GO:0065007;biological regulation | GO:0006875;cellular metal ion homeostasis | 116 | 65 | 14 | 33 | 0 | 5 | 36 |
| BP | GO:0065007;biological regulation | GO:0051350;negative regulation of lyase activity | 50 | 27 | 2 | 15 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:0072503;cellular divalent inorganic cation homeostasis | 106 | 56 | 10 | 30 | 0 | 4 | 30 |
| BP | GO:0042592;homeostatic process | GO:0006874;cellular calcium ion homeostasis | 70 | 47 | 11 | 19 | 0 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:0008285;negative regulation of cell population proliferation | 389 | 200 | 60 | 134 | 2 | 11 | 115 |
| BP | GO:0065007;biological regulation | GO:0007204;positive regulation of cytosolic calcium ion concentration | 104 | 64 | 33 | 25 | 0 | 8 | 29 |
| BP | GO:0032501;multicellular organismal process | GO:0099565;chemical synaptic transmission, postsynaptic | 26 | 19 | 1 | 10 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0030334;regulation of cell migration | 926 | 384 | 43 | 277 | 1 | 25 | 241 |
| BP | GO:0065007;biological regulation | GO:1904427;positive regulation of calcium ion transmembrane transport | 319 | 155 | 55 | 106 | 0 | 9 | 72 |
| BP | GO:0065007;biological regulation | GO:0010524;positive regulation of calcium ion transport into cytosol | 268 | 125 | 40 | 87 | 0 | 6 | 66 |
| BP | GO:0065007;biological regulation | GO:0051281;positive regulation of release of sequestered calcium ion into cytosol | 269 | 132 | 40 | 92 | 0 | 6 | 70 |
| BP | GO:0065007;biological regulation | GO:0060078;regulation of postsynaptic membrane potential | 23 | 16 | 2 | 8 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0007190;activation of adenylate cyclase activity | 180 | 98 | 13 | 68 | 0 | 4 | 46 |
| BP | GO:0065007;biological regulation | GO:0032467;positive regulation of cytokinesis | 99 | 44 | 4 | 28 | 0 | 3 | 24 |
| BP | GO:0065007;biological regulation | GO:0051898;negative regulation of protein kinase B signaling | 105 | 48 | 6 | 32 | 0 | 0 | 29 |
| BP | GO:0065007;biological regulation | GO:0051781;positive regulation of cell division | 126 | 67 | 12 | 32 | 0 | 6 | 32 |
| BP | GO:0009987;cellular process | GO:0031623;receptor internalization | 5 | 5 | 1 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0098916;anterograde trans-synaptic signaling | 234 | 152 | 94 | 56 | 0 | 10 | 52 |
| BP | GO:0065007;biological regulation | GO:0051279;regulation of release of sequestered calcium ion into cytosol | 209 | 93 | 23 | 68 | 0 | 5 | 53 |
| BP | GO:0065007;biological regulation | GO:2000377;regulation of reactive oxygen species metabolic process | 554 | 271 | 89 | 167 | 1 | 15 | 149 |
| BP | GO:0009987;cellular process | GO:0007187;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 305 | 172 | 43 | 89 | 0 | 11 | 83 |
| BP | GO:0065007;biological regulation | GO:1903532;positive regulation of secretion by cell | 52 | 32 | 5 | 21 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process | 76 | 32 | 4 | 25 | 0 | 1 | 19 |
| BP | GO:0065007;biological regulation | GO:0032465;regulation of cytokinesis | 86 | 36 | 3 | 23 | 0 | 2 | 26 |
| BP | GO:0065007;biological regulation | GO:0090068;positive regulation of cell cycle process | 85 | 36 | 2 | 23 | 0 | 2 | 26 |
| BP | GO:0065007;biological regulation | GO:2000146;negative regulation of cell motility | 57 | 31 | 2 | 17 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 56 | 22 | 0 | 16 | 0 | 1 | 15 |
| BP | GO:0032502;developmental process | GO:0007399;nervous system development | 77 | 52 | 3 | 25 | 0 | 1 | 26 |
| BP | GO:0065007;biological regulation | GO:0032415;regulation of sodium:proton antiporter activity | 16 | 11 | 0 | 4 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:1903421;regulation of synaptic vesicle recycling | 138 | 64 | 18 | 41 | 0 | 2 | 33 |
| BP | GO:0008152;metabolic process | GO:0120178;steroid hormone biosynthetic process | 804 | 302 | 45 | 232 | 1 | 18 | 214 |
| BP | GO:0008152;metabolic process | GO:0006703;estrogen biosynthetic process | 932 | 366 | 68 | 275 | 1 | 24 | 254 |
| BP | GO:0009987;cellular process | GO:0097062;dendritic spine maintenance | 310 | 118 | 12 | 90 | 0 | 4 | 75 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0035635;entry of bacterium into host cell | 270 | 96 | 8 | 81 | 0 | 3 | 68 |
| BP | GO:0065007;biological regulation | GO:0022407;regulation of cell-cell adhesion | 149 | 53 | 3 | 43 | 0 | 5 | 45 |
| BP | GO:0009987;cellular process | GO:0030261;chromosome condensation | 335 | 104 | 11 | 101 | 0 | 7 | 83 |
| BP | GO:0065007;biological regulation | GO:0031401;positive regulation of protein modification process | 236 | 92 | 12 | 69 | 0 | 2 | 62 |
| BP | GO:0065007;biological regulation | GO:0001558;regulation of cell growth | 267 | 110 | 8 | 66 | 1 | 4 | 65 |
| BP | GO:0065007;biological regulation | GO:0051900;regulation of mitochondrial depolarization | 437 | 149 | 14 | 117 | 0 | 9 | 118 |
| BP | GO:0065007;biological regulation | GO:0051893;regulation of focal adhesion assembly | 268 | 89 | 6 | 65 | 0 | 3 | 75 |
| BP | GO:0065007;biological regulation | GO:0001934;positive regulation of protein phosphorylation | 406 | 173 | 57 | 116 | 0 | 10 | 103 |
| BP | GO:0065007;biological regulation | GO:0090342;regulation of cell aging | 382 | 158 | 14 | 110 | 2 | 6 | 97 |
| BP | GO:0009987;cellular process | GO:0043954;cellular component maintenance | 244 | 85 | 7 | 66 | 0 | 2 | 60 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0044409;entry into host | 227 | 75 | 5 | 61 | 0 | 2 | 61 |
| BP | GO:0008152;metabolic process | GO:0006706;steroid catabolic process | 1113 | 444 | 94 | 319 | 1 | 24 | 276 |
| BP | GO:0065007;biological regulation | GO:0043243;positive regulation of protein-containing complex disassembly | 223 | 71 | 5 | 57 | 0 | 2 | 58 |
| BP | GO:0008152;metabolic process | GO:0006694;steroid biosynthetic process | 754 | 299 | 43 | 223 | 0 | 16 | 203 |
| BP | GO:0065007;biological regulation | GO:0001932;regulation of protein phosphorylation | 141 | 49 | 10 | 38 | 0 | 2 | 39 |
| BP | GO:0065007;biological regulation | GO:0051983;regulation of chromosome segregation | 471 | 154 | 9 | 130 | 0 | 9 | 130 |
| BP | GO:0065007;biological regulation | GO:0043244;regulation of protein-containing complex disassembly | 192 | 59 | 4 | 46 | 0 | 2 | 53 |
| BP | GO:0065007;biological regulation | GO:0045927;positive regulation of growth | 224 | 72 | 7 | 59 | 0 | 2 | 57 |
| BP | GO:0065007;biological regulation | GO:0051894;positive regulation of focal adhesion assembly | 179 | 56 | 4 | 39 | 0 | 1 | 51 |
| BP | GO:0065007;biological regulation | GO:2001234;negative regulation of apoptotic signaling pathway | 412 | 162 | 33 | 123 | 0 | 10 | 95 |
| BP | GO:0009987;cellular process | GO:0061515;myeloid cell development | 135 | 62 | 6 | 31 | 0 | 2 | 42 |
| BP | GO:0065007;biological regulation | GO:0051094;positive regulation of developmental process | 238 | 81 | 5 | 51 | 1 | 4 | 78 |
| BP | GO:0008152;metabolic process | GO:0008209;androgen metabolic process | 564 | 249 | 59 | 170 | 0 | 18 | 131 |
| BP | GO:0008152;metabolic process | GO:0042276;error-prone translesion synthesis | 156 | 51 | 3 | 34 | 0 | 1 | 43 |
| BP | GO:0009987;cellular process | GO:0030316;osteoclast differentiation | 23 | 6 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0007179;transforming growth factor beta receptor signaling pathway | 169 | 57 | 3 | 35 | 0 | 2 | 54 |
| BP | GO:0008152;metabolic process | GO:0008207;C21-steroid hormone metabolic process | 258 | 120 | 23 | 78 | 0 | 3 | 72 |
| BP | GO:0009987;cellular process | GO:0036315;cellular response to sterol | 520 | 175 | 12 | 145 | 0 | 10 | 120 |
| BP | GO:0065007;biological regulation | GO:2000648;positive regulation of stem cell proliferation | 172 | 71 | 6 | 45 | 0 | 5 | 42 |
| BP | GO:0065007;biological regulation | GO:0050857;positive regulation of antigen receptor-mediated signaling pathway | 248 | 89 | 7 | 72 | 0 | 9 | 62 |
| BP | GO:0065007;biological regulation | GO:0019218;regulation of steroid metabolic process | 428 | 150 | 11 | 121 | 0 | 9 | 107 |
| BP | GO:0051179;localization | GO:0015721;bile acid and bile salt transport | 121 | 63 | 11 | 45 | 0 | 4 | 34 |
| BP | GO:0008152;metabolic process | GO:0006656;phosphatidylcholine biosynthetic process | 586 | 204 | 13 | 157 | 0 | 14 | 164 |
| BP | GO:0065007;biological regulation | GO:0033628;regulation of cell adhesion mediated by integrin | 844 | 291 | 24 | 222 | 2 | 19 | 210 |
| BP | GO:0008152;metabolic process | GO:1901362;organic cyclic compound biosynthetic process | 551 | 196 | 13 | 148 | 0 | 13 | 153 |
| BP | GO:0009987;cellular process | GO:0070301;cellular response to hydrogen peroxide | 286 | 105 | 5 | 70 | 2 | 6 | 70 |
| BP | GO:0009987;cellular process | GO:0043542;endothelial cell migration | 814 | 298 | 23 | 219 | 2 | 17 | 194 |
| BP | GO:0051179;localization | GO:0015850;organic hydroxy compound transport | 96 | 53 | 11 | 35 | 0 | 2 | 23 |
| BP | GO:0009987;cellular process | GO:0010631;epithelial cell migration | 807 | 290 | 21 | 216 | 2 | 16 | 194 |
| BP | GO:0050896;response to stimulus | GO:0042542;response to hydrogen peroxide | 240 | 71 | 6 | 59 | 2 | 6 | 62 |
| BP | GO:0051179;localization | GO:0015718;monocarboxylic acid transport | 107 | 54 | 10 | 40 | 0 | 2 | 25 |
| BP | GO:0009987;cellular process | GO:0071396;cellular response to lipid | 732 | 288 | 66 | 208 | 1 | 18 | 157 |
| BP | GO:0065007;biological regulation | GO:0032757;positive regulation of interleukin-8 production | 175 | 60 | 3 | 45 | 0 | 4 | 45 |
| BP | GO:0009987;cellular process | GO:0034614;cellular response to reactive oxygen species | 799 | 398 | 149 | 236 | 1 | 29 | 181 |
| BP | GO:0008152;metabolic process | GO:0016101;diterpenoid metabolic process | 157 | 60 | 5 | 50 | 0 | 2 | 51 |
| BP | GO:0008152;metabolic process | GO:1903508;positive regulation of nucleic acid-templated transcription | 601 | 247 | 58 | 183 | 2 | 17 | 124 |
| BP | GO:0008152;metabolic process | GO:0046470;phosphatidylcholine metabolic process | 289 | 100 | 5 | 74 | 0 | 6 | 81 |
| BP | GO:0008152;metabolic process | GO:0008610;lipid biosynthetic process | 291 | 108 | 8 | 75 | 0 | 6 | 79 |
| BP | GO:0032501;multicellular organismal process | GO:0042110;T cell activation | 63 | 24 | 0 | 15 | 0 | 0 | 19 |
| BP | GO:0065007;biological regulation | GO:1905818;regulation of chromosome separation | 286 | 97 | 5 | 72 | 0 | 6 | 80 |
| BP | GO:0051179;localization | GO:0015849;organic acid transport | 100 | 50 | 5 | 32 | 0 | 2 | 28 |
| BP | GO:0008152;metabolic process | GO:0006366;transcription by RNA polymerase II | 324 | 139 | 31 | 98 | 1 | 7 | 70 |
| BP | GO:0009987;cellular process | GO:1901701;cellular response to oxygen-containing compound | 1096 | 539 | 187 | 321 | 1 | 35 | 253 |
| BP | GO:0009987;cellular process | GO:0071417;cellular response to organonitrogen compound | 340 | 126 | 13 | 108 | 0 | 8 | 71 |
| BP | GO:0065007;biological regulation | GO:0050796;regulation of insulin secretion | 157 | 70 | 5 | 54 | 0 | 3 | 42 |
| BP | GO:0050896;response to stimulus | GO:0070391;response to lipoteichoic acid | 229 | 74 | 3 | 69 | 0 | 4 | 54 |
| BP | GO:0050896;response to stimulus | GO:0032494;response to peptidoglycan | 220 | 70 | 3 | 68 | 0 | 4 | 54 |
| BP | GO:0009987;cellular process | GO:0071223;cellular response to lipoteichoic acid | 229 | 74 | 3 | 69 | 0 | 4 | 54 |
| BP | GO:0065007;biological regulation | GO:0000122;negative regulation of transcription by RNA polymerase II | 278 | 91 | 14 | 84 | 0 | 4 | 69 |
| BP | GO:0008152;metabolic process | GO:0072521;purine-containing compound metabolic process | 212 | 73 | 4 | 46 | 0 | 5 | 62 |
| BP | GO:0002376;immune system process | GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway | 196 | 60 | 3 | 62 | 0 | 4 | 49 |
| BP | GO:0009987;cellular process | GO:1904385;cellular response to angiotensin | 1093 | 462 | 92 | 330 | 1 | 25 | 289 |
| BP | GO:0008152;metabolic process | GO:0006001;fructose catabolic process | 73 | 26 | 1 | 20 | 0 | 4 | 18 |
| BP | GO:0008152;metabolic process | GO:0061624;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate | 73 | 26 | 1 | 20 | 0 | 4 | 18 |
| BP | GO:0008152;metabolic process | GO:0009448;gamma-aminobutyric acid metabolic process | 73 | 26 | 1 | 20 | 0 | 4 | 18 |
| BP | GO:0065007;biological regulation | GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation | 326 | 129 | 9 | 87 | 1 | 10 | 67 |
| BP | GO:0065007;biological regulation | GO:0002862;negative regulation of inflammatory response to antigenic stimulus | 411 | 220 | 43 | 138 | 0 | 12 | 94 |
| BP | GO:0065007;biological regulation | GO:0002861;regulation of inflammatory response to antigenic stimulus | 406 | 216 | 42 | 134 | 0 | 12 | 92 |
| BP | GO:0008152;metabolic process | GO:0046348;amino sugar catabolic process | 69 | 24 | 0 | 19 | 0 | 4 | 18 |
| BP | GO:0008152;metabolic process | GO:0019682;glyceraldehyde-3-phosphate metabolic process | 69 | 24 | 0 | 19 | 0 | 4 | 18 |
| BP | GO:0008152;metabolic process | GO:0008652;cellular amino acid biosynthetic process | 69 | 24 | 0 | 19 | 0 | 4 | 18 |
| BP | GO:0009987;cellular process | GO:0036089;cleavage furrow formation | 145 | 51 | 2 | 35 | 0 | 4 | 45 |
| BP | GO:0032502;developmental process | GO:0061042;vascular wound healing | 96 | 37 | 2 | 24 | 0 | 4 | 30 |
| BP | GO:0032502;developmental process | GO:0001886;endothelial cell morphogenesis | 68 | 26 | 1 | 14 | 0 | 3 | 18 |
| BP | GO:0065007;biological regulation | GO:0043433;negative regulation of DNA-binding transcription factor activity | 191 | 71 | 5 | 44 | 0 | 5 | 45 |
| BP | GO:0065007;biological regulation | GO:0002903;negative regulation of B cell apoptotic process | 72 | 30 | 2 | 20 | 0 | 4 | 22 |
| BP | GO:0009987;cellular process | GO:0038089;positive regulation of cell migration by vascular endothelial growth factor signaling pathway | 68 | 27 | 2 | 20 | 0 | 4 | 21 |
| BP | GO:0065007;biological regulation | GO:0010656;negative regulation of muscle cell apoptotic process | 63 | 21 | 1 | 17 | 0 | 4 | 19 |
| BP | GO:0008152;metabolic process | GO:0006775;fat-soluble vitamin metabolic process | 366 | 136 | 19 | 92 | 1 | 5 | 83 |
| BP | GO:0065007;biological regulation | GO:0030641;regulation of cellular pH | 825 | 281 | 28 | 240 | 1 | 18 | 204 |
| BP | GO:0065007;biological regulation | GO:0051453;regulation of intracellular pH | 658 | 227 | 21 | 195 | 1 | 15 | 164 |
| BP | GO:0008152;metabolic process | GO:0030258;lipid modification | 1049 | 430 | 130 | 301 | 1 | 24 | 245 |
| BP | GO:0065007;biological regulation | GO:0031323;regulation of cellular metabolic process | 183 | 56 | 6 | 53 | 2 | 2 | 50 |
| BP | GO:0065007;biological regulation | GO:2000379;positive regulation of reactive oxygen species metabolic process | 211 | 105 | 33 | 70 | 1 | 8 | 63 |
| BP | GO:0065007;biological regulation | GO:0042326;negative regulation of phosphorylation | 68 | 24 | 0 | 22 | 0 | 0 | 20 |
| BP | GO:0051179;localization | GO:0015670;carbon dioxide transport | 493 | 181 | 13 | 135 | 1 | 9 | 131 |
| BP | GO:0008152;metabolic process | GO:0046102;inosine metabolic process | 86 | 28 | 2 | 27 | 0 | 0 | 26 |
| BP | GO:0008152;metabolic process | GO:0046130;purine ribonucleoside catabolic process | 84 | 27 | 0 | 27 | 0 | 0 | 26 |
| BP | GO:0009987;cellular process | GO:0038166;angiotensin-activated signaling pathway | 518 | 183 | 14 | 153 | 1 | 9 | 132 |
| BP | GO:0008152;metabolic process | GO:0009169;purine ribonucleoside monophosphate catabolic process | 81 | 25 | 0 | 25 | 0 | 0 | 24 |
| BP | GO:0008152;metabolic process | GO:0042373;vitamin K metabolic process | 80 | 25 | 0 | 25 | 0 | 0 | 24 |
| BP | GO:0008152;metabolic process | GO:0046085;adenosine metabolic process | 82 | 26 | 0 | 26 | 0 | 0 | 26 |
| BP | GO:0051179;localization | GO:0019755;one-carbon compound transport | 280 | 99 | 4 | 80 | 1 | 2 | 70 |
| BP | GO:0032502;developmental process | GO:0046545;development of primary female sexual characteristics | 236 | 90 | 4 | 64 | 0 | 6 | 64 |
| BP | GO:0065007;biological regulation | GO:0045601;regulation of endothelial cell differentiation | 50 | 15 | 0 | 15 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:1900747;negative regulation of vascular endothelial growth factor signaling pathway | 87 | 34 | 0 | 24 | 0 | 0 | 21 |
| BP | GO:0065007;biological regulation | GO:0045596;negative regulation of cell differentiation | 91 | 38 | 0 | 31 | 1 | 2 | 19 |
| BP | GO:0065007;biological regulation | GO:1902548;negative regulation of cellular response to vascular endothelial growth factor stimulus | 74 | 29 | 0 | 21 | 0 | 0 | 20 |
| BP | GO:0051179;localization | GO:0015669;gas transport | 233 | 82 | 5 | 66 | 1 | 2 | 56 |
| BP | GO:0065007;biological regulation | GO:1902532;negative regulation of intracellular signal transduction | 443 | 180 | 40 | 117 | 0 | 12 | 104 |
| BP | GO:0008152;metabolic process | GO:0006195;purine nucleotide catabolic process | 47 | 13 | 0 | 14 | 0 | 0 | 15 |
| BP | GO:0008152;metabolic process | GO:0072523;purine-containing compound catabolic process | 47 | 13 | 0 | 14 | 0 | 0 | 15 |
| BP | GO:0008152;metabolic process | GO:0046033;AMP metabolic process | 47 | 13 | 0 | 14 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:1900373;positive regulation of purine nucleotide biosynthetic process | 60 | 22 | 0 | 17 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0010745;negative regulation of macrophage derived foam cell differentiation | 62 | 26 | 0 | 18 | 0 | 0 | 18 |
| BP | GO:0065007;biological regulation | GO:0032370;positive regulation of lipid transport | 140 | 54 | 2 | 33 | 0 | 4 | 37 |
| BP | GO:0065007;biological regulation | GO:1903427;negative regulation of reactive oxygen species biosynthetic process | 62 | 22 | 0 | 14 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:0031998;regulation of fatty acid beta-oxidation | 55 | 19 | 0 | 14 | 0 | 0 | 17 |
| BP | GO:0065007;biological regulation | GO:2001212;regulation of vasculogenesis | 99 | 29 | 2 | 28 | 0 | 3 | 26 |
| BP | GO:0065007;biological regulation | GO:0034764;positive regulation of transmembrane transport | 198 | 60 | 2 | 52 | 1 | 1 | 47 |
| BP | GO:0008152;metabolic process | GO:0042574;retinal metabolic process | 494 | 199 | 41 | 139 | 2 | 9 | 129 |
| BP | GO:0065007;biological regulation | GO:1902894;negative regulation of pri-miRNA transcription by RNA polymerase II | 179 | 65 | 5 | 59 | 0 | 3 | 46 |
| BP | GO:0065007;biological regulation | GO:0010889;regulation of sequestering of triglyceride | 48 | 21 | 0 | 17 | 0 | 0 | 15 |
| BP | GO:0009987;cellular process | GO:0071492;cellular response to UV-A | 452 | 271 | 104 | 143 | 0 | 20 | 121 |
| BP | GO:0050896;response to stimulus | GO:0070141;response to UV-A | 498 | 295 | 106 | 161 | 1 | 20 | 124 |
| BP | GO:0065007;biological regulation | GO:1903670;regulation of sprouting angiogenesis | 35 | 11 | 0 | 8 | 0 | 0 | 6 |
| BP | GO:0009987;cellular process | GO:0014065;phosphatidylinositol 3-kinase signaling | 182 | 86 | 9 | 50 | 0 | 3 | 35 |
| BP | GO:0065007;biological regulation | GO:0032769;negative regulation of monooxygenase activity | 441 | 234 | 105 | 134 | 0 | 11 | 120 |
| BP | GO:0008152;metabolic process | GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process | 142 | 62 | 5 | 39 | 0 | 0 | 27 |
| BP | GO:0050896;response to stimulus | GO:1904645;response to amyloid-beta | 556 | 309 | 108 | 172 | 0 | 20 | 159 |
| BP | GO:0065007;biological regulation | GO:0022898;regulation of transmembrane transporter activity | 466 | 228 | 76 | 137 | 0 | 15 | 113 |
| BP | GO:0009987;cellular process | GO:0048017;inositol lipid-mediated signaling | 136 | 57 | 1 | 38 | 0 | 0 | 27 |
| BP | GO:0065007;biological regulation | GO:0009889;regulation of biosynthetic process | 135 | 79 | 65 | 35 | 0 | 2 | 27 |
| BP | GO:0065007;biological regulation | GO:1903671;negative regulation of sprouting angiogenesis | 100 | 39 | 0 | 24 | 0 | 0 | 18 |
| BP | GO:0065007;biological regulation | GO:0090336;positive regulation of brown fat cell differentiation | 135 | 53 | 1 | 31 | 0 | 1 | 34 |
| BP | GO:0065007;biological regulation | GO:0038084;vascular endothelial growth factor signaling pathway | 117 | 42 | 1 | 32 | 0 | 1 | 28 |
| BP | GO:0009987;cellular process | GO:0022411;cellular component disassembly | 380 | 210 | 53 | 124 | 0 | 15 | 110 |
| BP | GO:0009987;cellular process | GO:0022617;extracellular matrix disassembly | 376 | 206 | 51 | 122 | 0 | 15 | 109 |
| BP | GO:0008152;metabolic process | GO:0046222;aflatoxin metabolic process | 409 | 179 | 40 | 108 | 1 | 5 | 99 |
| BP | GO:0008152;metabolic process | GO:1901376;organic heteropentacyclic compound metabolic process | 407 | 177 | 40 | 108 | 1 | 5 | 99 |
| BP | GO:0008152;metabolic process | GO:0042359;vitamin D metabolic process | 390 | 153 | 31 | 98 | 1 | 5 | 82 |
| BP | GO:0009987;cellular process | GO:0043385;mycotoxin metabolic process | 399 | 171 | 37 | 107 | 1 | 5 | 99 |
| BP | GO:0009987;cellular process | GO:0051262;protein tetramerization | 37 | 26 | 3 | 14 | 0 | 1 | 5 |
| BP | GO:0009987;cellular process | GO:0048015;phosphatidylinositol-mediated signaling | 116 | 58 | 1 | 33 | 0 | 1 | 22 |
| BP | GO:0002376;immune system process | GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis | 154 | 70 | 7 | 42 | 0 | 2 | 34 |
| BP | GO:0065007;biological regulation | GO:0038094;Fc-gamma receptor signaling pathway | 154 | 70 | 7 | 42 | 0 | 2 | 34 |
| BP | GO:0009987;cellular process | GO:0002431;Fc receptor mediated stimulatory signaling pathway | 153 | 70 | 6 | 43 | 0 | 2 | 34 |
| BP | GO:0065007;biological regulation | GO:0090335;regulation of brown fat cell differentiation | 90 | 31 | 0 | 21 | 0 | 1 | 25 |
| BP | GO:0065007;biological regulation | GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis | 107 | 30 | 0 | 28 | 0 | 1 | 34 |
| BP | GO:0009987;cellular process | GO:0030198;extracellular matrix organization | 636 | 309 | 74 | 190 | 0 | 17 | 177 |
| BP | GO:0065007;biological regulation | GO:0150077;regulation of neuroinflammatory response | 18 | 13 | 0 | 8 | 0 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:2000811;negative regulation of anoikis | 103 | 33 | 3 | 22 | 0 | 1 | 28 |
| BP | GO:0065007;biological regulation | GO:2000209;regulation of anoikis | 51 | 17 | 1 | 8 | 0 | 1 | 16 |
| BP | GO:0065007;biological regulation | GO:0038095;Fc-epsilon receptor signaling pathway | 296 | 127 | 27 | 85 | 0 | 7 | 63 |
| BP | GO:0065007;biological regulation | GO:0038093;Fc receptor signaling pathway | 296 | 127 | 27 | 85 | 0 | 7 | 63 |
| BP | GO:0009987;cellular process | GO:0050851;antigen receptor-mediated signaling pathway | 326 | 129 | 8 | 87 | 0 | 6 | 69 |
| BP | GO:0065007;biological regulation | GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 196 | 93 | 19 | 52 | 0 | 10 | 52 |
| BP | GO:0008152;metabolic process | GO:0043651;linoleic acid metabolic process | 291 | 160 | 103 | 79 | 0 | 8 | 71 |
| BP | GO:0065007;biological regulation | GO:0038127;ERBB signaling pathway | 53 | 26 | 2 | 10 | 0 | 2 | 19 |
| BP | GO:0008152;metabolic process | GO:0006691;leukotriene metabolic process | 137 | 58 | 12 | 44 | 0 | 5 | 29 |
| BP | GO:0009987;cellular process | GO:0050852;T cell receptor signaling pathway | 316 | 124 | 6 | 81 | 0 | 6 | 69 |
| BP | GO:0065007;biological regulation | GO:0048013;ephrin receptor signaling pathway | 262 | 133 | 16 | 86 | 0 | 7 | 74 |
| BP | GO:0065007;biological regulation | GO:0120041;positive regulation of macrophage proliferation | 115 | 71 | 25 | 31 | 0 | 4 | 25 |
| BP | GO:0065007;biological regulation | GO:0120040;regulation of macrophage proliferation | 88 | 56 | 15 | 25 | 0 | 2 | 24 |
| BP | GO:0009987;cellular process | GO:0007411;axon guidance | 69 | 29 | 2 | 11 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0010810;regulation of cell-substrate adhesion | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:1990858;cellular response to lectin | 139 | 48 | 0 | 40 | 0 | 3 | 41 |
| BP | GO:0002376;immune system process | GO:0002223;stimulatory C-type lectin receptor signaling pathway | 139 | 48 | 0 | 40 | 0 | 3 | 41 |
| BP | GO:0065007;biological regulation | GO:0031334;positive regulation of protein-containing complex assembly | 69 | 41 | 19 | 17 | 0 | 2 | 19 |
| BP | GO:0065007;biological regulation | GO:0007173;epidermal growth factor receptor signaling pathway | 50 | 20 | 1 | 7 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0007198;adenylate cyclase-inhibiting serotonin receptor signaling pathway | 97 | 51 | 18 | 25 | 0 | 6 | 25 |
| BP | GO:0009987;cellular process | GO:0007188;adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 148 | 91 | 24 | 46 | 0 | 5 | 42 |
| BP | GO:0065007;biological regulation | GO:0035624;receptor transactivation | 88 | 55 | 28 | 30 | 0 | 3 | 22 |
| BP | GO:0065007;biological regulation | GO:0014060;regulation of epinephrine secretion | 73 | 46 | 17 | 26 | 0 | 3 | 21 |
| BP | GO:0065007;biological regulation | GO:0051283;negative regulation of sequestering of calcium ion | 82 | 55 | 21 | 19 | 0 | 7 | 19 |
| BP | GO:0065007;biological regulation | GO:0033604;negative regulation of catecholamine secretion | 70 | 44 | 15 | 26 | 0 | 3 | 20 |
| BP | GO:0065007;biological regulation | GO:0014061;regulation of norepinephrine secretion | 69 | 43 | 17 | 23 | 0 | 3 | 21 |
| BP | GO:0009987;cellular process | GO:0051209;release of sequestered calcium ion into cytosol | 79 | 52 | 19 | 18 | 0 | 7 | 19 |
| BP | GO:0032501;multicellular organismal process | GO:0014821;phasic smooth muscle contraction | 55 | 37 | 14 | 12 | 0 | 4 | 14 |
| BP | GO:0009987;cellular process | GO:0097553;calcium ion transmembrane import into cytosol | 72 | 47 | 17 | 14 | 0 | 5 | 17 |
| BP | GO:0065007;biological regulation | GO:0050777;negative regulation of immune response | 322 | 188 | 50 | 115 | 0 | 9 | 71 |
| BP | GO:0065007;biological regulation | GO:1904707;positive regulation of vascular associated smooth muscle cell proliferation | 331 | 170 | 32 | 98 | 0 | 12 | 93 |
| BP | GO:0065007;biological regulation | GO:0032148;activation of protein kinase B activity | 54 | 29 | 5 | 17 | 0 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:1904705;regulation of vascular associated smooth muscle cell proliferation | 211 | 109 | 11 | 66 | 0 | 9 | 61 |
| BP | GO:0065007;biological regulation | GO:2000273;positive regulation of signaling receptor activity | 53 | 30 | 8 | 19 | 0 | 2 | 17 |
| BP | GO:0065007;biological regulation | GO:0042053;regulation of dopamine metabolic process | 52 | 23 | 2 | 15 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0051254;positive regulation of RNA metabolic process | 431 | 174 | 26 | 134 | 1 | 9 | 101 |
| BP | GO:0065007;biological regulation | GO:0048661;positive regulation of smooth muscle cell proliferation | 195 | 94 | 8 | 55 | 0 | 9 | 52 |
| BP | GO:0050896;response to stimulus | GO:0070741;response to interleukin-6 | 288 | 111 | 11 | 89 | 0 | 7 | 72 |
| BP | GO:0065007;biological regulation | GO:0034762;regulation of transmembrane transport | 327 | 152 | 80 | 93 | 0 | 12 | 81 |
| BP | GO:0009987;cellular process | GO:0097306;cellular response to alcohol | 270 | 94 | 21 | 80 | 1 | 8 | 59 |
| BP | GO:0009987;cellular process | GO:0007077;mitotic nuclear membrane disassembly | 42 | 14 | 0 | 12 | 0 | 1 | 9 |
| BP | GO:0008152;metabolic process | GO:0018107;peptidyl-threonine phosphorylation | 235 | 89 | 10 | 70 | 0 | 4 | 66 |
| BP | GO:0009987;cellular process | GO:0051081;nuclear membrane disassembly | 39 | 13 | 0 | 12 | 0 | 1 | 9 |
| BP | GO:0008152;metabolic process | GO:0018210;peptidyl-threonine modification | 177 | 72 | 8 | 56 | 0 | 3 | 50 |
| BP | GO:0065007;biological regulation | GO:0010885;regulation of cholesterol storage | 195 | 72 | 8 | 62 | 0 | 4 | 44 |
| BP | GO:0065007;biological regulation | GO:0062013;positive regulation of small molecule metabolic process | 202 | 77 | 8 | 67 | 0 | 4 | 45 |
| BP | GO:0009987;cellular process | GO:0071398;cellular response to fatty acid | 170 | 64 | 6 | 55 | 0 | 5 | 44 |
| BP | GO:0065007;biological regulation | GO:0002819;regulation of adaptive immune response | 181 | 51 | 15 | 49 | 1 | 5 | 48 |
| BP | GO:0002376;immune system process | GO:0045087;innate immune response | 6 | 3 | 1 | 4 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0051403;stress-activated MAPK cascade | 84 | 37 | 23 | 17 | 0 | 1 | 19 |
| BP | GO:0065007;biological regulation | GO:0038128;ERBB2 signaling pathway | 63 | 27 | 4 | 18 | 0 | 1 | 18 |
| BP | GO:0065007;biological regulation | GO:2000668;regulation of dendritic cell apoptotic process | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002902;regulation of B cell apoptotic process | 18 | 4 | 1 | 7 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0071347;cellular response to interleukin-1 | 106 | 39 | 2 | 38 | 0 | 2 | 29 |
| BP | GO:0050896;response to stimulus | GO:0071363;cellular response to growth factor stimulus | 143 | 44 | 4 | 35 | 0 | 2 | 42 |
| BP | GO:0065007;biological regulation | GO:0070498;interleukin-1-mediated signaling pathway | 118 | 44 | 0 | 39 | 0 | 2 | 27 |
| BP | GO:0065007;biological regulation | GO:0043405;regulation of MAP kinase activity | 18 | 14 | 2 | 7 | 0 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:0032872;regulation of stress-activated MAPK cascade | 193 | 114 | 79 | 43 | 0 | 6 | 43 |
| BP | GO:0065007;biological regulation | GO:0051270;regulation of cellular component movement | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0090330;regulation of platelet aggregation | 31 | 10 | 0 | 14 | 0 | 2 | 12 |
| BP | GO:0009987;cellular process | GO:0031663;lipopolysaccharide-mediated signaling pathway | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000145;regulation of cell motility | 23 | 15 | 1 | 7 | 1 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0042509;regulation of tyrosine phosphorylation of STAT protein | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043406;positive regulation of MAP kinase activity | 36 | 20 | 1 | 9 | 0 | 1 | 9 |
| BP | GO:0002376;immune system process | GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway | 12 | 5 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0032481;positive regulation of type I interferon production | 46 | 20 | 0 | 17 | 0 | 0 | 11 |
| BP | GO:0002376;immune system process | GO:0034134;toll-like receptor 2 signaling pathway | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0032496;response to lipopolysaccharide | 121 | 59 | 24 | 41 | 0 | 2 | 28 |
| BP | GO:0065007;biological regulation | GO:1903039;positive regulation of leukocyte cell-cell adhesion | 34 | 15 | 2 | 14 | 0 | 1 | 8 |
| BP | GO:0050896;response to stimulus | GO:0070555;response to interleukin-1 | 457 | 214 | 90 | 138 | 0 | 7 | 124 |
| BP | GO:0065007;biological regulation | GO:0045893;positive regulation of transcription, DNA-templated | 327 | 139 | 28 | 107 | 2 | 9 | 57 |
| BP | GO:0050896;response to stimulus | GO:0035924;cellular response to vascular endothelial growth factor stimulus | 95 | 33 | 1 | 24 | 0 | 2 | 27 |
| BP | GO:0009987;cellular process | GO:0032870;cellular response to hormone stimulus | 88 | 36 | 7 | 26 | 0 | 3 | 29 |
| BP | GO:0065007;biological regulation | GO:2000637;positive regulation of gene silencing by miRNA | 25 | 18 | 1 | 14 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0051348;negative regulation of transferase activity | 28 | 23 | 2 | 16 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0034504;protein localization to nucleus | 10 | 9 | 1 | 3 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:1905050;positive regulation of metallopeptidase activity | 4 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0050896;response to stimulus | GO:1990416;cellular response to brain-derived neurotrophic factor stimulus | 35 | 26 | 2 | 17 | 0 | 3 | 5 |
| BP | GO:0009987;cellular process | GO:0048312;intracellular distribution of mitochondria | 35 | 26 | 2 | 17 | 0 | 3 | 5 |
| BP | GO:0065007;biological regulation | GO:1904428;negative regulation of tubulin deacetylation | 34 | 25 | 1 | 17 | 0 | 2 | 5 |
| BP | GO:0032502;developmental process | GO:0072079;nephron tubule formation | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:1902474;positive regulation of protein localization to synapse | 34 | 25 | 1 | 17 | 0 | 2 | 5 |
| BP | GO:0032502;developmental process | GO:0072235;metanephric distal tubule development | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0032502;developmental process | GO:0072207;metanephric epithelium development | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0032502;developmental process | GO:0072282;metanephric nephron tubule morphogenesis | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0032502;developmental process | GO:0072283;metanephric renal vesicle morphogenesis | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0009987;cellular process | GO:0060019;radial glial cell differentiation | 4 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1903748;negative regulation of establishment of protein localization to mitochondrion | 32 | 23 | 1 | 16 | 0 | 2 | 5 |
| BP | GO:0009987;cellular process | GO:0008088;axo-dendritic transport | 83 | 50 | 19 | 30 | 0 | 2 | 17 |
| BP | GO:0065007;biological regulation | GO:2000698;positive regulation of epithelial cell differentiation involved in kidney development | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0050896;response to stimulus | GO:0034698;response to gonadotropin | 27 | 12 | 2 | 8 | 0 | 0 | 11 |
| BP | GO:0009987;cellular process | GO:0070841;inclusion body assembly | 27 | 18 | 1 | 12 | 0 | 1 | 4 |
| BP | GO:0009987;cellular process | GO:0072540;T-helper 17 cell lineage commitment | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis | 29 | 12 | 2 | 8 | 0 | 0 | 10 |
| BP | GO:0032502;developmental process | GO:0048793;pronephros development | 26 | 11 | 2 | 7 | 0 | 0 | 10 |
| BP | GO:0009987;cellular process | GO:0072386;plus-end-directed organelle transport along microtubule | 27 | 18 | 1 | 12 | 0 | 1 | 4 |
| BP | GO:0009987;cellular process | GO:0035850;epithelial cell differentiation involved in kidney development | 26 | 11 | 2 | 7 | 0 | 0 | 10 |
| BP | GO:0009987;cellular process | GO:0048708;astrocyte differentiation | 23 | 9 | 0 | 6 | 0 | 1 | 8 |
| BP | GO:0065007;biological regulation | GO:0090043;regulation of tubulin deacetylation | 25 | 16 | 1 | 11 | 0 | 1 | 3 |
| BP | GO:0050896;response to stimulus | GO:0010288;response to lead ion | 25 | 16 | 1 | 11 | 0 | 1 | 3 |
| BP | GO:0008152;metabolic process | GO:0044270;cellular nitrogen compound catabolic process | 131 | 76 | 11 | 40 | 0 | 2 | 34 |
| BP | GO:0008152;metabolic process | GO:1905618;positive regulation of miRNA mediated inhibition of translation | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071371;cellular response to gonadotropin stimulus | 26 | 11 | 2 | 7 | 0 | 0 | 10 |
| BP | GO:0032502;developmental process | GO:0072234;metanephric nephron tubule development | 24 | 9 | 1 | 5 | 0 | 0 | 9 |
| BP | GO:0032502;developmental process | GO:1905616;regulation of miRNA mediated inhibition of translation | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0046530;photoreceptor cell differentiation | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010917;negative regulation of mitochondrial membrane potential | 24 | 15 | 1 | 10 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0038114;interleukin-21-mediated signaling pathway | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006475;internal protein amino acid acetylation | 23 | 15 | 1 | 10 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:1903747;regulation of establishment of protein localization to mitochondrion | 23 | 15 | 1 | 10 | 0 | 1 | 3 |
| BP | GO:0032502;developmental process | GO:0072073;kidney epithelium development | 23 | 9 | 1 | 5 | 0 | 0 | 8 |
| BP | GO:0050896;response to stimulus | GO:0098757;cellular response to interleukin-21 | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0002295;T-helper cell lineage commitment | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0030878;thyroid gland development | 22 | 8 | 1 | 4 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0043067;regulation of programmed cell death | 109 | 36 | 2 | 23 | 0 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:0045837;negative regulation of membrane potential | 23 | 15 | 1 | 10 | 0 | 1 | 3 |
| BP | GO:0050896;response to stimulus | GO:0044321;response to leptin | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0038155;interleukin-23-mediated signaling pathway | 5 | 4 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0038113;interleukin-9-mediated signaling pathway | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071355;cellular response to interleukin-9 | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0044320;cellular response to leptin stimulus | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0072182;regulation of nephron tubule epithelial cell differentiation | 20 | 7 | 1 | 2 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:1904950;negative regulation of establishment of protein localization | 19 | 13 | 0 | 9 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0072202;cell differentiation involved in metanephros development | 20 | 7 | 1 | 2 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0033210;leptin-mediated signaling pathway | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900452;regulation of long-term synaptic depression | 19 | 13 | 0 | 9 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0060231;mesenchymal to epithelial transition | 20 | 7 | 1 | 2 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:0006351;transcription, DNA-templated | 45 | 17 | 1 | 9 | 0 | 2 | 14 |
| BP | GO:0065007;biological regulation | GO:0099622;cardiac muscle cell membrane repolarization | 4 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070757;interleukin-35-mediated signaling pathway | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060148;positive regulation of posttranscriptional gene silencing | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903800;positive regulation of production of miRNAs involved in gene silencing by miRNA | 111 | 47 | 3 | 32 | 1 | 1 | 18 |
| BP | GO:0032502;developmental process | GO:0001823;mesonephros development | 18 | 6 | 1 | 2 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:1990440;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 34 | 11 | 0 | 3 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:0042772;DNA damage response, signal transduction resulting in transcription | 34 | 11 | 0 | 3 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:0010506;regulation of autophagy | 9 | 6 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis | 17 | 6 | 1 | 2 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:0007197;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway | 36 | 29 | 7 | 11 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0007213;G protein-coupled acetylcholine receptor signaling pathway | 30 | 24 | 6 | 10 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:0095500;acetylcholine receptor signaling pathway | 27 | 21 | 6 | 8 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:0001996;positive regulation of heart rate by epinephrine-norepinephrine | 42 | 25 | 6 | 14 | 0 | 3 | 10 |
| BP | GO:0032501;multicellular organismal process | GO:0019229;regulation of vasoconstriction | 40 | 19 | 4 | 10 | 0 | 2 | 11 |
| BP | GO:0032501;multicellular organismal process | GO:0045907;positive regulation of vasoconstriction | 29 | 13 | 3 | 7 | 0 | 2 | 10 |
| BP | GO:0065007;biological regulation | GO:0010460;positive regulation of heart rate | 32 | 16 | 4 | 9 | 0 | 2 | 10 |
| BP | GO:0065007;biological regulation | GO:0032147;activation of protein kinase activity | 42 | 16 | 2 | 11 | 0 | 3 | 16 |
| BP | GO:0065007;biological regulation | GO:0006940;regulation of smooth muscle contraction | 19 | 13 | 2 | 5 | 0 | 1 | 9 |
| BP | GO:0042592;homeostatic process | GO:0051480;regulation of cytosolic calcium ion concentration | 60 | 34 | 6 | 16 | 0 | 3 | 16 |
| BP | GO:0065007;biological regulation | GO:0045666;positive regulation of neuron differentiation | 16 | 9 | 2 | 5 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0090276;regulation of peptide hormone secretion | 99 | 60 | 9 | 37 | 1 | 3 | 27 |
| BP | GO:0065007;biological regulation | GO:0045664;regulation of neuron differentiation | 13 | 8 | 1 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0045760;positive regulation of action potential | 18 | 13 | 3 | 7 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0045955;negative regulation of calcium ion-dependent exocytosis | 15 | 12 | 1 | 7 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:0060452;positive regulation of cardiac muscle contraction | 11 | 8 | 3 | 4 | 0 | 0 | 4 |
| BP | GO:0032501;multicellular organismal process | GO:0003056;regulation of vascular associated smooth muscle contraction | 16 | 10 | 1 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0045989;positive regulation of striated muscle contraction | 8 | 5 | 2 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0032230;positive regulation of synaptic transmission, GABAergic | 8 | 5 | 2 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:1903306;negative regulation of regulated secretory pathway | 10 | 9 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0060251;regulation of glial cell proliferation | 14 | 8 | 1 | 2 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0090037;positive regulation of protein kinase C signaling | 6 | 4 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0055083;monovalent inorganic anion homeostasis | 440 | 161 | 12 | 111 | 2 | 11 | 105 |
| BP | GO:0042592;homeostatic process | GO:0055064;chloride ion homeostasis | 453 | 170 | 12 | 118 | 2 | 11 | 108 |
| BP | GO:0009987;cellular process | GO:1905145;cellular response to acetylcholine | 16 | 10 | 1 | 4 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:1903170;negative regulation of calcium ion transmembrane transport | 13 | 12 | 1 | 7 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0007205;protein kinase C-activating G protein-coupled receptor signaling pathway | 22 | 16 | 1 | 4 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0045741;positive regulation of epidermal growth factor-activated receptor activity | 7 | 6 | 0 | 4 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0090343;positive regulation of cell aging | 208 | 98 | 5 | 61 | 2 | 3 | 54 |
| BP | GO:0032501;multicellular organismal process | GO:0006939;smooth muscle contraction | 4 | 3 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0090036;regulation of protein kinase C signaling | 4 | 3 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0050892;intestinal absorption | 29 | 7 | 0 | 9 | 0 | 0 | 14 |
| BP | GO:0009987;cellular process | GO:0070206;protein trimerization | 4 | 2 | 1 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032228;regulation of synaptic transmission, GABAergic | 29 | 14 | 1 | 6 | 0 | 2 | 11 |
| BP | GO:0009987;cellular process | GO:0070207;protein homotrimerization | 4 | 2 | 1 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0051044;positive regulation of membrane protein ectodomain proteolysis | 6 | 4 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0046676;negative regulation of insulin secretion | 5 | 4 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0050995;negative regulation of lipid catabolic process | 11 | 9 | 2 | 3 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0090278;negative regulation of peptide hormone secretion | 8 | 7 | 0 | 4 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0051926;negative regulation of calcium ion transport | 6 | 5 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0045823;positive regulation of heart contraction | 4 | 3 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032413;negative regulation of ion transmembrane transporter activity | 8 | 7 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0060402;calcium ion transport into cytosol | 4 | 3 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0050994;regulation of lipid catabolic process | 10 | 8 | 2 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0051043;regulation of membrane protein ectodomain proteolysis | 5 | 3 | 0 | 2 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0045833;negative regulation of lipid metabolic process | 9 | 7 | 2 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0045597;positive regulation of cell differentiation | 16 | 8 | 9 | 5 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0043271;negative regulation of ion transport | 33 | 18 | 2 | 8 | 0 | 2 | 9 |
| BP | GO:0065007;biological regulation | GO:0007176;regulation of epidermal growth factor-activated receptor activity | 4 | 3 | 0 | 2 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0060401;cytosolic calcium ion transport | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0006937;regulation of muscle contraction | 13 | 7 | 1 | 2 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0061178;regulation of insulin secretion involved in cellular response to glucose stimulus | 23 | 13 | 0 | 11 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:1903036;positive regulation of response to wounding | 4 | 3 | 0 | 2 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:1901019;regulation of calcium ion transmembrane transporter activity | 7 | 6 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0017158;regulation of calcium ion-dependent exocytosis | 4 | 3 | 0 | 2 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0007202;activation of phospholipase C activity | 44 | 25 | 6 | 10 | 0 | 4 | 12 |
| MF | GO:0060089;molecular transducer activity | GO:0004936;alpha-adrenergic receptor activity | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0016907;G protein-coupled acetylcholine receptor activity | 13 | 7 | 0 | 3 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0099528;G protein-coupled neurotransmitter receptor activity | 13 | 7 | 0 | 3 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0008227;G protein-coupled amine receptor activity | 20 | 12 | 0 | 4 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0015464;acetylcholine receptor activity | 14 | 8 | 0 | 3 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0099589;serotonin receptor activity | 20 | 12 | 0 | 4 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0004993;G protein-coupled serotonin receptor activity | 20 | 12 | 0 | 4 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0004930;G protein-coupled receptor activity | 16 | 13 | 1 | 4 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0051379;epinephrine binding | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010468;regulation of gene expression | 226 | 100 | 19 | 69 | 1 | 6 | 53 |
| BP | GO:0009987;cellular process | GO:0002076;osteoblast development | 361 | 143 | 10 | 87 | 0 | 9 | 97 |
| BP | GO:0065007;biological regulation | GO:0010605;negative regulation of macromolecule metabolic process | 247 | 112 | 33 | 73 | 0 | 8 | 70 |
| BP | GO:0008152;metabolic process | GO:0006508;proteolysis | 320 | 162 | 31 | 100 | 0 | 14 | 82 |
| BP | GO:0065007;biological regulation | GO:0010822;positive regulation of mitochondrion organization | 188 | 85 | 11 | 53 | 0 | 6 | 70 |
| BP | GO:0065007;biological regulation | GO:0010972;negative regulation of G2/M transition of mitotic cell cycle | 107 | 33 | 2 | 28 | 0 | 4 | 33 |
| BP | GO:0065007;biological regulation | GO:0010629;negative regulation of gene expression | 88 | 44 | 20 | 31 | 0 | 3 | 21 |
| BP | GO:0065007;biological regulation | GO:2001237;negative regulation of extrinsic apoptotic signaling pathway | 152 | 62 | 8 | 50 | 0 | 2 | 37 |
| BP | GO:0065007;biological regulation | GO:0072091;regulation of stem cell proliferation | 11 | 6 | 0 | 6 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050927;positive regulation of positive chemotaxis | 136 | 63 | 7 | 50 | 0 | 4 | 31 |
| BP | GO:0065007;biological regulation | GO:1904355;positive regulation of telomere capping | 160 | 88 | 31 | 62 | 1 | 8 | 30 |
| BP | GO:0065007;biological regulation | GO:0090141;positive regulation of mitochondrial fission | 68 | 25 | 5 | 17 | 0 | 3 | 21 |
| BP | GO:0009987;cellular process | GO:0043062;extracellular structure organization | 390 | 213 | 58 | 126 | 0 | 13 | 116 |
| BP | GO:0009987;cellular process | GO:0045229;external encapsulating structure organization | 386 | 209 | 57 | 123 | 0 | 13 | 115 |
| BP | GO:0065007;biological regulation | GO:0035584;calcium-mediated signaling using intracellular calcium source | 96 | 38 | 5 | 29 | 0 | 3 | 23 |
| BP | GO:0008152;metabolic process | GO:0031293;membrane protein intracellular domain proteolysis | 196 | 76 | 7 | 58 | 0 | 6 | 48 |
| BP | GO:0065007;biological regulation | GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 101 | 38 | 4 | 31 | 0 | 3 | 21 |
| BP | GO:0065007;biological regulation | GO:1901099;negative regulation of signal transduction in absence of ligand | 101 | 38 | 4 | 31 | 0 | 3 | 21 |
| BP | GO:0065007;biological regulation | GO:1904353;regulation of telomere capping | 100 | 67 | 21 | 45 | 1 | 8 | 16 |
| BP | GO:0065007;biological regulation | GO:0090140;regulation of mitochondrial fission | 79 | 36 | 5 | 25 | 0 | 3 | 22 |
| BP | GO:0065007;biological regulation | GO:2001239;regulation of extrinsic apoptotic signaling pathway in absence of ligand | 99 | 36 | 3 | 30 | 0 | 2 | 21 |
| BP | GO:0009987;cellular process | GO:0071354;cellular response to interleukin-6 | 246 | 90 | 10 | 64 | 0 | 8 | 75 |
| BP | GO:0065007;biological regulation | GO:0043393;regulation of protein binding | 39 | 14 | 1 | 13 | 0 | 2 | 12 |
| BP | GO:0002376;immune system process | GO:0002220;innate immune response activating cell surface receptor signaling pathway | 136 | 46 | 0 | 39 | 0 | 3 | 41 |
| BP | GO:0065007;biological regulation | GO:0030890;positive regulation of B cell proliferation | 11 | 4 | 1 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000147;positive regulation of cell motility | 441 | 172 | 15 | 131 | 0 | 7 | 115 |
| BP | GO:0050896;response to stimulus | GO:0071560;cellular response to transforming growth factor beta stimulus | 111 | 39 | 3 | 23 | 0 | 1 | 36 |
| BP | GO:0065007;biological regulation | GO:0150117;positive regulation of cell-substrate junction organization | 131 | 48 | 4 | 29 | 0 | 1 | 39 |
| BP | GO:0065007;biological regulation | GO:0010557;positive regulation of macromolecule biosynthetic process | 118 | 48 | 5 | 31 | 0 | 1 | 36 |
| BP | GO:0065007;biological regulation | GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway | 84 | 29 | 3 | 16 | 0 | 1 | 29 |
| BP | GO:0065007;biological regulation | GO:2000352;negative regulation of endothelial cell apoptotic process | 105 | 40 | 4 | 25 | 0 | 2 | 28 |
| BP | GO:0065007;biological regulation | GO:0045429;positive regulation of nitric oxide biosynthetic process | 107 | 40 | 3 | 28 | 0 | 1 | 30 |
| BP | GO:0009987;cellular process | GO:0097061;dendritic spine organization | 107 | 43 | 4 | 27 | 0 | 1 | 28 |
| BP | GO:0065007;biological regulation | GO:0031116;positive regulation of microtubule polymerization | 106 | 42 | 3 | 29 | 0 | 1 | 29 |
| BP | GO:0065007;biological regulation | GO:1904407;positive regulation of nitric oxide metabolic process | 102 | 38 | 3 | 26 | 0 | 1 | 30 |
| BP | GO:0065007;biological regulation | GO:0045937;positive regulation of phosphate metabolic process | 221 | 125 | 91 | 68 | 0 | 7 | 41 |
| BP | GO:0008152;metabolic process | GO:0006287;base-excision repair, gap-filling | 222 | 84 | 7 | 57 | 0 | 4 | 49 |
| BP | GO:0065007;biological regulation | GO:1904036;negative regulation of epithelial cell apoptotic process | 108 | 45 | 5 | 38 | 1 | 3 | 29 |
| BP | GO:0009987;cellular process | GO:0034622;cellular protein-containing complex assembly | 48 | 19 | 3 | 11 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:0045428;regulation of nitric oxide biosynthetic process | 76 | 29 | 3 | 20 | 0 | 1 | 24 |
| BP | GO:0008152;metabolic process | GO:0019985;translesion synthesis | 52 | 19 | 3 | 10 | 0 | 0 | 15 |
| BP | GO:0008152;metabolic process | GO:0000731;DNA synthesis involved in DNA repair | 53 | 19 | 3 | 11 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:0001954;positive regulation of cell-matrix adhesion | 60 | 23 | 2 | 10 | 0 | 0 | 17 |
| BP | GO:0065007;biological regulation | GO:2000351;regulation of endothelial cell apoptotic process | 134 | 46 | 7 | 31 | 1 | 2 | 34 |
| BP | GO:0065007;biological regulation | GO:0006282;regulation of DNA repair | 122 | 43 | 4 | 38 | 0 | 1 | 27 |
| BP | GO:0008152;metabolic process | GO:0006301;postreplication repair | 32 | 12 | 2 | 5 | 0 | 0 | 7 |
| BP | GO:0008152;metabolic process | GO:0006284;base-excision repair | 135 | 54 | 5 | 32 | 0 | 3 | 23 |
| BP | GO:0032502;developmental process | GO:0002040;sprouting angiogenesis | 18 | 9 | 1 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:2000117;negative regulation of cysteine-type endopeptidase activity | 53 | 23 | 5 | 11 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:1901890;positive regulation of cell junction assembly | 11 | 7 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:1901653;cellular response to peptide | 145 | 58 | 14 | 38 | 0 | 5 | 50 |
| BP | GO:0065007;biological regulation | GO:0070372;regulation of ERK1 and ERK2 cascade | 338 | 187 | 108 | 91 | 0 | 12 | 85 |
| BP | GO:0065007;biological regulation | GO:2001243;negative regulation of intrinsic apoptotic signaling pathway | 56 | 25 | 2 | 16 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway | 9 | 6 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0042592;homeostatic process | GO:0033500;carbohydrate homeostasis | 42 | 17 | 0 | 7 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0035023;regulation of Rho protein signal transduction | 7 | 5 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0008286;insulin receptor signaling pathway | 24 | 8 | 0 | 5 | 0 | 0 | 10 |
| BP | GO:0008152;metabolic process | GO:0009251;glucan catabolic process | 5 | 4 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0044247;cellular polysaccharide catabolic process | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051782;negative regulation of cell division | 240 | 95 | 10 | 69 | 1 | 4 | 43 |
| BP | GO:0032502;developmental process | GO:0035162;embryonic hemopoiesis | 43 | 14 | 2 | 14 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:0002710;negative regulation of T cell mediated immunity | 136 | 39 | 5 | 42 | 1 | 5 | 30 |
| BP | GO:0008152;metabolic process | GO:0005980;glycogen catabolic process | 3 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0006268;DNA unwinding involved in DNA replication | 162 | 64 | 3 | 53 | 1 | 4 | 34 |
| BP | GO:0009987;cellular process | GO:0071312;cellular response to alkaloid | 111 | 61 | 11 | 29 | 0 | 8 | 23 |
| BP | GO:0050896;response to stimulus | GO:0070542;response to fatty acid | 116 | 47 | 6 | 46 | 0 | 5 | 29 |
| BP | GO:0008152;metabolic process | GO:0042438;melanin biosynthetic process | 267 | 77 | 4 | 67 | 1 | 6 | 68 |
| BP | GO:0065007;biological regulation | GO:0002840;regulation of T cell mediated immune response to tumor cell | 190 | 48 | 4 | 45 | 1 | 4 | 50 |
| BP | GO:0032502;developmental process | GO:0008406;gonad development | 85 | 35 | 4 | 30 | 0 | 0 | 24 |
| BP | GO:0065007;biological regulation | GO:0010971;positive regulation of G2/M transition of mitotic cell cycle | 58 | 33 | 3 | 20 | 0 | 2 | 6 |
| BP | GO:0065007;biological regulation | GO:1902751;positive regulation of cell cycle G2/M phase transition | 50 | 26 | 3 | 19 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:0032689;negative regulation of interferon-gamma production | 164 | 55 | 2 | 48 | 0 | 6 | 36 |
| BP | GO:0032501;multicellular organismal process | GO:0046651;lymphocyte proliferation | 83 | 32 | 2 | 25 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:0061097;regulation of protein tyrosine kinase activity | 104 | 51 | 11 | 40 | 0 | 4 | 20 |
| BP | GO:0032501;multicellular organismal process | GO:0030101;natural killer cell activation | 24 | 9 | 1 | 10 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0030888;regulation of B cell proliferation | 59 | 12 | 4 | 15 | 1 | 2 | 13 |
| BP | GO:0065007;biological regulation | GO:1901992;positive regulation of mitotic cell cycle phase transition | 23 | 13 | 0 | 8 | 0 | 0 | 3 |
| BP | GO:0050896;response to stimulus | GO:0034097;response to cytokine | 144 | 54 | 19 | 49 | 0 | 2 | 31 |
| BP | GO:0050896;response to stimulus | GO:0009411;response to UV | 170 | 55 | 2 | 48 | 0 | 3 | 42 |
| BP | GO:0009987;cellular process | GO:0071375;cellular response to peptide hormone stimulus | 256 | 118 | 22 | 73 | 0 | 5 | 68 |
| BP | GO:0050896;response to stimulus | GO:1901652;response to peptide | 310 | 161 | 27 | 99 | 0 | 11 | 91 |
| BP | GO:0065007;biological regulation | GO:0045913;positive regulation of carbohydrate metabolic process | 394 | 203 | 84 | 120 | 1 | 11 | 107 |
| BP | GO:0009987;cellular process | GO:0035987;endodermal cell differentiation | 264 | 120 | 16 | 80 | 0 | 10 | 77 |
| BP | GO:0032502;developmental process | GO:0001706;endoderm formation | 235 | 107 | 11 | 73 | 0 | 8 | 67 |
| BP | GO:0065007;biological regulation | GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 138 | 60 | 6 | 36 | 0 | 4 | 38 |
| BP | GO:0065007;biological regulation | GO:1904904;regulation of endothelial cell-matrix adhesion via fibronectin | 175 | 58 | 5 | 39 | 0 | 2 | 35 |
| BP | GO:0065007;biological regulation | GO:1900122;positive regulation of receptor binding | 86 | 35 | 5 | 22 | 0 | 4 | 25 |
| BP | GO:0009987;cellular process | GO:0071472;cellular response to salt stress | 53 | 17 | 1 | 12 | 0 | 0 | 11 |
| BP | GO:0009987;cellular process | GO:0071474;cellular hyperosmotic response | 33 | 9 | 1 | 6 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:0009804;coumarin metabolic process | 96 | 46 | 2 | 34 | 1 | 1 | 42 |
| BP | GO:0009987;cellular process | GO:1904322;cellular response to forskolin | 85 | 18 | 2 | 23 | 1 | 2 | 28 |
| BP | GO:0050896;response to stimulus | GO:1904321;response to forskolin | 86 | 19 | 3 | 23 | 1 | 3 | 28 |
| BP | GO:0008152;metabolic process | GO:0046189;phenol-containing compound biosynthetic process | 111 | 25 | 2 | 29 | 1 | 1 | 37 |
| BP | GO:0008152;metabolic process | GO:0006570;tyrosine metabolic process | 92 | 18 | 2 | 24 | 1 | 1 | 30 |
| BP | GO:0008152;metabolic process | GO:0006809;nitric oxide biosynthetic process | 212 | 82 | 8 | 55 | 1 | 5 | 49 |
| BP | GO:0008152;metabolic process | GO:0046209;nitric oxide metabolic process | 194 | 76 | 8 | 51 | 1 | 5 | 47 |
| BP | GO:0065007;biological regulation | GO:0050670;regulation of lymphocyte proliferation | 59 | 10 | 2 | 17 | 1 | 1 | 18 |
| BP | GO:0008152;metabolic process | GO:0006643;membrane lipid metabolic process | 161 | 54 | 3 | 38 | 1 | 2 | 44 |
| BP | GO:0065007;biological regulation | GO:0019933;cAMP-mediated signaling | 47 | 9 | 2 | 13 | 1 | 1 | 17 |
| BP | GO:0032502;developmental process | GO:0043010;camera-type eye development | 129 | 51 | 3 | 28 | 1 | 1 | 35 |
| BP | GO:0008152;metabolic process | GO:0044242;cellular lipid catabolic process | 124 | 53 | 5 | 30 | 1 | 3 | 33 |
| BP | GO:0065007;biological regulation | GO:0050864;regulation of B cell activation | 46 | 8 | 2 | 12 | 1 | 1 | 16 |
| BP | GO:0008152;metabolic process | GO:0044271;cellular nitrogen compound biosynthetic process | 120 | 48 | 4 | 29 | 1 | 3 | 30 |
| BP | GO:0009987;cellular process | GO:0071320;cellular response to cAMP | 44 | 7 | 2 | 12 | 1 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:1904894;positive regulation of receptor signaling pathway via STAT | 129 | 52 | 3 | 25 | 1 | 2 | 31 |
| BP | GO:0065007;biological regulation | GO:0046427;positive regulation of receptor signaling pathway via JAK-STAT | 120 | 46 | 3 | 24 | 1 | 2 | 29 |
| BP | GO:0065007;biological regulation | GO:0019935;cyclic-nucleotide-mediated signaling | 74 | 23 | 4 | 21 | 1 | 3 | 21 |
| BP | GO:0050896;response to stimulus | GO:0051591;response to cAMP | 42 | 6 | 2 | 11 | 1 | 1 | 14 |
| BP | GO:0009987;cellular process | GO:1901655;cellular response to ketone | 127 | 36 | 10 | 35 | 1 | 4 | 39 |
| BP | GO:0008152;metabolic process | GO:0019752;carboxylic acid metabolic process | 147 | 50 | 6 | 39 | 1 | 4 | 34 |
| BP | GO:0009987;cellular process | GO:0101024;mitotic nuclear membrane organization | 180 | 61 | 2 | 57 | 1 | 7 | 44 |
| BP | GO:0009987;cellular process | GO:0007084;mitotic nuclear membrane reassembly | 179 | 60 | 2 | 56 | 1 | 7 | 44 |
| BP | GO:0065007;biological regulation | GO:0036498;IRE1-mediated unfolded protein response | 54 | 9 | 0 | 12 | 1 | 1 | 20 |
| BP | GO:0009987;cellular process | GO:0031468;nuclear membrane reassembly | 176 | 57 | 2 | 55 | 1 | 7 | 44 |
| MF | GO:0003824;catalytic activity | GO:0008395;steroid hydroxylase activity | 173 | 55 | 2 | 41 | 1 | 4 | 36 |
| MF | GO:0003824;catalytic activity | GO:0101020;estrogen 16-alpha-hydroxylase activity | 216 | 66 | 3 | 53 | 1 | 5 | 49 |
| MF | GO:0003824;catalytic activity | GO:0016836;hydro-lyase activity | 206 | 79 | 5 | 59 | 2 | 3 | 45 |
| MF | GO:0003824;catalytic activity | GO:0004089;carbonate dehydratase activity | 201 | 78 | 4 | 57 | 2 | 3 | 43 |
| BP | GO:0003824;catalytic activity | GO:1903506;regulation of nucleic acid-templated transcription | 122 | 52 | 7 | 33 | 1 | 3 | 18 |
| BP | GO:0065007;biological regulation | GO:0043401;steroid hormone mediated signaling pathway | 341 | 164 | 41 | 87 | 1 | 6 | 66 |
| BP | GO:0065007;biological regulation | GO:0045944;positive regulation of transcription by RNA polymerase II | 215 | 100 | 22 | 65 | 2 | 6 | 42 |
| BP | GO:0065007;biological regulation | GO:0051302;regulation of cell division | 139 | 59 | 10 | 44 | 1 | 4 | 21 |
| BP | GO:0065007;biological regulation | GO:1903798;regulation of production of miRNAs involved in gene silencing by miRNA | 210 | 103 | 35 | 57 | 1 | 5 | 33 |
| BP | GO:0065007;biological regulation | GO:0030520;intracellular estrogen receptor signaling pathway | 299 | 129 | 34 | 71 | 1 | 6 | 59 |
| BP | GO:0009987;cellular process | GO:0071392;cellular response to estradiol stimulus | 127 | 60 | 13 | 34 | 1 | 3 | 15 |
| BP | GO:0009987;cellular process | GO:0007095;mitotic G2 DNA damage checkpoint signaling | 73 | 26 | 1 | 14 | 0 | 0 | 12 |
| BP | GO:0008152;metabolic process | GO:0016579;protein deubiquitination | 138 | 57 | 7 | 36 | 0 | 1 | 36 |
| BP | GO:0008152;metabolic process | GO:0070646;protein modification by small protein removal | 132 | 53 | 7 | 33 | 0 | 1 | 34 |
| BP | GO:0065007;biological regulation | GO:0001961;positive regulation of cytokine-mediated signaling pathway | 268 | 90 | 5 | 79 | 0 | 3 | 71 |
| BP | GO:0050896;response to stimulus | GO:0006954;inflammatory response | 222 | 113 | 13 | 80 | 1 | 6 | 57 |
| BP | GO:0065007;biological regulation | GO:1903238;positive regulation of leukocyte tethering or rolling | 101 | 38 | 3 | 30 | 0 | 2 | 23 |
| BP | GO:0008152;metabolic process | GO:1901566;organonitrogen compound biosynthetic process | 118 | 46 | 4 | 27 | 0 | 4 | 33 |
| BP | GO:0008152;metabolic process | GO:0046474;glycerophospholipid biosynthetic process | 187 | 76 | 2 | 46 | 0 | 4 | 47 |
| BP | GO:0008152;metabolic process | GO:0006144;purine nucleobase metabolic process | 138 | 55 | 4 | 33 | 0 | 5 | 37 |
| BP | GO:0065007;biological regulation | GO:1903054;negative regulation of extracellular matrix organization | 253 | 111 | 7 | 63 | 1 | 6 | 52 |
| BP | GO:0065007;biological regulation | GO:0033632;regulation of cell-cell adhesion mediated by integrin | 254 | 111 | 7 | 64 | 1 | 6 | 54 |
| BP | GO:0009987;cellular process | GO:0030219;megakaryocyte differentiation | 90 | 37 | 3 | 14 | 0 | 3 | 19 |
| BP | GO:0008152;metabolic process | GO:0042136;neurotransmitter biosynthetic process | 273 | 133 | 56 | 54 | 0 | 11 | 66 |
| BP | GO:0065007;biological regulation | GO:0010715;regulation of extracellular matrix disassembly | 141 | 68 | 2 | 34 | 1 | 3 | 28 |
| BP | GO:0009987;cellular process | GO:0071243;cellular response to arsenic-containing substance | 83 | 39 | 1 | 18 | 0 | 1 | 22 |
| BP | GO:0008152;metabolic process | GO:0042982;amyloid precursor protein metabolic process | 146 | 62 | 2 | 31 | 0 | 3 | 37 |
| BP | GO:0065007;biological regulation | GO:0007271;synaptic transmission, cholinergic | 120 | 57 | 1 | 28 | 0 | 2 | 31 |
| BP | GO:0065007;biological regulation | GO:0046887;positive regulation of hormone secretion | 97 | 49 | 15 | 23 | 0 | 2 | 25 |
| BP | GO:0032502;developmental process | GO:0008585;female gonad development | 72 | 30 | 0 | 13 | 0 | 2 | 21 |
| BP | GO:0009987;cellular process | GO:0097696;receptor signaling pathway via STAT | 59 | 28 | 0 | 8 | 0 | 1 | 16 |
| BP | GO:0065007;biological regulation | GO:0090022;regulation of neutrophil chemotaxis | 75 | 42 | 1 | 16 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:1903051;negative regulation of proteolysis involved in cellular protein catabolic process | 60 | 27 | 0 | 11 | 0 | 1 | 18 |
| BP | GO:0009987;cellular process | GO:0007076;mitotic chromosome condensation | 328 | 112 | 4 | 88 | 0 | 6 | 91 |
| BP | GO:0009987;cellular process | GO:0097435;supramolecular fiber organization | 57 | 24 | 2 | 11 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:2000059;negative regulation of ubiquitin-dependent protein catabolic process | 39 | 16 | 0 | 10 | 0 | 0 | 13 |
| BP | GO:0065007;biological regulation | GO:0060054;positive regulation of epithelial cell proliferation involved in wound healing | 81 | 34 | 4 | 18 | 0 | 2 | 15 |
| BP | GO:0009987;cellular process | GO:0035313;wound healing, spreading of epidermal cells | 81 | 34 | 4 | 18 | 0 | 2 | 15 |
| BP | GO:0008152;metabolic process | GO:0050667;homocysteine metabolic process | 51 | 19 | 4 | 9 | 0 | 2 | 6 |
| MF | GO:0003824;catalytic activity | GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 129 | 48 | 2 | 33 | 0 | 2 | 26 |
| MF | GO:0005488;binding | GO:0020037;heme binding | 109 | 36 | 3 | 27 | 0 | 2 | 22 |
| MF | GO:0005488;binding | GO:0051879;Hsp90 protein binding | 140 | 42 | 2 | 31 | 0 | 4 | 28 |
| MF | GO:0003824;catalytic activity | GO:0101021;estrogen 2-hydroxylase activity | 138 | 50 | 4 | 32 | 0 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:0019228;neuronal action potential | 8 | 6 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086010;membrane depolarization during action potential | 8 | 6 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0051899;membrane depolarization | 7 | 5 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0001508;action potential | 7 | 5 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0035725;sodium ion transmembrane transport | 55 | 26 | 19 | 12 | 0 | 2 | 18 |
| BP | GO:0051179;localization | GO:0006814;sodium ion transport | 70 | 28 | 20 | 13 | 0 | 2 | 17 |
| BP | GO:0051179;localization | GO:0006812;cation transport | 32 | 9 | 0 | 9 | 0 | 0 | 9 |
| BP | GO:0051179;localization | GO:0098662;inorganic cation transmembrane transport | 14 | 10 | 5 | 3 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0090218;positive regulation of lipid kinase activity | 97 | 42 | 1 | 30 | 0 | 2 | 19 |
| BP | GO:0065007;biological regulation | GO:1903580;positive regulation of ATP metabolic process | 211 | 94 | 31 | 65 | 1 | 4 | 56 |
| BP | GO:0008152;metabolic process | GO:0006310;DNA recombination | 50 | 25 | 4 | 22 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0030195;negative regulation of blood coagulation | 34 | 13 | 0 | 15 | 0 | 2 | 8 |
| BP | GO:0065007;biological regulation | GO:1900015;regulation of cytokine production involved in inflammatory response | 118 | 37 | 3 | 36 | 1 | 3 | 32 |
| BP | GO:0065007;biological regulation | GO:0030518;intracellular steroid hormone receptor signaling pathway | 175 | 86 | 16 | 58 | 1 | 6 | 31 |
| BP | GO:0009987;cellular process | GO:0038003;G protein-coupled opioid receptor signaling pathway | 42 | 19 | 1 | 10 | 0 | 3 | 17 |
| BP | GO:0009987;cellular process | GO:0007218;neuropeptide signaling pathway | 12 | 4 | 0 | 3 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0019934;cGMP-mediated signaling | 42 | 24 | 2 | 13 | 0 | 3 | 12 |
| BP | GO:0032501;multicellular organismal process | GO:0019233;sensory perception of pain | 19 | 9 | 1 | 7 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0043268;positive regulation of potassium ion transport | 9 | 8 | 1 | 5 | 0 | 1 | 6 |
| BP | GO:0065007;biological regulation | GO:0010863;positive regulation of phospholipase C activity | 139 | 73 | 13 | 37 | 1 | 6 | 23 |
| BP | GO:0032501;multicellular organismal process | GO:0007600;sensory perception | 17 | 10 | 0 | 8 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0071902;positive regulation of protein serine/threonine kinase activity | 91 | 37 | 2 | 25 | 0 | 4 | 25 |
| BP | GO:0051179;localization | GO:0006837;serotonin transport | 15 | 9 | 5 | 4 | 0 | 2 | 5 |
| BP | GO:0051179;localization | GO:0051610;serotonin uptake | 14 | 8 | 4 | 4 | 0 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:0044057;regulation of system process | 19 | 15 | 1 | 5 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0060161;positive regulation of dopamine receptor signaling pathway | 57 | 27 | 2 | 12 | 0 | 2 | 22 |
| BP | GO:0065007;biological regulation | GO:0098915;membrane repolarization during ventricular cardiac muscle cell action potential | 5 | 4 | 0 | 3 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0046621;negative regulation of organ growth | 11 | 9 | 6 | 3 | 0 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:0001817;regulation of cytokine production | 5 | 5 | 0 | 3 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0046877;regulation of saliva secretion | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0044058;regulation of digestive system process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0002031;G protein-coupled receptor internalization | 9 | 6 | 1 | 4 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0048715;negative regulation of oligodendrocyte differentiation | 9 | 6 | 1 | 4 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:1903764;regulation of potassium ion export across plasma membrane | 4 | 3 | 0 | 2 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0098810;neurotransmitter reuptake | 10 | 6 | 1 | 3 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0099625;ventricular cardiac muscle cell membrane repolarization | 3 | 3 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0051179;localization | GO:0015844;monoamine transport | 73 | 60 | 63 | 8 | 0 | 6 | 17 |
| BP | GO:0051179;localization | GO:0046717;acid secretion | 7 | 5 | 1 | 3 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0045686;negative regulation of glial cell differentiation | 6 | 4 | 1 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0046620;regulation of organ growth | 2 | 2 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0002029;desensitization of G protein-coupled receptor signaling pathway | 21 | 7 | 0 | 4 | 0 | 2 | 6 |
| BP | GO:0032501;multicellular organismal process | GO:0042310;vasoconstriction | 8 | 8 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1901380;negative regulation of potassium ion transmembrane transport | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0070528;protein kinase C signaling | 8 | 8 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0048854;brain morphogenesis | 2 | 2 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045744;negative regulation of G protein-coupled receptor signaling pathway | 105 | 49 | 13 | 34 | 0 | 3 | 26 |
| BP | GO:0065007;biological regulation | GO:1903902;positive regulation of viral life cycle | 36 | 12 | 1 | 14 | 0 | 1 | 8 |
| BP | GO:0065007;biological regulation | GO:0010564;regulation of cell cycle process | 125 | 36 | 2 | 34 | 0 | 3 | 38 |
| BP | GO:0065007;biological regulation | GO:0031113;regulation of microtubule polymerization | 72 | 43 | 11 | 25 | 0 | 4 | 12 |
| BP | GO:0009987;cellular process | GO:0043620;regulation of DNA-templated transcription in response to stress | 150 | 44 | 2 | 50 | 0 | 4 | 40 |
| BP | GO:0050896;response to stimulus | GO:1903350;response to dopamine | 118 | 75 | 22 | 44 | 0 | 1 | 26 |
| BP | GO:0009987;cellular process | GO:1903351;cellular response to dopamine | 120 | 77 | 23 | 45 | 0 | 1 | 25 |
| BP | GO:0065007;biological regulation | GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling | 85 | 30 | 2 | 32 | 0 | 4 | 22 |
| BP | GO:0065007;biological regulation | GO:1904994;regulation of leukocyte adhesion to vascular endothelial cell | 190 | 58 | 2 | 61 | 0 | 6 | 46 |
| BP | GO:0050896;response to stimulus | GO:0010224;response to UV-B | 75 | 20 | 0 | 28 | 0 | 2 | 22 |
| BP | GO:0009987;cellular process | GO:0071404;cellular response to low-density lipoprotein particle stimulus | 116 | 41 | 0 | 43 | 0 | 2 | 29 |
| BP | GO:0051179;localization | GO:0043252;sodium-independent organic anion transport | 64 | 36 | 3 | 21 | 0 | 2 | 18 |
| BP | GO:0008152;metabolic process | GO:0033619;membrane protein proteolysis | 98 | 40 | 2 | 30 | 0 | 1 | 29 |
| BP | GO:0065007;biological regulation | GO:0045892;negative regulation of transcription, DNA-templated | 108 | 46 | 7 | 40 | 0 | 2 | 26 |
| BP | GO:0065007;biological regulation | GO:0032479;regulation of type I interferon production | 44 | 19 | 0 | 15 | 0 | 0 | 11 |
| BP | GO:0050896;response to stimulus | GO:0140546;defense response to symbiont | 115 | 35 | 2 | 30 | 0 | 3 | 31 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0051607;defense response to virus | 110 | 34 | 2 | 29 | 0 | 3 | 30 |
| BP | GO:0008152;metabolic process | GO:0016311;dephosphorylation | 48 | 18 | 0 | 17 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:0051092;positive regulation of NF-kappaB transcription factor activity | 54 | 24 | 2 | 21 | 0 | 1 | 13 |
| BP | GO:0050896;response to stimulus | GO:0033273;response to vitamin | 102 | 32 | 1 | 33 | 0 | 2 | 29 |
| BP | GO:0050896;response to stimulus | GO:0033280;response to vitamin D | 102 | 32 | 1 | 33 | 0 | 2 | 29 |
| BP | GO:0065007;biological regulation | GO:2000615;regulation of histone H3-K9 acetylation | 15 | 10 | 3 | 6 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0051571;positive regulation of histone H3-K4 methylation | 17 | 11 | 2 | 6 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0097193;intrinsic apoptotic signaling pathway | 25 | 15 | 0 | 11 | 0 | 3 | 12 |
| BP | GO:0065007;biological regulation | GO:0051569;regulation of histone H3-K4 methylation | 14 | 9 | 0 | 5 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0031062;positive regulation of histone methylation | 10 | 7 | 0 | 4 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0043153;entrainment of circadian clock by photoperiod | 16 | 7 | 0 | 8 | 0 | 0 | 9 |
| BP | GO:0050896;response to stimulus | GO:0009648;photoperiodism | 16 | 7 | 0 | 8 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0035065;regulation of histone acetylation | 19 | 15 | 2 | 11 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage | 17 | 10 | 1 | 7 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0006915;apoptotic process | 12 | 9 | 3 | 2 | 0 | 0 | 2 |
| BP | GO:0050896;response to stimulus | GO:0010212;response to ionizing radiation | 18 | 14 | 1 | 9 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0032088;negative regulation of NF-kappaB transcription factor activity | 63 | 22 | 1 | 17 | 0 | 1 | 21 |
| BP | GO:0065007;biological regulation | GO:0043068;positive regulation of programmed cell death | 34 | 15 | 0 | 10 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:0043065;positive regulation of apoptotic process | 12 | 6 | 0 | 6 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:2000617;positive regulation of histone H3-K9 acetylation | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0050896;response to stimulus | GO:0071680;response to indole-3-methanol | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0071681;cellular response to indole-3-methanol | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:2000618;regulation of histone H4-K16 acetylation | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0051573;negative regulation of histone H3-K9 methylation | 32 | 13 | 0 | 11 | 0 | 1 | 9 |
| BP | GO:0032501;multicellular organismal process | GO:0098596;imitative learning | 29 | 12 | 0 | 9 | 0 | 0 | 16 |
| BP | GO:0032501;multicellular organismal process | GO:0042297;vocal learning | 29 | 12 | 0 | 9 | 0 | 0 | 16 |
| BP | GO:0009987;cellular process | GO:0043933;protein-containing complex subunit organization | 26 | 9 | 0 | 6 | 0 | 0 | 15 |
| BP | GO:0065007;biological regulation | GO:0046600;negative regulation of centriole replication | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0090240;positive regulation of histone H4 acetylation | 5 | 4 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0044648;histone H3-K4 dimethylation | 10 | 7 | 1 | 4 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:0097692;histone H3-K4 monomethylation | 8 | 5 | 1 | 3 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:1903599;positive regulation of autophagy of mitochondrion | 27 | 11 | 0 | 8 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:1903265;positive regulation of tumor necrosis factor-mediated signaling pathway | 4 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0085020;protein K6-linked ubiquitination | 4 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0030336;negative regulation of cell migration | 38 | 22 | 0 | 12 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:2000757;negative regulation of peptidyl-lysine acetylation | 47 | 21 | 1 | 15 | 0 | 0 | 18 |
| BP | GO:0065007;biological regulation | GO:0044030;regulation of DNA methylation | 7 | 4 | 1 | 2 | 0 | 0 | 3 |
| BP | GO:0032501;multicellular organismal process | GO:0030183;B cell differentiation | 19 | 6 | 0 | 6 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0042113;B cell activation | 21 | 7 | 0 | 7 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0045860;positive regulation of protein kinase activity | 34 | 12 | 2 | 6 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0051099;positive regulation of binding | 61 | 33 | 4 | 18 | 0 | 1 | 20 |
| BP | GO:0009987;cellular process | GO:0007215;glutamate receptor signaling pathway | 143 | 112 | 127 | 26 | 0 | 8 | 22 |
| BP | GO:0065007;biological regulation | GO:0050804;modulation of chemical synaptic transmission | 143 | 112 | 127 | 26 | 0 | 8 | 22 |
| BP | GO:0065007;biological regulation | GO:0007216;G protein-coupled glutamate receptor signaling pathway | 141 | 110 | 124 | 26 | 0 | 7 | 21 |
| BP | GO:0065007;biological regulation | GO:0035249;synaptic transmission, glutamatergic | 135 | 105 | 119 | 24 | 0 | 6 | 21 |
| BP | GO:0065007;biological regulation | GO:0099177;regulation of trans-synaptic signaling | 131 | 103 | 115 | 24 | 0 | 5 | 20 |
| BP | GO:0065007;biological regulation | GO:0033673;negative regulation of kinase activity | 39 | 28 | 20 | 13 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0070302;regulation of stress-activated protein kinase signaling cascade | 130 | 84 | 63 | 35 | 0 | 2 | 19 |
| BP | GO:0065007;biological regulation | GO:0006469;negative regulation of protein kinase activity | 22 | 15 | 13 | 7 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:1905606;regulation of presynapse assembly | 85 | 57 | 55 | 29 | 0 | 1 | 21 |
| BP | GO:0065007;biological regulation | GO:0099174;regulation of presynapse organization | 83 | 56 | 54 | 27 | 0 | 1 | 20 |
| BP | GO:0008152;metabolic process | GO:0006692;prostanoid metabolic process | 111 | 69 | 40 | 31 | 0 | 1 | 28 |
| BP | GO:0065007;biological regulation | GO:0051173;positive regulation of nitrogen compound metabolic process | 123 | 71 | 38 | 33 | 0 | 3 | 33 |
| BP | GO:0032501;multicellular organismal process | GO:0001774;microglial cell activation | 96 | 68 | 55 | 34 | 0 | 1 | 25 |
| BP | GO:0065007;biological regulation | GO:0045859;regulation of protein kinase activity | 16 | 12 | 10 | 6 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0010800;positive regulation of peptidyl-threonine phosphorylation | 63 | 47 | 45 | 24 | 0 | 2 | 10 |
| BP | GO:0009987;cellular process | GO:0071276;cellular response to cadmium ion | 206 | 161 | 108 | 62 | 0 | 11 | 38 |
| BP | GO:0065007;biological regulation | GO:0045931;positive regulation of mitotic cell cycle | 18 | 7 | 3 | 11 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0031098;stress-activated protein kinase signaling cascade | 124 | 62 | 37 | 31 | 0 | 4 | 33 |
| BP | GO:0050896;response to stimulus | GO:0046686;response to cadmium ion | 190 | 150 | 104 | 57 | 0 | 11 | 35 |
| BP | GO:0065007;biological regulation | GO:0034248;regulation of cellular amide metabolic process | 47 | 27 | 8 | 24 | 0 | 3 | 11 |
| BP | GO:0065007;biological regulation | GO:2000310;regulation of NMDA receptor activity | 23 | 14 | 18 | 4 | 0 | 0 | 3 |
| BP | GO:0032501;multicellular organismal process | GO:0042116;macrophage activation | 58 | 41 | 35 | 23 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0001933;negative regulation of protein phosphorylation | 9 | 7 | 6 | 6 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010799;regulation of peptidyl-threonine phosphorylation | 39 | 27 | 29 | 14 | 0 | 2 | 7 |
| BP | GO:0065007;biological regulation | GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling | 60 | 32 | 21 | 16 | 0 | 2 | 8 |
| BP | GO:0065007;biological regulation | GO:0032720;negative regulation of tumor necrosis factor production | 15 | 12 | 7 | 9 | 0 | 2 | 0 |
| BP | GO:0065007;biological regulation | GO:0051963;regulation of synapse assembly | 33 | 21 | 23 | 13 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:1903556;negative regulation of tumor necrosis factor superfamily cytokine production | 15 | 12 | 7 | 9 | 0 | 2 | 0 |
| BP | GO:0065007;biological regulation | GO:0032268;regulation of cellular protein metabolic process | 65 | 30 | 17 | 18 | 0 | 2 | 13 |
| BP | GO:0065007;biological regulation | GO:0070373;negative regulation of ERK1 and ERK2 cascade | 7 | 6 | 5 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031327;negative regulation of cellular biosynthetic process | 52 | 18 | 12 | 16 | 1 | 1 | 13 |
| BP | GO:0065007;biological regulation | GO:0001960;negative regulation of cytokine-mediated signaling pathway | 7 | 5 | 5 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0099601;regulation of neurotransmitter receptor activity | 16 | 8 | 12 | 3 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0000413;protein peptidyl-prolyl isomerization | 5 | 5 | 1 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0018208;peptidyl-proline modification | 5 | 5 | 1 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:1990000;amyloid fibril formation | 126 | 64 | 33 | 40 | 0 | 2 | 33 |
| BP | GO:0065007;biological regulation | GO:0010523;negative regulation of calcium ion transport into cytosol | 8 | 7 | 1 | 3 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0051280;negative regulation of release of sequestered calcium ion into cytosol | 5 | 5 | 1 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity | 5 | 5 | 1 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0006787;porphyrin-containing compound catabolic process | 75 | 36 | 4 | 29 | 0 | 2 | 20 |
| BP | GO:0008152;metabolic process | GO:0042167;heme catabolic process | 75 | 36 | 4 | 29 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0035308;negative regulation of protein dephosphorylation | 3 | 3 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032515;negative regulation of phosphoprotein phosphatase activity | 3 | 3 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity | 4 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0062197;cellular response to chemical stress | 36 | 27 | 19 | 11 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:1903900;regulation of viral life cycle | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0019722;calcium-mediated signaling | 17 | 9 | 1 | 7 | 0 | 1 | 8 |
| BP | GO:0008152;metabolic process | GO:0006699;bile acid biosynthetic process | 5 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010923;negative regulation of phosphatase activity | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032273;positive regulation of protein polymerization | 46 | 21 | 2 | 14 | 0 | 3 | 7 |
| BP | GO:0065007;biological regulation | GO:1902905;positive regulation of supramolecular fiber organization | 59 | 36 | 14 | 19 | 0 | 3 | 13 |
| BP | GO:0065007;biological regulation | GO:0051972;regulation of telomerase activity | 198 | 94 | 19 | 57 | 1 | 7 | 50 |
| BP | GO:0065007;biological regulation | GO:0031331;positive regulation of cellular catabolic process | 94 | 44 | 23 | 27 | 0 | 1 | 32 |
| BP | GO:0065007;biological regulation | GO:0051769;regulation of nitric-oxide synthase biosynthetic process | 67 | 29 | 21 | 16 | 0 | 2 | 18 |
| BP | GO:0065007;biological regulation | GO:0090200;positive regulation of release of cytochrome c from mitochondria | 29 | 24 | 6 | 10 | 0 | 2 | 8 |
| BP | GO:0009987;cellular process | GO:0038171;cannabinoid signaling pathway | 140 | 69 | 14 | 46 | 0 | 4 | 40 |
| BP | GO:0009987;cellular process | GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 37 | 15 | 1 | 14 | 0 | 1 | 12 |
| BP | GO:0009987;cellular process | GO:0031571;mitotic G1 DNA damage checkpoint signaling | 36 | 13 | 1 | 11 | 0 | 0 | 12 |
| BP | GO:0009987;cellular process | GO:0071482;cellular response to light stimulus | 36 | 15 | 0 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0030330;DNA damage response, signal transduction by p53 class mediator | 32 | 11 | 1 | 9 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:1902749;regulation of cell cycle G2/M phase transition | 54 | 15 | 1 | 11 | 0 | 0 | 21 |
| BP | GO:0065007;biological regulation | GO:1901987;regulation of cell cycle phase transition | 70 | 20 | 0 | 20 | 0 | 1 | 20 |
| BP | GO:0065007;biological regulation | GO:1904996;positive regulation of leukocyte adhesion to vascular endothelial cell | 134 | 39 | 2 | 40 | 0 | 5 | 31 |
| BP | GO:0065007;biological regulation | GO:0051129;negative regulation of cellular component organization | 79 | 27 | 1 | 20 | 0 | 1 | 27 |
| BP | GO:0008152;metabolic process | GO:0006261;DNA-dependent DNA replication | 95 | 39 | 3 | 28 | 0 | 2 | 18 |
| BP | GO:0008152;metabolic process | GO:0010499;proteasomal ubiquitin-independent protein catabolic process | 45 | 14 | 1 | 13 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0033238;regulation of cellular amine metabolic process | 40 | 12 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0006521;regulation of cellular amino acid metabolic process | 40 | 12 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1902750;negative regulation of cell cycle G2/M phase transition | 40 | 12 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0036388;pre-replicative complex assembly | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0000209;protein polyubiquitination | 41 | 11 | 0 | 10 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:1902036;regulation of hematopoietic stem cell differentiation | 41 | 13 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0002376;immune system process | GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0038061;NIK/NF-kappaB signaling | 41 | 13 | 1 | 13 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1901532;regulation of hematopoietic progenitor cell differentiation | 41 | 13 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia | 189 | 64 | 3 | 58 | 1 | 6 | 47 |
| BP | GO:0002376;immune system process | GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0060071;Wnt signaling pathway, planar cell polarity pathway | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0090175;regulation of establishment of planar polarity | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 39 | 11 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:2000736;regulation of stem cell differentiation | 44 | 16 | 2 | 13 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1901991;negative regulation of mitotic cell cycle phase transition | 40 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0033209;tumor necrosis factor-mediated signaling pathway | 43 | 15 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0051260;protein homooligomerization | 49 | 19 | 1 | 15 | 0 | 2 | 12 |
| BP | GO:0065007;biological regulation | GO:0061013;regulation of mRNA catabolic process | 42 | 12 | 0 | 12 | 0 | 2 | 12 |
| BP | GO:0065007;biological regulation | GO:0035567;non-canonical Wnt signaling pathway | 38 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0090263;positive regulation of canonical Wnt signaling pathway | 86 | 34 | 5 | 30 | 1 | 4 | 19 |
| BP | GO:0065007;biological regulation | GO:0080090;regulation of primary metabolic process | 55 | 17 | 1 | 14 | 0 | 1 | 13 |
| BP | GO:0008152;metabolic process | GO:0016567;protein ubiquitination | 50 | 12 | 0 | 13 | 1 | 2 | 12 |
| BP | GO:0009987;cellular process | GO:0065004;protein-DNA complex assembly | 38 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0043488;regulation of mRNA stability | 39 | 11 | 0 | 11 | 0 | 2 | 10 |
| BP | GO:0065007;biological regulation | GO:0010389;regulation of G2/M transition of mitotic cell cycle | 47 | 16 | 1 | 13 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0030177;positive regulation of Wnt signaling pathway | 173 | 61 | 10 | 52 | 1 | 6 | 42 |
| BP | GO:0065007;biological regulation | GO:0051454;intracellular pH elevation | 76 | 25 | 2 | 22 | 0 | 3 | 16 |
| BP | GO:0065007;biological regulation | GO:0090090;negative regulation of canonical Wnt signaling pathway | 38 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0044806;G-quadruplex DNA unwinding | 118 | 53 | 3 | 38 | 1 | 3 | 21 |
| BP | GO:0065007;biological regulation | GO:0007346;regulation of mitotic cell cycle | 57 | 21 | 1 | 18 | 0 | 1 | 14 |
| BP | GO:0008152;metabolic process | GO:0061820;telomeric D-loop disassembly | 110 | 47 | 2 | 35 | 1 | 3 | 19 |
| BP | GO:0008152;metabolic process | GO:0048478;replication fork protection | 113 | 49 | 2 | 37 | 1 | 3 | 20 |
| BP | GO:0008152;metabolic process | GO:0090646;mitochondrial tRNA processing | 83 | 45 | 3 | 21 | 0 | 4 | 17 |
| BP | GO:0065007;biological regulation | GO:1901990;regulation of mitotic cell cycle phase transition | 42 | 12 | 1 | 11 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0030178;negative regulation of Wnt signaling pathway | 38 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0071356;cellular response to tumor necrosis factor | 43 | 14 | 1 | 12 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0042355;L-fucose catabolic process | 61 | 19 | 1 | 18 | 0 | 2 | 16 |
| BP | GO:0008152;metabolic process | GO:0042354;L-fucose metabolic process | 61 | 19 | 1 | 18 | 0 | 2 | 16 |
| BP | GO:0008152;metabolic process | GO:0019317;fucose catabolic process | 61 | 19 | 1 | 18 | 0 | 2 | 16 |
| BP | GO:0065007;biological regulation | GO:0060353;regulation of cell adhesion molecule production | 68 | 22 | 2 | 19 | 0 | 2 | 20 |
| BP | GO:0008152;metabolic process | GO:0070900;mitochondrial tRNA modification | 63 | 32 | 2 | 18 | 0 | 3 | 14 |
| BP | GO:0065007;biological regulation | GO:0002691;regulation of cellular extravasation | 61 | 19 | 1 | 18 | 0 | 2 | 16 |
| BP | GO:0008152;metabolic process | GO:0010498;proteasomal protein catabolic process | 38 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0072711;cellular response to hydroxyurea | 109 | 46 | 2 | 34 | 1 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:1903236;regulation of leukocyte tethering or rolling | 59 | 18 | 1 | 17 | 0 | 2 | 16 |
| BP | GO:0008152;metabolic process | GO:0090657;telomeric loop disassembly | 106 | 43 | 2 | 33 | 1 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:0002709;regulation of T cell mediated immunity | 58 | 17 | 1 | 16 | 0 | 2 | 16 |
| BP | GO:0008152;metabolic process | GO:0001325;formation of extrachromosomal circular DNA | 103 | 42 | 1 | 32 | 1 | 3 | 19 |
| BP | GO:0008152;metabolic process | GO:0090656;t-circle formation | 102 | 41 | 1 | 32 | 1 | 3 | 19 |
| BP | GO:0008152;metabolic process | GO:0090737;telomere maintenance via telomere trimming | 102 | 41 | 1 | 32 | 1 | 3 | 19 |
| BP | GO:0050896;response to stimulus | GO:0072710;response to hydroxyurea | 102 | 41 | 1 | 31 | 1 | 3 | 19 |
| BP | GO:0008152;metabolic process | GO:0033169;histone H3-K9 demethylation | 62 | 19 | 1 | 17 | 0 | 2 | 16 |
| BP | GO:0065007;biological regulation | GO:0090329;regulation of DNA-dependent DNA replication | 119 | 49 | 1 | 34 | 1 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:2000104;negative regulation of DNA-dependent DNA replication | 117 | 49 | 1 | 34 | 1 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 40 | 11 | 1 | 10 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0006098;pentose-phosphate shunt | 39 | 10 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1902165;regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 40 | 11 | 1 | 10 | 0 | 1 | 10 |
| BP | GO:0050896;response to stimulus | GO:0010165;response to X-ray | 99 | 40 | 1 | 32 | 1 | 3 | 19 |
| BP | GO:0065007;biological regulation | GO:0060828;regulation of canonical Wnt signaling pathway | 57 | 18 | 0 | 17 | 1 | 2 | 14 |
| BP | GO:0009987;cellular process | GO:0035457;cellular response to interferon-alpha | 21 | 12 | 1 | 3 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0000022;mitotic spindle elongation | 39 | 15 | 2 | 11 | 0 | 2 | 13 |
| BP | GO:0051179;localization | GO:0015874;norepinephrine transport | 61 | 48 | 52 | 7 | 0 | 3 | 12 |
| BP | GO:0051179;localization | GO:0090493;catecholamine uptake | 55 | 42 | 46 | 6 | 0 | 3 | 12 |
| BP | GO:0051179;localization | GO:0090494;dopamine uptake | 128 | 89 | 74 | 23 | 0 | 5 | 27 |
| BP | GO:0065007;biological regulation | GO:0006110;regulation of glycolytic process | 136 | 44 | 9 | 38 | 1 | 2 | 38 |
| BP | GO:0032501;multicellular organismal process | GO:0150104;transport across blood-brain barrier | 41 | 8 | 0 | 7 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:1903961;positive regulation of anion transmembrane transport | 67 | 20 | 0 | 18 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:2001225;regulation of chloride transport | 69 | 22 | 1 | 20 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0010359;regulation of anion channel activity | 66 | 19 | 0 | 17 | 0 | 2 | 20 |
| BP | GO:0032501;multicellular organismal process | GO:1990962;xenobiotic transport across blood-brain barrier | 73 | 21 | 1 | 23 | 0 | 2 | 24 |
| BP | GO:0065007;biological regulation | GO:0003085;negative regulation of systemic arterial blood pressure | 22 | 8 | 2 | 5 | 0 | 2 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0042311;vasodilation | 25 | 9 | 1 | 5 | 0 | 3 | 5 |
| BP | GO:0065007;biological regulation | GO:0051053;negative regulation of DNA metabolic process | 31 | 17 | 2 | 11 | 0 | 1 | 11 |
| BP | GO:0032501;multicellular organismal process | GO:0003015;heart process | 57 | 26 | 5 | 12 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:0032411;positive regulation of transporter activity | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0080182;histone H3-K4 trimethylation | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900017;positive regulation of cytokine production involved in inflammatory response | 28 | 18 | 1 | 8 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0071634;regulation of transforming growth factor beta production | 72 | 34 | 1 | 21 | 0 | 3 | 21 |
| BP | GO:0008152;metabolic process | GO:0006516;glycoprotein catabolic process | 16 | 10 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0000729;DNA double-strand break processing | 32 | 20 | 1 | 12 | 0 | 2 | 7 |
| BP | GO:0008152;metabolic process | GO:0018027;peptidyl-lysine dimethylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0043984;histone H4-K16 acetylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 42 | 22 | 1 | 13 | 1 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:1901699;cellular response to nitrogen compound | 136 | 50 | 4 | 48 | 0 | 4 | 30 |
| BP | GO:0065007;biological regulation | GO:1903320;regulation of protein modification by small protein conjugation or removal | 44 | 21 | 1 | 9 | 0 | 0 | 12 |
| MF | GO:0003824;catalytic activity | GO:0033764;steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 50 | 15 | 1 | 13 | 0 | 1 | 10 |
| MF | GO:0003824;catalytic activity | GO:0030283;testosterone dehydrogenase [NAD(P)] activity | 103 | 35 | 2 | 26 | 0 | 2 | 18 |
| MF | GO:0003824;catalytic activity | GO:0004303;estradiol 17-beta-dehydrogenase activity | 93 | 29 | 1 | 22 | 0 | 2 | 16 |
| MF | GO:0003824;catalytic activity | GO:0001758;retinal dehydrogenase activity | 11 | 7 | 0 | 6 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004032;alditol:NADP+ 1-oxidoreductase activity | 6 | 4 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008106;alcohol dehydrogenase | 6 | 4 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008391;arachidonic acid monooxygenase activity | 58 | 22 | 0 | 14 | 0 | 1 | 11 |
| MF | GO:0003824;catalytic activity | GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 7 | 6 | 0 | 4 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0042803;protein homodimerization activity | 42 | 13 | 0 | 8 | 0 | 0 | 9 |
| MF | GO:0005488;binding | GO:0046914;transition metal ion binding | 24 | 12 | 1 | 6 | 0 | 0 | 3 |
| MF | GO:0005488;binding | GO:0062037;D-loop DNA binding | 42 | 23 | 1 | 16 | 1 | 0 | 6 |
| MF | GO:0003824;catalytic activity | GO:0047086;ketosteroid monooxygenase activity | 3 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0000403;Y-form DNA binding | 36 | 23 | 1 | 16 | 1 | 0 | 4 |
| MF | GO:0003824;catalytic activity | GO:0004064;arylesterase activity | 25 | 20 | 1 | 8 | 0 | 0 | 2 |
| MF | GO:0140657;ATP-dependent activity | GO:0009378;four-way junction helicase activity | 50 | 27 | 1 | 18 | 1 | 0 | 6 |
| MF | GO:0003824;catalytic activity | GO:0052689;carboxylic ester hydrolase activity | 10 | 8 | 0 | 6 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0003697;single-stranded DNA binding | 29 | 15 | 1 | 9 | 1 | 0 | 3 |
| MF | GO:0005488;binding | GO:0036041;long-chain fatty acid binding | 15 | 11 | 1 | 5 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0000405;bubble DNA binding | 24 | 15 | 0 | 11 | 1 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0010857;calcium-dependent protein kinase activity | 56 | 21 | 1 | 14 | 0 | 1 | 11 |
| MF | GO:0003824;catalytic activity | GO:0009931;calcium-dependent protein serine/threonine kinase activity | 56 | 21 | 1 | 14 | 0 | 1 | 11 |
| MF | GO:0003824;catalytic activity | GO:0047023;androsterone dehydrogenase activity | 3 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0032052;bile acid binding | 10 | 7 | 1 | 6 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0045125;bioactive lipid receptor activity | 3 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0032357;oxidized purine DNA binding | 24 | 15 | 0 | 11 | 1 | 0 | 1 |
| MF | GO:0005488;binding | GO:0051880;G-quadruplex DNA binding | 23 | 14 | 0 | 10 | 1 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004033;aldo-keto reductase | 4 | 3 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008239;dipeptidyl-peptidase activity | 33 | 15 | 1 | 8 | 1 | 0 | 3 |
| BP | GO:0051179;localization | GO:0006820;anion transport | 44 | 22 | 3 | 11 | 0 | 1 | 13 |
| BP | GO:0051179;localization | GO:0071702;organic substance transport | 48 | 36 | 26 | 5 | 0 | 3 | 17 |
| BP | GO:0051179;localization | GO:0051647;nucleus localization | 20 | 12 | 0 | 3 | 0 | 0 | 8 |
| BP | GO:0009987;cellular process | GO:0097067;cellular response to thyroid hormone stimulus | 16 | 8 | 0 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0035561;regulation of chromatin binding | 16 | 7 | 0 | 2 | 0 | 0 | 7 |
| BP | GO:0032502;developmental process | GO:0061548;ganglion development | 15 | 7 | 0 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0051547;regulation of keratinocyte migration | 33 | 22 | 1 | 8 | 0 | 0 | 11 |
| BP | GO:0050896;response to stimulus | GO:0097066;response to thyroid hormone | 15 | 8 | 0 | 2 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:1901836;regulation of transcription of nucleolar large rRNA by RNA polymerase I | 18 | 11 | 0 | 2 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0008156;negative regulation of DNA replication | 12 | 6 | 0 | 1 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0032516;positive regulation of phosphoprotein phosphatase activity | 24 | 14 | 0 | 7 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0032793;positive regulation of CREB transcription factor activity | 4 | 2 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0010922;positive regulation of phosphatase activity | 14 | 8 | 0 | 1 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0006359;regulation of transcription by RNA polymerase III | 13 | 7 | 0 | 1 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0045948;positive regulation of translational initiation | 10 | 5 | 0 | 1 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0045943;positive regulation of transcription by RNA polymerase I | 10 | 5 | 0 | 1 | 0 | 0 | 5 |
| BP | GO:0050896;response to stimulus | GO:0031667;response to nutrient levels | 10 | 5 | 0 | 1 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0008361;regulation of cell size | 10 | 5 | 0 | 1 | 0 | 0 | 5 |
| BP | GO:0032502;developmental process | GO:0007422;peripheral nervous system development | 12 | 6 | 0 | 2 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0045834;positive regulation of lipid metabolic process | 33 | 16 | 3 | 7 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0016242;negative regulation of macroautophagy | 9 | 4 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0031929;TOR signaling | 9 | 4 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0009057;macromolecule catabolic process | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0071229;cellular response to acid chemical | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0032535;regulation of cellular component size | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0050896;response to stimulus | GO:0043200;response to amino acid | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0080171;lytic vacuole organization | 8 | 4 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0035307;positive regulation of protein dephosphorylation | 9 | 5 | 0 | 2 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0071230;cellular response to amino acid stimulus | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0046890;regulation of lipid biosynthetic process | 8 | 4 | 0 | 2 | 0 | 0 | 3 |
| MF | GO:0005215;transporter activity | GO:0015347;sodium-independent organic anion transmembrane transporter activity | 17 | 9 | 0 | 3 | 0 | 0 | 4 |
| MF | GO:0005215;transporter activity | GO:0022853;active ion transmembrane transporter activity | 14 | 7 | 0 | 2 | 0 | 0 | 4 |
| MF | GO:0005215;transporter activity | GO:0015291;secondary active transmembrane transporter activity | 14 | 7 | 0 | 2 | 0 | 0 | 4 |
| MF | GO:0005215;transporter activity | GO:0008514;organic anion transmembrane transporter activity | 12 | 5 | 0 | 2 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0000992;RNA polymerase III cis-regulatory region sequence-specific DNA binding | 18 | 10 | 0 | 2 | 0 | 0 | 5 |
| MF | GO:0005488;binding | GO:0001006;RNA polymerase III type 3 promoter sequence-specific DNA binding | 18 | 10 | 0 | 2 | 0 | 0 | 5 |
| MF | GO:0060089;molecular transducer activity | GO:0004985;G protein-coupled opioid receptor activity | 5 | 3 | 0 | 2 | 0 | 0 | 3 |
| MF | GO:0005488;binding | GO:0005525;GTP binding | 9 | 5 | 0 | 1 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0032561;guanyl ribonucleotide binding | 9 | 5 | 0 | 1 | 0 | 0 | 4 |
| MF | GO:0005215;transporter activity | GO:0008509;anion transmembrane transporter activity | 9 | 4 | 0 | 1 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0001223;transcription coactivator binding | 41 | 15 | 0 | 8 | 0 | 0 | 13 |
| MF | GO:0005488;binding | GO:0042923;neuropeptide binding | 3 | 2 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0035639;purine ribonucleoside triphosphate binding | 9 | 3 | 1 | 2 | 0 | 0 | 4 |
| CC | GO:0110165;cellular anatomical entity | GO:0045335;phagocytic vesicle | 6 | 2 | 0 | 1 | 0 | 0 | 4 |
| CC | GO:0032991;protein-containing complex | GO:0031931;TORC1 complex | 8 | 3 | 0 | 1 | 0 | 0 | 5 |
| CC | GO:0110165;cellular anatomical entity | GO:0030139;endocytic vesicle | 7 | 1 | 0 | 2 | 0 | 0 | 5 |
| CC | GO:0032991;protein-containing complex | GO:0031932;TORC2 complex | 8 | 3 | 0 | 1 | 0 | 0 | 5 |
| CC | GO:0110165;cellular anatomical entity | GO:0000323;lytic vacuole | 7 | 2 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:1900182;positive regulation of protein localization to nucleus | 37 | 14 | 1 | 10 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0032210;regulation of telomere maintenance via telomerase | 109 | 45 | 7 | 28 | 1 | 5 | 24 |
| BP | GO:0065007;biological regulation | GO:0010544;negative regulation of platelet activation | 60 | 21 | 0 | 19 | 0 | 2 | 14 |
| BP | GO:0008152;metabolic process | GO:0071897;DNA biosynthetic process | 33 | 8 | 1 | 7 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0010888;negative regulation of lipid storage | 131 | 52 | 6 | 44 | 0 | 2 | 28 |
| BP | GO:0065007;biological regulation | GO:0045923;positive regulation of fatty acid metabolic process | 21 | 10 | 2 | 4 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:1902652;secondary alcohol metabolic process | 15 | 6 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0008203;cholesterol metabolic process | 13 | 4 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0060967;negative regulation of gene silencing by RNA | 44 | 18 | 0 | 8 | 0 | 0 | 12 |
| BP | GO:0065007;biological regulation | GO:0060149;negative regulation of posttranscriptional gene silencing | 44 | 18 | 0 | 8 | 0 | 0 | 12 |
| BP | GO:0065007;biological regulation | GO:0060965;negative regulation of gene silencing by miRNA | 134 | 59 | 2 | 38 | 1 | 2 | 24 |
| BP | GO:0009987;cellular process | GO:0006929;substrate-dependent cell migration | 52 | 17 | 0 | 13 | 0 | 1 | 12 |
| BP | GO:0032501;multicellular organismal process | GO:0033077;T cell differentiation in thymus | 52 | 17 | 0 | 13 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:0045646;regulation of erythrocyte differentiation | 21 | 8 | 0 | 10 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0007254;JNK cascade | 3 | 2 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070228;regulation of lymphocyte apoptotic process | 8 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070664;negative regulation of leukocyte proliferation | 8 | 6 | 2 | 6 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043300;regulation of leukocyte degranulation | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901224;positive regulation of NIK/NF-kappaB signaling | 33 | 11 | 3 | 11 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:0033006;regulation of mast cell activation involved in immune response | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002886;regulation of myeloid leukocyte mediated immunity | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000108;positive regulation of leukocyte apoptotic process | 38 | 22 | 2 | 11 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0030889;negative regulation of B cell proliferation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001257;regulation of cation channel activity | 26 | 18 | 16 | 7 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0033135;regulation of peptidyl-serine phosphorylation | 37 | 24 | 24 | 11 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0009154;purine ribonucleotide catabolic process | 17 | 5 | 1 | 8 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0043949;regulation of cAMP-mediated signaling | 4 | 4 | 1 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010942;positive regulation of cell death | 45 | 29 | 12 | 14 | 0 | 1 | 13 |
| BP | GO:0009987;cellular process | GO:0034330;cell junction organization | 39 | 26 | 22 | 17 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0050806;positive regulation of synaptic transmission | 6 | 5 | 3 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032649;regulation of interferon-gamma production | 60 | 18 | 1 | 15 | 0 | 2 | 13 |
| BP | GO:0009987;cellular process | GO:0032392;DNA geometric change | 91 | 36 | 2 | 26 | 0 | 3 | 20 |
| BP | GO:0008152;metabolic process | GO:0070212;protein poly-ADP-ribosylation | 28 | 16 | 4 | 11 | 1 | 2 | 4 |
| BP | GO:0008152;metabolic process | GO:0070213;protein auto-ADP-ribosylation | 25 | 13 | 4 | 9 | 1 | 2 | 4 |
| BP | GO:0009987;cellular process | GO:0070198;protein localization to chromosome, telomeric region | 24 | 11 | 3 | 8 | 1 | 2 | 3 |
| BP | GO:0065007;biological regulation | GO:0032205;negative regulation of telomere maintenance | 22 | 10 | 2 | 8 | 1 | 2 | 3 |
| BP | GO:0065007;biological regulation | GO:1904356;regulation of telomere maintenance via telomere lengthening | 22 | 10 | 2 | 8 | 1 | 2 | 3 |
| BP | GO:0065007;biological regulation | GO:1904357;negative regulation of telomere maintenance via telomere lengthening | 21 | 9 | 1 | 8 | 1 | 2 | 3 |
| BP | GO:0065007;biological regulation | GO:0006471;protein ADP-ribosylation | 21 | 9 | 1 | 8 | 1 | 2 | 3 |
| BP | GO:0065007;biological regulation | GO:0032206;positive regulation of telomere maintenance | 80 | 50 | 12 | 34 | 1 | 6 | 13 |
| BP | GO:0065007;biological regulation | GO:0032212;positive regulation of telomere maintenance via telomerase | 81 | 50 | 12 | 34 | 1 | 6 | 13 |
| BP | GO:0009987;cellular process | GO:0034502;protein localization to chromosome | 35 | 22 | 7 | 12 | 1 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:1904358;positive regulation of telomere maintenance via telomere lengthening | 62 | 42 | 11 | 26 | 1 | 5 | 6 |
| BP | GO:0065007;biological regulation | GO:2000573;positive regulation of DNA biosynthetic process | 40 | 21 | 6 | 14 | 1 | 3 | 5 |
| BP | GO:0008152;metabolic process | GO:0046457;prostanoid biosynthetic process | 135 | 53 | 4 | 38 | 0 | 1 | 31 |
| BP | GO:0050896;response to stimulus | GO:0032355;response to estradiol | 150 | 72 | 14 | 46 | 1 | 4 | 18 |
| BP | GO:0042592;homeostatic process | GO:0001678;cellular glucose homeostasis | 154 | 49 | 3 | 40 | 0 | 2 | 50 |
| MF | GO:0003824;catalytic activity | GO:0004713;protein tyrosine kinase activity | 66 | 19 | 1 | 17 | 0 | 3 | 13 |
| MF | GO:0003824;catalytic activity | GO:0019199;transmembrane receptor protein kinase activity | 66 | 19 | 1 | 17 | 0 | 3 | 13 |
| MF | GO:0003824;catalytic activity | GO:0004714;transmembrane receptor protein tyrosine kinase activity | 63 | 17 | 1 | 15 | 0 | 3 | 13 |
| MF | GO:0003824;catalytic activity | GO:0005021;vascular endothelial growth factor-activated receptor activity | 61 | 19 | 1 | 13 | 0 | 2 | 9 |
| MF | GO:0003824;catalytic activity | GO:0035173;histone kinase activity | 40 | 12 | 1 | 9 | 0 | 2 | 6 |
| CC | GO:0110165;cellular anatomical entity | GO:0005876;spindle microtubule | 4 | 1 | 1 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0043231;intracellular membrane-bounded organelle | 26 | 7 | 1 | 5 | 0 | 0 | 4 |
| CC | GO:0110165;cellular anatomical entity | GO:0005789;endoplasmic reticulum membrane | 31 | 9 | 1 | 7 | 0 | 0 | 5 |
| CC | GO:0110165;cellular anatomical entity | GO:0005694;chromosome | 14 | 4 | 1 | 3 | 0 | 0 | 2 |
| CC | GO:0110165;cellular anatomical entity | GO:0005874;microtubule | 4 | 1 | 1 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0000793;condensed chromosome | 4 | 1 | 1 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005819;spindle | 4 | 1 | 1 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005887;integral component of plasma membrane | 22 | 15 | 1 | 5 | 0 | 0 | 4 |
| CC | GO:0110165;cellular anatomical entity | GO:0097443;sorting endosome | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0043232;intracellular non-membrane-bounded organelle | 7 | 4 | 1 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0034765;regulation of ion transmembrane transport | 11 | 6 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032412;regulation of ion transmembrane transporter activity | 11 | 6 | 1 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004435;phosphatidylinositol phospholipase C activity | 11 | 6 | 0 | 2 | 0 | 0 | 3 |
| MF | GO:0003824;catalytic activity | GO:0004629;phospholipase C activity | 10 | 5 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0060089;molecular transducer activity | GO:0001594;trace-amine receptor activity | 9 | 4 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0030544;Hsp70 protein binding | 12 | 6 | 0 | 3 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0030425;dendrite | 18 | 11 | 0 | 4 | 0 | 0 | 3 |
| CC | GO:0110165;cellular anatomical entity | GO:0043005;neuron projection | 19 | 11 | 0 | 4 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0031112;positive regulation of microtubule polymerization or depolymerization | 9 | 7 | 0 | 6 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:1903008;organelle disassembly | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903829;positive regulation of cellular protein localization | 13 | 11 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004674;protein serine/threonine kinase activity | 30 | 11 | 0 | 7 | 0 | 0 | 4 |
| MF | GO:0003824;catalytic activity | GO:0004715;non-membrane spanning protein tyrosine kinase activity | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0098708;glucose import across plasma membrane | 74 | 18 | 6 | 15 | 0 | 1 | 21 |
| BP | GO:0009987;cellular process | GO:0140271;hexose import across plasma membrane | 73 | 18 | 5 | 15 | 0 | 1 | 21 |
| BP | GO:0009987;cellular process | GO:0046323;glucose import | 48 | 11 | 0 | 12 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:0015749;monosaccharide transmembrane transport | 46 | 10 | 0 | 11 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:0098719;sodium ion import across plasma membrane | 45 | 9 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0008645;hexose transmembrane transport | 43 | 8 | 0 | 9 | 0 | 0 | 10 |
| BP | GO:0009987;cellular process | GO:0098659;inorganic cation import across plasma membrane | 28 | 6 | 0 | 7 | 0 | 0 | 11 |
| BP | GO:0008152;metabolic process | GO:0042416;dopamine biosynthetic process | 132 | 60 | 18 | 39 | 0 | 2 | 33 |
| BP | GO:0065007;biological regulation | GO:0035542;regulation of SNARE complex assembly | 120 | 54 | 12 | 38 | 0 | 2 | 30 |
| BP | GO:0065007;biological regulation | GO:0032410;negative regulation of transporter activity | 117 | 53 | 11 | 36 | 0 | 2 | 30 |
| BP | GO:0065007;biological regulation | GO:0010919;regulation of inositol phosphate biosynthetic process | 94 | 39 | 8 | 29 | 0 | 2 | 23 |
| BP | GO:0065007;biological regulation | GO:0031340;positive regulation of vesicle fusion | 93 | 38 | 7 | 28 | 0 | 2 | 23 |
| BP | GO:0050896;response to stimulus | GO:0071871;response to epinephrine | 56 | 29 | 5 | 18 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:1904714;regulation of chaperone-mediated autophagy | 53 | 26 | 4 | 16 | 0 | 0 | 12 |
| BP | GO:0009987;cellular process | GO:0071872;cellular response to epinephrine stimulus | 53 | 28 | 4 | 17 | 0 | 0 | 12 |
| BP | GO:0065007;biological regulation | GO:0045920;negative regulation of exocytosis | 46 | 21 | 2 | 14 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:0060732;positive regulation of inositol phosphate biosynthetic process | 51 | 24 | 1 | 16 | 0 | 0 | 12 |
| BP | GO:0050896;response to stimulus | GO:0032026;response to magnesium ion | 44 | 20 | 1 | 13 | 0 | 0 | 11 |
| BP | GO:0009987;cellular process | GO:0035493;SNARE complex assembly | 37 | 14 | 0 | 10 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0001921;positive regulation of receptor recycling | 35 | 12 | 0 | 10 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:1902932;positive regulation of alcohol biosynthetic process | 33 | 10 | 0 | 9 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0010894;negative regulation of steroid biosynthetic process | 90 | 36 | 2 | 27 | 0 | 3 | 24 |
| BP | GO:0065007;biological regulation | GO:0032375;negative regulation of cholesterol transport | 95 | 39 | 2 | 29 | 0 | 3 | 25 |
| BP | GO:0065007;biological regulation | GO:1905954;positive regulation of lipid localization | 91 | 37 | 2 | 26 | 0 | 3 | 24 |
| BP | GO:0065007;biological regulation | GO:0010517;regulation of phospholipase activity | 33 | 9 | 0 | 10 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway | 33 | 10 | 0 | 9 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0035067;negative regulation of histone acetylation | 38 | 13 | 1 | 12 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:0031115;negative regulation of microtubule polymerization | 53 | 17 | 2 | 17 | 0 | 1 | 14 |
| BP | GO:0008152;metabolic process | GO:0042423;catecholamine biosynthetic process | 31 | 8 | 0 | 9 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0015791;polyol transport | 23 | 2 | 0 | 5 | 0 | 0 | 8 |
| BP | GO:0009987;cellular process | GO:0010676;positive regulation of cellular carbohydrate metabolic process | 31 | 8 | 0 | 10 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1902931;negative regulation of alcohol biosynthetic process | 65 | 22 | 1 | 17 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0060191;regulation of lipase activity | 26 | 3 | 0 | 6 | 0 | 0 | 8 |
| BP | GO:0051179;localization | GO:0008643;carbohydrate transport | 23 | 2 | 0 | 5 | 0 | 0 | 8 |
| BP | GO:0032501;multicellular organismal process | GO:0003081;regulation of systemic arterial blood pressure by renin-angiotensin | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0072001;renal system development | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0001822;kidney development | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0035296;regulation of tube diameter | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0003018;vascular process in circulatory system | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0001990;regulation of systemic arterial blood pressure by hormone | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006289;nucleotide-excision repair | 7 | 5 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0034645;cellular macromolecule biosynthetic process | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903522;regulation of blood circulation | 6 | 6 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0097746;blood vessel diameter maintenance | 9 | 8 | 0 | 3 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0061098;positive regulation of protein tyrosine kinase activity | 34 | 13 | 0 | 9 | 0 | 0 | 13 |
| BP | GO:0065007;biological regulation | GO:0097659;nucleic acid-templated transcription | 7 | 4 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0071478;cellular response to radiation | 16 | 14 | 1 | 9 | 0 | 1 | 4 |
| BP | GO:0009987;cellular process | GO:0071479;cellular response to ionizing radiation | 16 | 13 | 1 | 8 | 0 | 1 | 3 |
| BP | GO:0032501;multicellular organismal process | GO:0008015;blood circulation | 9 | 9 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0006303;double-strand break repair via nonhomologous end joining | 6 | 2 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0009101;glycoprotein biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0010467;gene expression | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0042749;regulation of circadian sleep/wake cycle | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032430;positive regulation of phospholipase A2 activity | 2 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006269;DNA replication, synthesis of RNA primer | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:1902315;nuclear cell cycle DNA replication initiation | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:1902975;mitotic DNA replication initiation | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000169;regulation of peptidyl-cysteine S-nitrosylation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033860;regulation of NAD(P)H oxidase activity | 41 | 15 | 0 | 14 | 0 | 1 | 12 |
| BP | GO:0008152;metabolic process | GO:0006486;protein glycosylation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901897;regulation of relaxation of cardiac muscle | 8 | 7 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901078;negative regulation of relaxation of muscle | 8 | 7 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903115;regulation of actin filament-based movement | 11 | 10 | 0 | 6 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043281;regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0033138;positive regulation of peptidyl-serine phosphorylation | 38 | 25 | 24 | 11 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:0051091;positive regulation of DNA-binding transcription factor activity | 60 | 36 | 17 | 21 | 0 | 3 | 15 |
| BP | GO:0065007;biological regulation | GO:0010883;regulation of lipid storage | 48 | 17 | 1 | 12 | 0 | 2 | 17 |
| BP | GO:0065007;biological regulation | GO:0051130;positive regulation of cellular component organization | 59 | 30 | 6 | 21 | 0 | 1 | 13 |
| BP | GO:0065007;biological regulation | GO:0043254;regulation of protein-containing complex assembly | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032743;positive regulation of interleukin-2 production | 6 | 5 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086004;regulation of cardiac muscle cell contraction | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0055117;regulation of cardiac muscle contraction | 6 | 5 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001233;regulation of apoptotic signaling pathway | 19 | 5 | 0 | 7 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0023056;positive regulation of signaling | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901216;positive regulation of neuron death | 39 | 15 | 1 | 10 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0032663;regulation of interleukin-2 production | 3 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032729;positive regulation of interferon-gamma production | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0072584;caveolin-mediated endocytosis | 110 | 67 | 25 | 30 | 0 | 4 | 24 |
| BP | GO:0050896;response to stimulus | GO:0034976;response to endoplasmic reticulum stress | 14 | 12 | 2 | 5 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0052150;modulation by symbiont of host apoptotic process | 42 | 35 | 10 | 17 | 0 | 1 | 5 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0033668;negative regulation by symbiont of host apoptotic process | 36 | 30 | 9 | 13 | 0 | 1 | 5 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0052041;negative regulation by symbiont of host programmed cell death | 35 | 29 | 8 | 13 | 0 | 1 | 4 |
| BP | GO:0009987;cellular process | GO:0071383;cellular response to steroid hormone stimulus | 64 | 29 | 4 | 18 | 0 | 1 | 21 |
| BP | GO:0065007;biological regulation | GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus | 179 | 68 | 3 | 53 | 1 | 4 | 41 |
| BP | GO:0065007;biological regulation | GO:0045821;positive regulation of glycolytic process | 100 | 54 | 11 | 31 | 0 | 0 | 26 |
| BP | GO:0065007;biological regulation | GO:1900544;positive regulation of purine nucleotide metabolic process | 100 | 54 | 11 | 31 | 0 | 0 | 26 |
| BP | GO:0065007;biological regulation | GO:0032642;regulation of chemokine production | 44 | 16 | 1 | 15 | 0 | 0 | 14 |
| BP | GO:0065007;biological regulation | GO:0032722;positive regulation of chemokine production | 42 | 14 | 1 | 14 | 0 | 0 | 13 |
| BP | GO:0002376;immune system process | GO:0034142;toll-like receptor 4 signaling pathway | 61 | 17 | 0 | 24 | 0 | 2 | 15 |
| MF | GO:0005488;binding | GO:0046982;protein heterodimerization activity | 26 | 9 | 0 | 6 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0031648;protein destabilization | 43 | 13 | 1 | 16 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0060548;negative regulation of cell death | 38 | 11 | 0 | 13 | 0 | 1 | 11 |
| BP | GO:0008152;metabolic process | GO:0042428;serotonin metabolic process | 48 | 20 | 0 | 15 | 0 | 1 | 13 |
| BP | GO:0008152;metabolic process | GO:0018958;phenol-containing compound metabolic process | 48 | 20 | 0 | 15 | 0 | 1 | 13 |
| BP | GO:0065007;biological regulation | GO:0070163;regulation of adiponectin secretion | 72 | 30 | 15 | 24 | 0 | 3 | 20 |
| BP | GO:0009987;cellular process | GO:0021795;cerebral cortex cell migration | 54 | 26 | 0 | 17 | 0 | 1 | 14 |
| BP | GO:0009987;cellular process | GO:0022029;telencephalon cell migration | 54 | 26 | 0 | 17 | 0 | 1 | 14 |
| BP | GO:0008152;metabolic process | GO:0018364;peptidyl-glutamine methylation | 36 | 9 | 0 | 12 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0045762;positive regulation of adenylate cyclase activity | 42 | 16 | 0 | 14 | 0 | 1 | 12 |
| BP | GO:0009987;cellular process | GO:0044818;mitotic G2/M transition checkpoint | 10 | 6 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045807;positive regulation of endocytosis | 35 | 11 | 1 | 8 | 0 | 2 | 6 |
| BP | GO:0065007;biological regulation | GO:0001952;regulation of cell-matrix adhesion | 7 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900274;regulation of phospholipase C activity | 58 | 31 | 1 | 22 | 1 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0032092;positive regulation of protein binding | 30 | 15 | 3 | 8 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0060396;growth hormone receptor signaling pathway | 7 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0007498;mesoderm development | 6 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051128;regulation of cellular component organization | 9 | 3 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0010518;positive regulation of phospholipase activity | 26 | 16 | 1 | 10 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0045595;regulation of cell differentiation | 9 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process | 6 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity | 26 | 18 | 0 | 7 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0010975;regulation of neuron projection development | 7 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:1904885;beta-catenin destruction complex assembly | 10 | 5 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0060993;kidney morphogenesis | 6 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010976;positive regulation of neuron projection development | 6 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010508;positive regulation of autophagy | 8 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0046928;regulation of neurotransmitter secretion | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043551;regulation of phosphatidylinositol 3-kinase activity | 12 | 6 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032886;regulation of microtubule-based process | 12 | 6 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0050773;regulation of dendrite development | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070233;negative regulation of T cell apoptotic process | 6 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1904781;positive regulation of protein localization to centrosome | 9 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051493;regulation of cytoskeleton organization | 47 | 19 | 0 | 9 | 0 | 2 | 15 |
| BP | GO:0008152;metabolic process | GO:0036289;peptidyl-serine autophosphorylation | 30 | 11 | 0 | 10 | 0 | 1 | 6 |
| BP | GO:0008152;metabolic process | GO:0007260;tyrosine phosphorylation of STAT protein | 7 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0001837;epithelial to mesenchymal transition | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1904779;regulation of protein localization to centrosome | 8 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0120039;plasma membrane bounded cell projection morphogenesis | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0030099;myeloid cell differentiation | 6 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0030155;regulation of cell adhesion | 62 | 16 | 2 | 9 | 0 | 1 | 23 |
| BP | GO:0065007;biological regulation | GO:0010665;regulation of cardiac muscle cell apoptotic process | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070232;regulation of T cell apoptotic process | 6 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071378;cellular response to growth hormone stimulus | 7 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0009968;negative regulation of signal transduction | 8 | 4 | 0 | 3 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:1901983;regulation of protein acetylation | 8 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0044843;cell cycle G1/S phase transition | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060397;growth hormone receptor signaling pathway via JAK-STAT | 6 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060070;canonical Wnt signaling pathway | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060333;interferon-gamma-mediated signaling pathway | 6 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010811;positive regulation of cell-substrate adhesion | 5 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0031175;neuron projection development | 8 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0034250;positive regulation of cellular amide metabolic process | 11 | 0 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0006704;glucocorticoid biosynthetic process | 38 | 17 | 2 | 13 | 0 | 0 | 6 |
| BP | GO:0008152;metabolic process | GO:0008211;glucocorticoid metabolic process | 34 | 13 | 1 | 11 | 0 | 0 | 6 |
| BP | GO:0032501;multicellular organismal process | GO:0042093;T-helper cell differentiation | 70 | 19 | 0 | 26 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0050862;positive regulation of T cell receptor signaling pathway | 83 | 23 | 0 | 26 | 0 | 2 | 21 |
| BP | GO:0065007;biological regulation | GO:0051046;regulation of secretion | 95 | 30 | 0 | 37 | 0 | 2 | 24 |
| BP | GO:0065007;biological regulation | GO:0001911;negative regulation of leukocyte mediated cytotoxicity | 35 | 10 | 0 | 12 | 0 | 1 | 9 |
| BP | GO:0008152;metabolic process | GO:0051791;medium-chain fatty acid metabolic process | 90 | 27 | 0 | 35 | 0 | 2 | 24 |
| BP | GO:0065007;biological regulation | GO:1903978;regulation of microglial cell activation | 35 | 10 | 0 | 12 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:0010675;regulation of cellular carbohydrate metabolic process | 61 | 13 | 0 | 21 | 0 | 2 | 19 |
| BP | GO:0065007;biological regulation | GO:1903649;regulation of cytoplasmic transport | 91 | 45 | 8 | 25 | 0 | 2 | 21 |
| BP | GO:0065007;biological regulation | GO:0070665;positive regulation of leukocyte proliferation | 55 | 28 | 4 | 9 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0010759;positive regulation of macrophage chemotaxis | 52 | 25 | 2 | 9 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:2000641;regulation of early endosome to late endosome transport | 71 | 32 | 3 | 20 | 0 | 1 | 19 |
| BP | GO:0065007;biological regulation | GO:1905523;positive regulation of macrophage migration | 42 | 19 | 2 | 7 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0071622;regulation of granulocyte chemotaxis | 41 | 18 | 2 | 6 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0010758;regulation of macrophage chemotaxis | 41 | 19 | 2 | 8 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:0071675;regulation of mononuclear cell migration | 39 | 17 | 2 | 6 | 0 | 1 | 15 |
| BP | GO:0032502;developmental process | GO:0007409;axonogenesis | 64 | 24 | 3 | 12 | 0 | 2 | 20 |
| BP | GO:0065007;biological regulation | GO:0010632;regulation of epithelial cell migration | 31 | 9 | 0 | 4 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0002690;positive regulation of leukocyte chemotaxis | 31 | 9 | 0 | 4 | 0 | 1 | 14 |
| BP | GO:0009987;cellular process | GO:0007229;integrin-mediated signaling pathway | 31 | 9 | 0 | 4 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0033043;regulation of organelle organization | 38 | 16 | 1 | 7 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:0010594;regulation of endothelial cell migration | 33 | 10 | 0 | 5 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:0060627;regulation of vesicle-mediated transport | 41 | 17 | 1 | 10 | 0 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:2001286;regulation of caveolin-mediated endocytosis | 31 | 9 | 0 | 4 | 0 | 1 | 14 |
| BP | GO:0065007;biological regulation | GO:0010743;regulation of macrophage derived foam cell differentiation | 78 | 39 | 12 | 29 | 1 | 2 | 24 |
| BP | GO:0065007;biological regulation | GO:1900034;regulation of cellular response to heat | 19 | 16 | 1 | 8 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0080135;regulation of cellular response to stress | 28 | 19 | 1 | 12 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0042363;fat-soluble vitamin catabolic process | 51 | 28 | 2 | 12 | 0 | 0 | 12 |
| BP | GO:0008152;metabolic process | GO:1901616;organic hydroxy compound catabolic process | 50 | 27 | 2 | 12 | 0 | 0 | 12 |
| BP | GO:0032502;developmental process | GO:0001655;urogenital system development | 18 | 6 | 1 | 3 | 0 | 0 | 7 |
| BP | GO:0051179;localization | GO:0006836;neurotransmitter transport | 22 | 17 | 22 | 2 | 0 | 2 | 6 |
| BP | GO:0065007;biological regulation | GO:0060261;positive regulation of transcription initiation from RNA polymerase II promoter | 24 | 17 | 8 | 8 | 0 | 1 | 5 |
| BP | GO:0051179;localization | GO:0071705;nitrogen compound transport | 9 | 7 | 9 | 0 | 0 | 2 | 3 |
| BP | GO:0008152;metabolic process | GO:0043436;oxoacid metabolic process | 3 | 3 | 3 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0090199;regulation of release of cytochrome c from mitochondria | 20 | 17 | 2 | 9 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:2001242;regulation of intrinsic apoptotic signaling pathway | 31 | 20 | 5 | 8 | 0 | 2 | 5 |
| BP | GO:0008152;metabolic process | GO:0072524;pyridine-containing compound metabolic process | 68 | 37 | 9 | 23 | 1 | 4 | 6 |
| MF | GO:0003824;catalytic activity | GO:0004683;calmodulin-dependent protein kinase activity | 33 | 13 | 1 | 8 | 0 | 1 | 4 |
| MF | GO:0005488;binding | GO:0005524;ATP binding | 7 | 1 | 1 | 1 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0032559;adenyl ribonucleotide binding | 7 | 1 | 1 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0016174;NAD(P)H oxidase H2O2-forming activity | 25 | 9 | 0 | 4 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0014002;astrocyte development | 20 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0009987;cellular process | GO:0002068;glandular epithelial cell development | 20 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0009987;cellular process | GO:0003323;type B pancreatic cell development | 20 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0009987;cellular process | GO:0003309;type B pancreatic cell differentiation | 20 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0090331;negative regulation of platelet aggregation | 28 | 7 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0043247;telomere maintenance in response to DNA damage | 45 | 17 | 0 | 14 | 0 | 1 | 12 |
| BP | GO:0065007;biological regulation | GO:0034111;negative regulation of homotypic cell-cell adhesion | 28 | 7 | 0 | 10 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:2000773;negative regulation of cellular senescence | 20 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0045655;regulation of monocyte differentiation | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0090344;negative regulation of cell aging | 23 | 9 | 1 | 8 | 0 | 1 | 7 |
| BP | GO:0009987;cellular process | GO:0042063;gliogenesis | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0010744;positive regulation of macrophage derived foam cell differentiation | 32 | 15 | 1 | 9 | 0 | 2 | 9 |
| BP | GO:0065007;biological regulation | GO:0010884;positive regulation of lipid storage | 32 | 15 | 1 | 9 | 0 | 2 | 9 |
| BP | GO:0065007;biological regulation | GO:0045638;negative regulation of myeloid cell differentiation | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0032374;regulation of cholesterol transport | 31 | 14 | 2 | 9 | 0 | 2 | 9 |
| BP | GO:0009987;cellular process | GO:0021782;glial cell development | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0048146;positive regulation of fibroblast proliferation | 22 | 8 | 1 | 7 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0002762;negative regulation of myeloid leukocyte differentiation | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:2000772;regulation of cellular senescence | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0045668;negative regulation of osteoblast differentiation | 19 | 6 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:1902807;negative regulation of cell cycle G1/S phase transition | 19 | 5 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:2000134;negative regulation of G1/S transition of mitotic cell cycle | 19 | 5 | 0 | 6 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0031324;negative regulation of cellular metabolic process | 20 | 6 | 1 | 7 | 0 | 0 | 8 |
| BP | GO:0008152;metabolic process | GO:1901570;fatty acid derivative biosynthetic process | 48 | 17 | 0 | 16 | 0 | 1 | 16 |
| BP | GO:0065007;biological regulation | GO:0030194;positive regulation of blood coagulation | 32 | 16 | 2 | 11 | 0 | 2 | 4 |
| BP | GO:0008152;metabolic process | GO:0006700;C21-steroid hormone biosynthetic process | 9 | 6 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046626;regulation of insulin receptor signaling pathway | 4 | 3 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1905599;positive regulation of low-density lipoprotein receptor activity | 18 | 12 | 0 | 6 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:1905563;negative regulation of vascular endothelial cell proliferation | 18 | 12 | 0 | 6 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:1905461;positive regulation of vascular associated smooth muscle cell apoptotic process | 18 | 12 | 0 | 6 | 0 | 0 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0030432;peristalsis | 28 | 20 | 1 | 6 | 0 | 0 | 7 |
| BP | GO:0009987;cellular process | GO:0090077;foam cell differentiation | 18 | 12 | 0 | 6 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0060124;positive regulation of growth hormone secretion | 15 | 12 | 1 | 4 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:1990535;neuron projection maintenance | 32 | 9 | 2 | 12 | 0 | 1 | 8 |
| BP | GO:0009987;cellular process | GO:0106027;neuron projection organization | 29 | 6 | 1 | 9 | 0 | 1 | 6 |
| BP | GO:0050896;response to stimulus | GO:0098586;cellular response to virus | 20 | 4 | 0 | 2 | 0 | 0 | 10 |
| BP | GO:0009987;cellular process | GO:0042149;cellular response to glucose starvation | 18 | 3 | 0 | 1 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0032880;regulation of protein localization | 21 | 5 | 0 | 3 | 0 | 0 | 10 |
| BP | GO:0042592;homeostatic process | GO:0042632;cholesterol homeostasis | 36 | 11 | 1 | 6 | 0 | 1 | 12 |
| BP | GO:0042592;homeostatic process | GO:0055092;sterol homeostasis | 36 | 11 | 1 | 6 | 0 | 1 | 12 |
| BP | GO:0050896;response to stimulus | GO:0009750;response to fructose | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0031670;cellular response to nutrient | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0008152;metabolic process | GO:0046351;disaccharide biosynthetic process | 20 | 3 | 0 | 2 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0022618;ribonucleoprotein complex assembly | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:2000345;regulation of hepatocyte proliferation | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1902949;positive regulation of tau-protein kinase activity | 20 | 4 | 0 | 3 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0061043;regulation of vascular wound healing | 29 | 6 | 0 | 5 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0045348;positive regulation of MHC class II biosynthetic process | 19 | 4 | 0 | 2 | 0 | 0 | 9 |
| BP | GO:0008152;metabolic process | GO:0097264;self proteolysis | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:0045579;positive regulation of B cell differentiation | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0036500;ATF6-mediated unfolded protein response | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0008152;metabolic process | GO:0019852;L-ascorbic acid metabolic process | 19 | 3 | 0 | 2 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1902947;regulation of tau-protein kinase activity | 20 | 4 | 0 | 3 | 0 | 0 | 9 |
| BP | GO:0050896;response to stimulus | GO:0070670;response to interleukin-4 | 18 | 3 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1900101;regulation of endoplasmic reticulum unfolded protein response | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0071353;cellular response to interleukin-4 | 18 | 3 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0051179;localization | GO:0044539;long-chain fatty acid import into cell | 19 | 3 | 0 | 2 | 0 | 0 | 9 |
| BP | GO:0042592;homeostatic process | GO:0055089;fatty acid homeostasis | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0008152;metabolic process | GO:0046146;tetrahydrobiopterin metabolic process | 21 | 4 | 0 | 2 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1900103;positive regulation of endoplasmic reticulum unfolded protein response | 17 | 2 | 0 | 1 | 0 | 0 | 9 |
| BP | GO:0009987;cellular process | GO:0006333;chromatin assembly or disassembly | 33 | 10 | 0 | 3 | 0 | 0 | 11 |
| BP | GO:0065007;biological regulation | GO:0009890;negative regulation of biosynthetic process | 23 | 20 | 17 | 8 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048147;negative regulation of fibroblast proliferation | 11 | 9 | 6 | 3 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:1903426;regulation of reactive oxygen species biosynthetic process | 42 | 30 | 14 | 17 | 0 | 0 | 10 |
| BP | GO:0065007;biological regulation | GO:0032091;negative regulation of protein binding | 32 | 10 | 1 | 10 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0051100;negative regulation of binding | 36 | 13 | 1 | 11 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:1902850;microtubule cytoskeleton organization involved in mitosis | 27 | 9 | 1 | 10 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:0007052;mitotic spindle organization | 26 | 8 | 1 | 9 | 0 | 1 | 11 |
| BP | GO:0009987;cellular process | GO:0051256;mitotic spindle midzone assembly | 31 | 9 | 1 | 10 | 0 | 2 | 12 |
| BP | GO:0065007;biological regulation | GO:0070229;negative regulation of lymphocyte apoptotic process | 24 | 6 | 1 | 8 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:2001214;positive regulation of vasculogenesis | 21 | 5 | 1 | 7 | 0 | 1 | 10 |
| BP | GO:0032502;developmental process | GO:0003158;endothelium development | 21 | 5 | 1 | 7 | 0 | 1 | 10 |
| BP | GO:0008152;metabolic process | GO:0019941;modification-dependent protein catabolic process | 16 | 3 | 1 | 5 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process | 18 | 6 | 1 | 6 | 0 | 1 | 7 |
| BP | GO:0032502;developmental process | GO:0060055;angiogenesis involved in wound healing | 16 | 4 | 1 | 5 | 0 | 1 | 7 |
| BP | GO:0032502;developmental process | GO:0016569;covalent chromatin modification | 14 | 2 | 1 | 4 | 0 | 1 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0001569;branching involved in blood vessel morphogenesis | 14 | 3 | 1 | 5 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0045446;endothelial cell differentiation | 13 | 2 | 1 | 4 | 0 | 1 | 5 |
| BP | GO:0009987;cellular process | GO:0002042;cell migration involved in sprouting angiogenesis | 11 | 0 | 0 | 4 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0043536;positive regulation of blood vessel endothelial cell migration | 121 | 42 | 4 | 37 | 0 | 4 | 44 |
| BP | GO:0065007;biological regulation | GO:0043535;regulation of blood vessel endothelial cell migration | 102 | 35 | 4 | 31 | 0 | 3 | 34 |
| BP | GO:0065007;biological regulation | GO:0006275;regulation of DNA replication | 81 | 38 | 3 | 25 | 1 | 3 | 9 |
| BP | GO:0065007;biological regulation | GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity | 62 | 33 | 2 | 22 | 1 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:1900020;positive regulation of protein kinase C activity | 60 | 32 | 2 | 21 | 1 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:1900019;regulation of protein kinase C activity | 60 | 32 | 2 | 21 | 1 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:0010749;regulation of nitric oxide mediated signal transduction | 60 | 32 | 2 | 21 | 1 | 2 | 4 |
| BP | GO:0065007;biological regulation | GO:1905208;negative regulation of cardiocyte differentiation | 56 | 29 | 2 | 18 | 1 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0006355;regulation of transcription, DNA-templated | 59 | 28 | 2 | 20 | 1 | 3 | 4 |
| BP | GO:0065007;biological regulation | GO:2000035;regulation of stem cell division | 55 | 26 | 2 | 18 | 1 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:1903799;negative regulation of production of miRNAs involved in gene silencing by miRNA | 101 | 47 | 2 | 32 | 1 | 2 | 15 |
| BP | GO:0065007;biological regulation | GO:2000737;negative regulation of stem cell differentiation | 44 | 20 | 0 | 16 | 1 | 1 | 4 |
| BP | GO:0008152;metabolic process | GO:0046394;carboxylic acid biosynthetic process | 56 | 30 | 0 | 20 | 1 | 2 | 9 |
| BP | GO:0065007;biological regulation | GO:0050729;positive regulation of inflammatory response | 27 | 18 | 18 | 10 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0031349;positive regulation of defense response | 24 | 15 | 16 | 7 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0032103;positive regulation of response to external stimulus | 8 | 7 | 5 | 5 | 0 | 0 | 2 |
| BP | GO:0051179;localization | GO:0033365;protein localization to organelle | 7 | 6 | 3 | 4 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0016198;axon choice point recognition | 69 | 32 | 17 | 22 | 0 | 1 | 17 |
| BP | GO:0065007;biological regulation | GO:1905598;negative regulation of low-density lipoprotein receptor activity | 11 | 9 | 7 | 6 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070303;negative regulation of stress-activated protein kinase signaling cascade | 10 | 7 | 4 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0002674;negative regulation of acute inflammatory response | 8 | 5 | 2 | 5 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0045055;regulated exocytosis | 3 | 3 | 2 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900272;negative regulation of long-term synaptic potentiation | 6 | 6 | 4 | 4 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0035235;ionotropic glutamate receptor signaling pathway | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0016322;neuron remodeling | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048169;regulation of long-term neuronal synaptic plasticity | 9 | 5 | 2 | 3 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0071637;regulation of monocyte chemotactic protein-1 production | 4 | 3 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043508;negative regulation of JUN kinase activity | 4 | 3 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0009166;nucleotide catabolic process | 14 | 3 | 0 | 6 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0030857;negative regulation of epithelial cell differentiation | 42 | 15 | 1 | 10 | 0 | 1 | 13 |
| BP | GO:0065007;biological regulation | GO:1900746;regulation of vascular endothelial growth factor signaling pathway | 29 | 8 | 0 | 10 | 0 | 0 | 9 |
| BP | GO:0065007;biological regulation | GO:1900745;positive regulation of p38MAPK cascade | 13 | 2 | 0 | 5 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0006163;purine nucleotide metabolic process | 13 | 2 | 0 | 5 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0046415;urate metabolic process | 13 | 2 | 1 | 6 | 0 | 0 | 3 |
| BP | GO:0051179;localization | GO:0070633;transepithelial transport | 16 | 3 | 1 | 6 | 0 | 0 | 3 |
| BP | GO:0051179;localization | GO:0043691;reverse cholesterol transport | 57 | 19 | 0 | 24 | 0 | 1 | 14 |
| BP | GO:0050896;response to stimulus | GO:0070723;response to cholesterol | 55 | 17 | 0 | 22 | 0 | 1 | 14 |
| BP | GO:0051179;localization | GO:0042908;xenobiotic transport | 17 | 3 | 1 | 6 | 0 | 0 | 3 |
| BP | GO:0032501;multicellular organismal process | GO:0043312;neutrophil degranulation | 44 | 30 | 13 | 15 | 0 | 1 | 8 |
| BP | GO:0032501;multicellular organismal process | GO:0002283;neutrophil activation involved in immune response | 43 | 30 | 13 | 15 | 0 | 1 | 8 |
| BP | GO:0002376;immune system process | GO:0002446;neutrophil mediated immunity | 41 | 29 | 13 | 14 | 0 | 1 | 8 |
| BP | GO:0009987;cellular process | GO:0030263;apoptotic chromosome condensation | 61 | 30 | 0 | 13 | 0 | 1 | 10 |
| BP | GO:0009987;cellular process | GO:0051276;chromosome organization | 23 | 12 | 0 | 5 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0044772;mitotic cell cycle phase transition | 8 | 5 | 1 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043304;regulation of mast cell degranulation | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060341;regulation of cellular localization | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0000086;G2/M transition of mitotic cell cycle | 12 | 8 | 1 | 4 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0044839;cell cycle G2/M phase transition | 12 | 8 | 1 | 4 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:2000249;regulation of actin cytoskeleton reorganization | 4 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060193;positive regulation of lipase activity | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034110;regulation of homotypic cell-cell adhesion | 9 | 7 | 0 | 8 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0051495;positive regulation of cytoskeleton organization | 4 | 2 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0000082;G1/S transition of mitotic cell cycle | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030218;erythrocyte differentiation | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901215;negative regulation of neuron death | 2 | 1 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1905562;regulation of vascular endothelial cell proliferation | 3 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010727;negative regulation of hydrogen peroxide metabolic process | 12 | 6 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010310;regulation of hydrogen peroxide metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903209;positive regulation of oxidative stress-induced cell death | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071732;cellular response to nitric oxide | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1902170;cellular response to reactive nitrogen species | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048311;mitochondrion distribution | 15 | 10 | 0 | 8 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0044819;mitotic G1/S transition checkpoint signaling | 17 | 8 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0042592;homeostatic process | GO:0030007;cellular potassium ion homeostasis | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0036376;sodium ion export across plasma membrane | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0042592;homeostatic process | GO:0006883;cellular sodium ion homeostasis | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0042592;homeostatic process | GO:0030004;cellular monovalent inorganic cation homeostasis | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0042592;homeostatic process | GO:0055075;potassium ion homeostasis | 4 | 3 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0042592;homeostatic process | GO:0055078;sodium ion homeostasis | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0051179;localization | GO:0070839;metal ion export | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0008206;bile acid metabolic process | 6 | 4 | 0 | 2 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:1902600;proton transmembrane transport | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:1990573;potassium ion import across plasma membrane | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0051170;import into nucleus | 3 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0044089;positive regulation of cellular component biogenesis | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0106070;regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 12 | 10 | 0 | 10 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0035405;histone-threonine phosphorylation | 13 | 11 | 0 | 11 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900120;regulation of receptor binding | 17 | 16 | 2 | 3 | 0 | 1 | 5 |
| BP | GO:0009987;cellular process | GO:0007264;small GTPase mediated signal transduction | 30 | 12 | 0 | 9 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0070200;establishment of protein localization to telomere | 29 | 11 | 0 | 10 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0034392;negative regulation of smooth muscle cell apoptotic process | 29 | 11 | 1 | 10 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0010792;DNA double-strand break processing involved in repair via single-strand annealing | 29 | 11 | 1 | 10 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0045002;double-strand break repair via single-strand annealing | 28 | 10 | 0 | 9 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0010216;maintenance of DNA methylation | 20 | 8 | 0 | 8 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:1905459;regulation of vascular associated smooth muscle cell apoptotic process | 26 | 13 | 0 | 12 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:1905064;negative regulation of vascular associated smooth muscle cell differentiation | 20 | 8 | 0 | 8 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:1904749;regulation of protein localization to nucleolus | 21 | 9 | 0 | 9 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0007265;Ras protein signal transduction | 20 | 9 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0008152;metabolic process | GO:0034205;amyloid-beta formation | 23 | 10 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0090311;regulation of protein deacetylation | 21 | 8 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0042634;regulation of hair cycle | 19 | 8 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0008152;metabolic process | GO:0030422;production of siRNA involved in RNA interference | 19 | 8 | 0 | 7 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0090309;positive regulation of DNA methylation-dependent heterochromatin assembly | 18 | 7 | 0 | 6 | 0 | 1 | 4 |
| BP | GO:0032502;developmental process | GO:0060348;bone development | 10 | 4 | 0 | 3 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0050730;regulation of peptidyl-tyrosine phosphorylation | 33 | 19 | 8 | 8 | 0 | 3 | 5 |
| BP | GO:0008152;metabolic process | GO:0009299;mRNA transcription | 13 | 5 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0050896;response to stimulus | GO:0042060;wound healing | 40 | 12 | 0 | 13 | 1 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:0030111;regulation of Wnt signaling pathway | 3 | 2 | 2 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051247;positive regulation of protein metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0042592;homeostatic process | GO:0042593;glucose homeostasis | 43 | 18 | 2 | 14 | 0 | 2 | 17 |
| BP | GO:0065007;biological regulation | GO:1903573;negative regulation of response to endoplasmic reticulum stress | 11 | 5 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0009895;negative regulation of catabolic process | 30 | 23 | 18 | 11 | 0 | 1 | 4 |
| BP | GO:0051179;localization | GO:0030301;cholesterol transport | 9 | 3 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0090150;establishment of protein localization to membrane | 6 | 0 | 0 | 0 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0003677;DNA binding | 64 | 29 | 1 | 17 | 1 | 0 | 11 |
| MF | GO:0005488;binding | GO:0017025;TBP-class protein binding | 15 | 3 | 0 | 2 | 0 | 0 | 5 |
| MF | GO:0005488;binding | GO:0003690;double-stranded DNA binding | 38 | 20 | 0 | 13 | 1 | 0 | 6 |
| MF | GO:0005488;binding | GO:0140296;general transcription initiation factor binding | 8 | 1 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0001221;transcription coregulator binding | 17 | 5 | 0 | 4 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0043565;sequence-specific DNA binding | 10 | 2 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0051117;ATPase binding | 34 | 16 | 0 | 11 | 1 | 0 | 5 |
| MF | GO:0005488;binding | GO:0001091;RNA polymerase II general transcription initiation factor binding | 43 | 18 | 0 | 12 | 1 | 0 | 7 |
| BP | GO:0009987;cellular process | GO:0032200;telomere organization | 10 | 8 | 2 | 4 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0000723;telomere maintenance | 8 | 6 | 2 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060123;regulation of growth hormone secretion | 12 | 9 | 1 | 3 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0045600;positive regulation of fat cell differentiation | 11 | 3 | 0 | 2 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:0001885;endothelial cell development | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0090049;regulation of cell migration involved in sprouting angiogenesis | 32 | 9 | 0 | 7 | 0 | 0 | 10 |
| BP | GO:0008152;metabolic process | GO:0044267;cellular protein metabolic process | 15 | 6 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0045652;regulation of megakaryocyte differentiation | 15 | 4 | 0 | 5 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0051241;negative regulation of multicellular organismal process | 9 | 6 | 0 | 4 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0006069;ethanol oxidation | 29 | 22 | 0 | 12 | 0 | 1 | 4 |
| BP | GO:0008152;metabolic process | GO:0006067;ethanol metabolic process | 18 | 15 | 1 | 7 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0032740;positive regulation of interleukin-17 production | 25 | 11 | 0 | 11 | 0 | 1 | 8 |
| BP | GO:0065007;biological regulation | GO:0010875;positive regulation of cholesterol efflux | 26 | 12 | 0 | 11 | 0 | 1 | 9 |
| BP | GO:0042592;homeostatic process | GO:0070328;triglyceride homeostasis | 17 | 9 | 0 | 8 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0010874;regulation of cholesterol efflux | 7 | 5 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032660;regulation of interleukin-17 production | 13 | 7 | 0 | 5 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0032376;positive regulation of cholesterol transport | 7 | 5 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:1902653;secondary alcohol biosynthetic process | 4 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006695;cholesterol biosynthetic process | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0016126;sterol biosynthetic process | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0120163;negative regulation of cold-induced thermogenesis | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0006968;cellular defense response | 18 | 9 | 0 | 5 | 0 | 0 | 6 |
| MF | GO:0005488;binding | GO:0050660;flavin adenine dinucleotide binding | 15 | 5 | 0 | 1 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0051537;2 iron, 2 sulfur cluster binding | 22 | 9 | 0 | 6 | 1 | 0 | 4 |
| MF | GO:0003824;catalytic activity | GO:0008392;arachidonic acid epoxygenase activity | 18 | 7 | 0 | 4 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:0032768;regulation of monooxygenase activity | 21 | 14 | 3 | 8 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:1901565;organonitrogen compound catabolic process | 19 | 12 | 1 | 4 | 0 | 0 | 8 |
| MF | GO:0005488;binding | GO:0000978;RNA polymerase II cis-regulatory region sequence-specific DNA binding | 16 | 9 | 0 | 5 | 1 | 0 | 2 |
| MF | GO:0005488;binding | GO:0000987;cis-regulatory region sequence-specific DNA binding | 9 | 5 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:2001236;regulation of extrinsic apoptotic signaling pathway | 40 | 16 | 1 | 10 | 0 | 1 | 11 |
| BP | GO:0065007;biological regulation | GO:0043409;negative regulation of MAPK cascade | 4 | 4 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033034;positive regulation of myeloid cell apoptotic process | 65 | 35 | 9 | 16 | 0 | 1 | 15 |
| BP | GO:0065007;biological regulation | GO:1903076;regulation of protein localization to plasma membrane | 8 | 5 | 1 | 4 | 0 | 2 | 1 |
| BP | GO:0050896;response to stimulus | GO:0043627;response to estrogen | 9 | 7 | 2 | 4 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0033143;regulation of intracellular steroid hormone receptor signaling pathway | 7 | 5 | 2 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1904377;positive regulation of protein localization to cell periphery | 3 | 3 | 0 | 3 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1903078;positive regulation of protein localization to plasma membrane | 3 | 3 | 0 | 3 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0042058;regulation of epidermal growth factor receptor signaling pathway | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050714;positive regulation of protein secretion | 10 | 9 | 7 | 7 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:1905477;positive regulation of protein localization to membrane | 7 | 7 | 1 | 4 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0051590;positive regulation of neurotransmitter transport | 4 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071394;cellular response to testosterone stimulus | 19 | 9 | 1 | 5 | 0 | 1 | 6 |
| BP | GO:0065007;biological regulation | GO:0032960;regulation of inositol trisphosphate biosynthetic process | 5 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045113;regulation of integrin biosynthetic process | 19 | 9 | 0 | 6 | 0 | 0 | 6 |
| BP | GO:0050896;response to stimulus | GO:0033574;response to testosterone | 16 | 6 | 0 | 3 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0001956;positive regulation of neurotransmitter secretion | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0006357;regulation of transcription by RNA polymerase II | 34 | 19 | 2 | 13 | 0 | 2 | 5 |
| BP | GO:0065007;biological regulation | GO:1905065;positive regulation of vascular associated smooth muscle cell differentiation | 4 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0042325;regulation of phosphorylation | 13 | 7 | 1 | 4 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0045987;positive regulation of smooth muscle contraction | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045785;positive regulation of cell adhesion | 11 | 8 | 1 | 9 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0072012;glomerulus vasculature development | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0060347;heart trabecula formation | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0060216;definitive hemopoiesis | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1904035;regulation of epithelial cell apoptotic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043031;negative regulation of macrophage activation | 30 | 8 | 0 | 10 | 0 | 1 | 8 |
| BP | GO:0032502;developmental process | GO:0061008;hepaticobiliary system development | 45 | 24 | 0 | 14 | 0 | 1 | 18 |
| BP | GO:0032502;developmental process | GO:0001889;liver development | 54 | 23 | 1 | 16 | 0 | 1 | 18 |
| BP | GO:0008152;metabolic process | GO:0046854;phosphatidylinositol phosphate biosynthetic process | 65 | 28 | 0 | 15 | 0 | 0 | 12 |
| BP | GO:0008152;metabolic process | GO:2001022;positive regulation of response to DNA damage stimulus | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043517;positive regulation of DNA damage response, signal transduction by p53 class mediator | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071480;cellular response to gamma radiation | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1901798;positive regulation of signal transduction by p53 class mediator | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0010332;response to gamma radiation | 3 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043516;regulation of DNA damage response, signal transduction by p53 class mediator | 5 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0000077;DNA damage checkpoint signaling | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0031297;replication fork processing | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0031570;DNA integrity checkpoint signaling | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0045005;DNA-dependent DNA replication maintenance of fidelity | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071481;cellular response to X-ray | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1904354;negative regulation of telomere capping | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0000425;pexophagy | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001267;regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 12 | 12 | 1 | 3 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0030225;macrophage differentiation | 6 | 6 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0099116;tRNA 5'-end processing | 13 | 12 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1903358;regulation of Golgi organization | 34 | 19 | 2 | 14 | 0 | 0 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0021513;spinal cord dorsal/ventral patterning | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033089;positive regulation of T cell differentiation in thymus | 5 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0021983;pituitary gland development | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0009954;proximal/distal pattern formation | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0021510;spinal cord development | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0021952;central nervous system projection neuron axonogenesis | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033081;regulation of T cell differentiation in thymus | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0042475;odontogenesis of dentin-containing tooth | 5 | 3 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045740;positive regulation of DNA replication | 21 | 14 | 1 | 8 | 1 | 1 | 3 |
| BP | GO:0032502;developmental process | GO:0048566;embryonic digestive tract development | 3 | 2 | 1 | 0 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0030879;mammary gland development | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0009953;dorsal/ventral pattern formation | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0035270;endocrine system development | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051248;negative regulation of protein metabolic process | 7 | 1 | 2 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045649;regulation of macrophage differentiation | 5 | 4 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0042176;regulation of protein catabolic process | 3 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0046627;negative regulation of insulin receptor signaling pathway | 4 | 3 | 0 | 3 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:1900077;negative regulation of cellular response to insulin stimulus | 4 | 3 | 0 | 3 | 0 | 1 | 3 |
| BP | GO:0009987;cellular process | GO:0032869;cellular response to insulin stimulus | 16 | 3 | 0 | 3 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:1901185;negative regulation of ERBB signaling pathway | 15 | 2 | 0 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway | 15 | 2 | 0 | 2 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:1903792;negative regulation of anion transport | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051956;negative regulation of amino acid transport | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071420;cellular response to histamine | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051253;negative regulation of RNA metabolic process | 41 | 19 | 1 | 13 | 0 | 1 | 9 |
| BP | GO:0065007;biological regulation | GO:0048016;inositol phosphate-mediated signaling | 2 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071241;cellular response to inorganic substance | 21 | 13 | 0 | 7 | 0 | 2 | 5 |
| BP | GO:0009987;cellular process | GO:0071168;protein localization to chromatin | 15 | 11 | 1 | 6 | 0 | 1 | 3 |
| BP | GO:0065007;biological regulation | GO:0033146;regulation of intracellular estrogen receptor signaling pathway | 2 | 2 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0000018;regulation of DNA recombination | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0099643;signal release from synapse | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007269;neurotransmitter secretion | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0050890;cognition | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0043097;pyrimidine nucleoside salvage | 19 | 15 | 3 | 9 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:0008655;pyrimidine-containing compound salvage | 19 | 15 | 3 | 9 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:0043174;nucleoside salvage | 19 | 15 | 3 | 9 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:0006206;pyrimidine nucleobase metabolic process | 6 | 6 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046134;pyrimidine nucleoside biosynthetic process | 18 | 14 | 2 | 9 | 0 | 1 | 1 |
| BP | GO:0008152;metabolic process | GO:0034654;nucleobase-containing compound biosynthetic process | 5 | 4 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0062014;negative regulation of small molecule metabolic process | 5 | 4 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045936;negative regulation of phosphate metabolic process | 15 | 13 | 2 | 8 | 0 | 0 | 5 |
| MF | GO:0003824;catalytic activity | GO:0004126;cytidine deaminase activity | 5 | 5 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0016814;hydrolase activity, acting on carbon-nitrogen | 4 | 4 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0098772;molecular function regulator activity | GO:0045499;chemorepellent activity | 5 | 3 | 1 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0008270;zinc ion binding | 6 | 5 | 1 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000026;regulation of multicellular organismal development | 7 | 5 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006705;mineralocorticoid biosynthetic process | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046184;aldehyde biosynthetic process | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046488;phosphatidylinositol metabolic process | 40 | 20 | 0 | 8 | 0 | 0 | 7 |
| BP | GO:0008152;metabolic process | GO:0006661;phosphatidylinositol biosynthetic process | 38 | 19 | 0 | 7 | 0 | 0 | 7 |
| BP | GO:0008152;metabolic process | GO:1901662;quinone catabolic process | 41 | 21 | 0 | 10 | 0 | 0 | 7 |
| BP | GO:0009987;cellular process | GO:0030835;negative regulation of actin filament depolymerization | 41 | 21 | 0 | 9 | 0 | 0 | 7 |
| BP | GO:0065007;biological regulation | GO:0003376;sphingosine-1-phosphate receptor signaling pathway | 40 | 20 | 0 | 8 | 0 | 0 | 7 |
| BP | GO:0009987;cellular process | GO:0070252;actin-mediated cell contraction | 36 | 18 | 0 | 7 | 0 | 0 | 6 |
| BP | GO:0065007;biological regulation | GO:0110053;regulation of actin filament organization | 36 | 18 | 0 | 7 | 0 | 0 | 6 |
| BP | GO:0009987;cellular process | GO:0030834;regulation of actin filament depolymerization | 25 | 14 | 0 | 5 | 0 | 0 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0055119;relaxation of cardiac muscle | 24 | 13 | 0 | 5 | 0 | 0 | 5 |
| BP | GO:0032501;multicellular organismal process | GO:0090075;relaxation of muscle | 22 | 11 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0008152;metabolic process | GO:0034356;NAD biosynthesis via nicotinamide riboside salvage pathway | 26 | 14 | 0 | 5 | 0 | 0 | 8 |
| BP | GO:0065007;biological regulation | GO:0002675;positive regulation of acute inflammatory response | 25 | 13 | 0 | 5 | 0 | 0 | 8 |
| BP | GO:0050896;response to stimulus | GO:0035994;response to muscle stretch | 20 | 9 | 0 | 4 | 0 | 0 | 5 |
| MF | GO:0003824;catalytic activity | GO:0004222;metalloendopeptidase activity | 3 | 2 | 0 | 1 | 0 | 1 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008237;metallopeptidase activity | 3 | 2 | 0 | 1 | 0 | 1 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004175;endopeptidase activity | 9 | 4 | 0 | 3 | 0 | 1 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004252;serine-type endopeptidase activity | 5 | 3 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1901214;regulation of neuron death | 14 | 12 | 0 | 6 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0010038;response to metal ion | 21 | 17 | 6 | 14 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0010728;regulation of hydrogen peroxide biosynthetic process | 10 | 5 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903997;positive regulation of non-membrane spanning protein tyrosine kinase activity | 15 | 10 | 1 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900449;regulation of glutamate receptor signaling pathway | 10 | 5 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903995;regulation of non-membrane spanning protein tyrosine kinase activity | 14 | 9 | 1 | 4 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1902950;regulation of dendritic spine maintenance | 9 | 4 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045921;positive regulation of exocytosis | 12 | 4 | 1 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0017157;regulation of exocytosis | 6 | 2 | 1 | 4 | 0 | 0 | 4 |
| BP | GO:0009987;cellular process | GO:0072683;T cell extravasation | 2 | 2 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:1902004;positive regulation of amyloid-beta formation | 34 | 9 | 0 | 14 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1902993;positive regulation of amyloid precursor protein catabolic process | 34 | 9 | 0 | 14 | 0 | 1 | 10 |
| BP | GO:0065007;biological regulation | GO:1901223;negative regulation of NIK/NF-kappaB signaling | 17 | 5 | 0 | 8 | 0 | 1 | 7 |
| BP | GO:0008152;metabolic process | GO:0006473;protein acetylation | 3 | 3 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0065003;protein-containing complex assembly | 9 | 8 | 0 | 4 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0006898;receptor-mediated endocytosis | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000535;regulation of entry of bacterium into host cell | 6 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0032501;multicellular organismal process | GO:0036230;granulocyte activation | 7 | 3 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0050930;induction of positive chemotaxis | 4 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0036499;PERK-mediated unfolded protein response | 4 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0042558;pteridine-containing compound metabolic process | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010558;negative regulation of macromolecule biosynthetic process | 10 | 6 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0032366;intracellular sterol transport | 11 | 5 | 1 | 3 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0021955;central nervous system neuron axonogenesis | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0032774;RNA biosynthetic process | 4 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1903828;negative regulation of cellular protein localization | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070507;regulation of microtubule cytoskeleton organization | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0030516;regulation of axon extension | 6 | 5 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043666;regulation of phosphoprotein phosphatase activity | 14 | 9 | 1 | 2 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0010821;regulation of mitochondrion organization | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051093;negative regulation of developmental process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031400;negative regulation of protein modification process | 5 | 4 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010760;negative regulation of macrophage chemotaxis | 4 | 4 | 2 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:1901984;negative regulation of protein acetylation | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0022603;regulation of anatomical structure morphogenesis | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045719;negative regulation of glycogen biosynthetic process | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0120036;plasma membrane bounded cell projection organization | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070874;negative regulation of glycogen metabolic process | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000465;regulation of glycogen | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048666;neuron development | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1905522;negative regulation of macrophage migration | 3 | 3 | 2 | 1 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0061387;regulation of extent of cell growth | 4 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010739;positive regulation of protein kinase A signaling | 2 | 2 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000074;regulation of type B pancreatic cell development | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0015695;organic cation transport | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0015872;dopamine transport | 6 | 2 | 1 | 1 | 0 | 0 | 2 |
| BP | GO:0051179;localization | GO:1901998;toxin transport | 4 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031282;regulation of guanylate cyclase activity | 8 | 6 | 1 | 5 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1900180;regulation of protein localization to nucleus | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032930;positive regulation of superoxide anion generation | 18 | 15 | 4 | 10 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0032928;regulation of superoxide anion generation | 17 | 14 | 3 | 10 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0030307;positive regulation of cell growth | 11 | 5 | 1 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900739;regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 3 | 3 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 3 | 3 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1901030;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3 | 3 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0071900;regulation of protein serine/threonine kinase activity | 6 | 5 | 0 | 3 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0046456;icosanoid biosynthetic process | 41 | 27 | 0 | 18 | 1 | 3 | 6 |
| MF | GO:0060089;molecular transducer activity | GO:0004952;dopamine neurotransmitter receptor activity | 16 | 6 | 0 | 3 | 0 | 0 | 3 |
| BP | GO:0032502;developmental process | GO:0048732;gland development | 17 | 10 | 0 | 5 | 0 | 1 | 8 |
| BP | GO:0009987;cellular process | GO:0071805;potassium ion transmembrane transport | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0098930;axonal transport | 6 | 3 | 0 | 5 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0021954;central nervous system neuron development | 11 | 8 | 0 | 7 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0034063;stress granule assembly | 5 | 3 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045773;positive regulation of axon extension | 5 | 3 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:1990090;cellular response to nerve growth factor stimulus | 5 | 3 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0043603;cellular amide metabolic process | 4 | 1 | 0 | 0 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:0009312;oligosaccharide biosynthetic process | 15 | 5 | 1 | 4 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0016051;carbohydrate biosynthetic process | 15 | 5 | 1 | 4 | 0 | 1 | 5 |
| BP | GO:0008152;metabolic process | GO:0070076;histone lysine demethylation | 9 | 4 | 1 | 2 | 0 | 1 | 2 |
| BP | GO:0008152;metabolic process | GO:0000096;sulfur amino acid metabolic process | 9 | 8 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway | 14 | 12 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0044319;wound healing, spreading of cells | 9 | 8 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045648;positive regulation of erythrocyte differentiation | 28 | 16 | 0 | 9 | 0 | 1 | 7 |
| BP | GO:0065007;biological regulation | GO:0001953;negative regulation of cell-matrix adhesion | 5 | 5 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071318;cellular response to ATP | 5 | 5 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0033198;response to ATP | 4 | 4 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0052651;monoacylglycerol catabolic process | 4 | 4 | 1 | 3 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0046462;monoacylglycerol metabolic process | 3 | 3 | 1 | 2 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0046475;glycerophospholipid catabolic process | 3 | 3 | 1 | 2 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0046461;neutral lipid catabolic process | 4 | 4 | 1 | 3 | 0 | 1 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004709;MAP kinase kinase kinase activity | 16 | 7 | 0 | 6 | 1 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004029;aldehyde dehydrogenase | 7 | 5 | 0 | 3 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004708;MAP kinase kinase activity | 16 | 6 | 0 | 3 | 0 | 0 | 3 |
| MF | GO:0003824;catalytic activity | GO:0004030;aldehyde dehydrogenase [NAD(P)+] activity | 6 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0140657;ATP-dependent activity | GO:0043138;3'-5' DNA helicase activity | 17 | 9 | 0 | 5 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0000400;four-way junction DNA binding | 10 | 6 | 0 | 4 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004523;RNA-DNA hybrid ribonuclease activity | 13 | 5 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004528;phosphodiesterase I activity | 13 | 5 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004035;alkaline phosphatase activity | 6 | 3 | 1 | 2 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 6 | 3 | 1 | 2 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0016803;ether hydrolase activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0003691;double-stranded telomeric DNA binding | 12 | 5 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0008296;3'-5'-exodeoxyribonuclease activity | 12 | 5 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0031579;membrane raft organization | 10 | 5 | 1 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0090189;regulation of branching involved in ureteric bud morphogenesis | 9 | 4 | 1 | 2 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0032367;intracellular cholesterol transport | 10 | 5 | 1 | 3 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0071384;cellular response to corticosteroid stimulus | 19 | 13 | 2 | 7 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0071385;cellular response to glucocorticoid stimulus | 11 | 7 | 1 | 4 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0001658;branching involved in ureteric bud morphogenesis | 10 | 4 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0060675;ureteric bud morphogenesis | 10 | 4 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0051179;localization | GO:0015918;sterol transport | 9 | 4 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0042471;ear morphogenesis | 8 | 3 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1905332;positive regulation of morphogenesis of an epithelium | 7 | 2 | 1 | 1 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0004896;cytokine receptor activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070102;interleukin-6-mediated signaling pathway | 17 | 6 | 0 | 4 | 0 | 1 | 6 |
| BP | GO:0009987;cellular process | GO:0071260;cellular response to mechanical stimulus | 4 | 2 | 1 | 1 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0038066;p38MAPK cascade | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031279;regulation of cyclase activity | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010831;positive regulation of myotube differentiation | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901741;positive regulation of myoblast fusion | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901739;regulation of myoblast fusion | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903201;regulation of oxidative stress-induced cell death | 9 | 4 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0035331;negative regulation of hippo signaling | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031281;positive regulation of cyclase activity | 12 | 6 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0051249;regulation of lymphocyte activation | 7 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034116;positive regulation of heterotypic cell-cell adhesion | 6 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900744;regulation of p38MAPK cascade | 7 | 2 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0001937;negative regulation of endothelial cell proliferation | 7 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0032501;multicellular organismal process | GO:0003140;determination of left/right asymmetry in lateral mesoderm | 5 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000027;regulation of animal organ morphogenesis | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0048745;smooth muscle tissue development | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0061053;somite development | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0060537;muscle tissue development | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045880;positive regulation of smoothened signaling pathway | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0007224;smoothened signaling pathway | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0007368;determination of left/right symmetry | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0001947;heart looping | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0061371;determination of heart left/right asymmetry | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003143;embryonic heart tube morphogenesis | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0008589;regulation of smoothened signaling pathway | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051152;positive regulation of smooth muscle cell differentiation | 5 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0002376;immune system process | GO:0045059;positive thymic T cell selection | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900175;regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0072359;circulatory system development | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0033084;regulation of immature T cell proliferation in thymus | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0007405;neuroblast proliferation | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0060242;contact inhibition | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0072205;metanephric collecting duct development | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0046637;regulation of alpha-beta T cell differentiation | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0072044;collecting duct development | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071679;commissural neuron axon guidance | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051151;negative regulation of smooth muscle cell differentiation | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1904646;cellular response to amyloid-beta | 12 | 11 | 7 | 5 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0048385;regulation of retinoic acid receptor signaling pathway | 5 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0070293;renal absorption | 9 | 5 | 0 | 4 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0006646;phosphatidylethanolamine biosynthetic process | 7 | 5 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2001169;regulation of ATP biosynthetic process | 4 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000353;positive regulation of endothelial cell apoptotic process | 5 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002705;positive regulation of leukocyte mediated immunity | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0002327;immature B cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002730;regulation of dendritic cell cytokine production | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0036018;cellular response to erythropoietin | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0001692;histamine metabolic process | 4 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1905063;regulation of vascular associated smooth muscle cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0002279;mast cell activation involved in immune response | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0043303;mast cell degranulation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002732;positive regulation of dendritic cell cytokine production | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0015697;quaternary ammonium group transport | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0002448;mast cell mediated immunity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0050910;detection of mechanical stimulus involved in sensory perception of sound | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0090136;epithelial cell-cell adhesion | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0001504;neurotransmitter uptake | 3 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0030318;melanocyte differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0055123;digestive system development | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000767;positive regulation of cytoplasmic translation | 8 | 6 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903672;positive regulation of sprouting angiogenesis | 6 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000765;regulation of cytoplasmic translation | 6 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031057;negative regulation of histone modification | 6 | 2 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0001919;regulation of receptor recycling | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071280;cellular response to copper ion | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0048545;response to steroid hormone | 11 | 5 | 1 | 3 | 0 | 1 | 5 |
| BP | GO:0065007;biological regulation | GO:1901222;regulation of NIK/NF-kappaB signaling | 6 | 4 | 2 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:2000369;regulation of clathrin-dependent endocytosis | 19 | 8 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0035020;regulation of Rac protein signal transduction | 17 | 6 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0032502;developmental process | GO:0001944;vasculature development | 19 | 7 | 0 | 4 | 0 | 0 | 6 |
| BP | GO:0009987;cellular process | GO:0048864;stem cell development | 8 | 5 | 0 | 5 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032703;negative regulation of interleukin-2 production | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0061099;negative regulation of protein tyrosine kinase activity | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0002526;acute inflammatory response | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0002637;regulation of immunoglobulin production | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0001914;regulation of T cell mediated cytotoxicity | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0032501;multicellular organismal process | GO:0042100;B cell proliferation | 9 | 2 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051973;positive regulation of telomerase activity | 38 | 29 | 7 | 17 | 0 | 3 | 5 |
| BP | GO:0065007;biological regulation | GO:0051924;regulation of calcium ion transport | 11 | 4 | 2 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0042177;negative regulation of protein catabolic process | 4 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045787;positive regulation of cell cycle | 10 | 8 | 1 | 5 | 0 | 1 | 1 |
| BP | GO:0008152;metabolic process | GO:0019441;tryptophan catabolic process to kynurenine | 4 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070230;positive regulation of lymphocyte apoptotic process | 3 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0070189;kynurenine metabolic process | 3 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051932;synaptic transmission, GABAergic | 3 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:1902476;chloride transmembrane transport | 3 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0098661;inorganic anion transmembrane transport | 3 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0006821;chloride transport | 3 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:1904862;inhibitory synapse assembly | 3 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0006816;calcium ion transport | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0006936;muscle contraction | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0035865;cellular response to potassium ion | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0035864;response to potassium ion | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071468;cellular response to acidic pH | 6 | 6 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000344;positive regulation of acrosome reaction | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0098660;inorganic ion transmembrane transport | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045956;positive regulation of calcium ion-dependent exocytosis | 2 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060046;regulation of acrosome reaction | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0098703;calcium ion import across plasma membrane | 4 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0010447;response to acidic pH | 4 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:1902656;calcium ion import into cytosol | 4 | 4 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0007520;myoblast fusion | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903307;positive regulation of regulated secretory pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071467;cellular response to pH | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0014902;myotube differentiation | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006527;arginine catabolic process | 7 | 5 | 1 | 4 | 0 | 1 | 1 |
| BP | GO:0008152;metabolic process | GO:0006525;arginine metabolic process | 6 | 5 | 0 | 4 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1901184;regulation of ERBB signaling pathway | 22 | 15 | 0 | 10 | 1 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity | 20 | 13 | 0 | 8 | 1 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:2000036;regulation of stem cell population maintenance | 16 | 11 | 0 | 7 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:1904031;positive regulation of cyclin-dependent protein kinase activity | 13 | 9 | 0 | 6 | 0 | 1 | 2 |
| BP | GO:0065007;biological regulation | GO:1900087;positive regulation of G1/S transition of mitotic cell cycle | 12 | 8 | 0 | 6 | 0 | 1 | 2 |
| BP | GO:0050896;response to stimulus | GO:0071364;cellular response to epidermal growth factor stimulus | 2 | 1 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0045746;negative regulation of Notch signaling pathway | 2 | 1 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0050896;response to stimulus | GO:0051384;response to glucocorticoid | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048671;negative regulation of collateral sprouting | 16 | 10 | 1 | 6 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032687;negative regulation of interferon-alpha production | 16 | 10 | 1 | 6 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0030308;negative regulation of cell growth | 16 | 10 | 1 | 6 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0048681;negative regulation of axon regeneration | 14 | 8 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0061000;negative regulation of dendritic spine development | 14 | 8 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048670;regulation of collateral sprouting | 14 | 8 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070571;negative regulation of neuron projection regeneration | 14 | 8 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006470;protein dephosphorylation | 10 | 5 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032688;negative regulation of interferon-beta production | 13 | 7 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000058;regulation of ubiquitin-dependent protein catabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0022008;neurogenesis | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0099111;microtubule-based transport | 2 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000479;regulation of cAMP-dependent protein kinase activity | 3 | 3 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0008152;metabolic process | GO:0006266;DNA ligation | 22 | 13 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:2001251;negative regulation of chromosome organization | 22 | 13 | 0 | 4 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0060045;positive regulation of cardiac muscle cell proliferation | 14 | 9 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:0000712;resolution of meiotic recombination intermediates | 17 | 11 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0055023;positive regulation of cardiac muscle tissue growth | 14 | 9 | 0 | 3 | 0 | 0 | 5 |
| BP | GO:0065007;biological regulation | GO:0045091;regulation of single stranded viral RNA replication via double stranded DNA intermediate | 18 | 11 | 0 | 2 | 0 | 0 | 5 |
| BP | GO:0009987;cellular process | GO:0071103;DNA conformation change | 19 | 12 | 0 | 3 | 0 | 0 | 4 |
| BP | GO:0065007;biological regulation | GO:0051783;regulation of nuclear division | 11 | 6 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0060043;regulation of cardiac muscle cell proliferation | 11 | 6 | 0 | 1 | 0 | 0 | 4 |
| BP | GO:0008152;metabolic process | GO:0006297;nucleotide-excision repair, DNA gap filling | 7 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0030262;apoptotic nuclear changes | 8 | 4 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0045070;positive regulation of viral genome replication | 7 | 3 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0000819;sister chromatid segregation | 5 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0009987;cellular process | GO:0031493;nucleosomal histone binding | 13 | 5 | 0 | 2 | 0 | 0 | 3 |
| MF | GO:0003824;catalytic activity | GO:0003906;DNA-(apurinic or apyrimidinic site) endonuclease activity | 11 | 4 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0016895;exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 7 | 3 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0097200;cysteine-type endopeptidase activity involved in execution phase of apoptosis | 8 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004536;deoxyribonuclease activity | 7 | 3 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0097153;cysteine-type endopeptidase activity involved in apoptotic process | 8 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0008301;DNA binding, bending | 10 | 6 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0007088;regulation of mitotic nuclear division | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006000;fructose metabolic process | 12 | 4 | 1 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:2000278;regulation of DNA biosynthetic process | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048585;negative regulation of response to stimulus | 6 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0035005;1-phosphatidylinositol-4-phosphate 3-kinase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0016303;1-phosphatidylinositol-3-kinase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0035004;phosphatidylinositol 3-kinase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0016307;phosphatidylinositol phosphate kinase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0052742;phosphatidylinositol kinase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0034061;DNA polymerase activity | 11 | 5 | 1 | 3 | 0 | 0 | 2 |
| MF | GO:0005215;transporter activity | GO:0015267;channel activity | 9 | 3 | 1 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0005506;iron ion binding | 8 | 3 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0016773;phosphotransferase activity, alcohol group as acceptor | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0090554;phosphatidylcholine floppase activity | 9 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0017083;4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 11 | 3 | 1 | 2 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0003964;RNA-directed DNA polymerase activity | 9 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0140657;ATP-dependent activity | GO:0090555;phosphatidylethanolamine flippase activity | 9 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0009008;DNA-methyltransferase activity | 9 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0003720;telomerase activity | 9 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0016972;thiol oxidase activity | 11 | 4 | 0 | 3 | 0 | 0 | 4 |
| MF | GO:0005488;binding | GO:0051400;BH domain binding | 11 | 4 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0051434;BH3 domain binding | 10 | 3 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0016301;kinase activity | 9 | 2 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0046920;alpha-(1->3)-fucosyltransferase activity | 11 | 3 | 1 | 2 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0002020;protease binding | 8 | 2 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0008401;retinoic acid 4-hydroxylase activity | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0031404;chloride ion binding | 6 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0008559;ABC-type xenobiotic transporter activity | 9 | 3 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0005215;transporter activity | GO:0005217;intracellular ligand-gated ion channel activity | 8 | 3 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0070513;death domain binding | 10 | 3 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0008417;fucosyltransferase activity | 11 | 3 | 1 | 2 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0140333;glycerophospholipid flippase activity | 8 | 3 | 0 | 1 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0032454;histone demethylase activity | 11 | 3 | 1 | 2 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0031965;nuclear membrane | 7 | 2 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005634;nucleus | 16 | 4 | 1 | 4 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0010720;positive regulation of cell development | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0050769;positive regulation of neurogenesis | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010754;negative regulation of cGMP-mediated signaling | 5 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0050896;response to stimulus | GO:0070305;response to cGMP | 5 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0071321;cellular response to cGMP | 5 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0010752;regulation of cGMP-mediated signaling | 5 | 3 | 0 | 2 | 0 | 0 | 3 |
| BP | GO:0008152;metabolic process | GO:0016926;protein desumoylation | 3 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0008306;associative learning | 9 | 6 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0043951;negative regulation of cAMP-mediated signaling | 9 | 7 | 0 | 4 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0002052;positive regulation of neuroblast proliferation | 5 | 2 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0080134;regulation of response to stress | 5 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0035627;ceramide transport | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0051289;protein homotetramerization | 10 | 8 | 0 | 4 | 0 | 2 | 1 |
| BP | GO:0065007;biological regulation | GO:0002684;positive regulation of immune system process | 5 | 4 | 1 | 0 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0034605;cellular response to heat | 3 | 3 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0005230;extracellular ligand-gated ion channel activity | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015278;calcium-release channel activity | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0099604;ligand-gated calcium channel activity | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0005231;excitatory extracellular ligand-gated ion channel activity | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015276;ligand-gated ion channel activity | 5 | 4 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015085;calcium ion transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0001540;amyloid-beta binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0008324;cation transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0008528;G protein-coupled peptide receptor activity | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0042826;histone deacetylase binding | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015220;choline transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0061459;L-arginine transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0035174;histone serine kinase activity | 6 | 4 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015214;pyrimidine nucleoside transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0015181;arginine transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005337;nucleoside transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0008504;monoamine transmembrane transporter activity | 2 | 2 | 1 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0070001;aspartic-type peptidase activity | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004190;aspartic-type endopeptidase activity | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0015101;organic cation transmembrane transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0098960;postsynaptic neurotransmitter receptor activity | 5 | 4 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0099529;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005798;Golgi-associated vesicle | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005802;trans-Golgi network | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0000228;nuclear chromosome | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0032588;trans-Golgi network membrane | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005641;nuclear envelope lumen | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0055037;recycling endosome | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway | 8 | 7 | 0 | 7 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0034350;regulation of glial cell apoptotic process | 12 | 10 | 0 | 10 | 0 | 1 | 4 |
| BP | GO:0009987;cellular process | GO:0002934;desmosome organization | 8 | 7 | 0 | 7 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0034351;negative regulation of glial cell apoptotic process | 12 | 10 | 0 | 10 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0016525;negative regulation of angiogenesis | 9 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0106014;regulation of inflammatory response to wounding | 18 | 8 | 1 | 8 | 0 | 1 | 1 |
| BP | GO:0009987;cellular process | GO:0002232;leukocyte chemotaxis involved in inflammatory response | 17 | 7 | 1 | 7 | 0 | 1 | 1 |
| BP | GO:0009987;cellular process | GO:0071351;cellular response to interleukin-18 | 15 | 6 | 0 | 6 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0035655;interleukin-18-mediated signaling pathway | 15 | 6 | 0 | 6 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1903034;regulation of response to wounding | 12 | 4 | 0 | 4 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900407;regulation of cellular response to oxidative stress | 10 | 3 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0006325;chromatin organization | 5 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:1902969;mitotic DNA replication | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0070914;UV-damage excision repair | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0022616;DNA strand elongation | 3 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006271;DNA strand elongation involved in DNA replication | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0003887;DNA-directed DNA polymerase activity | 4 | 2 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0016175;superoxide-generating NAD(P)H oxidase activity | 6 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0086003;cardiac muscle cell contraction | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086001;cardiac muscle cell action potential | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086002;cardiac muscle cell action potential involved in contraction | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0042552;myelination | 7 | 5 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086043;bundle of His cell action potential | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0014894;response to denervation involved in regulation of muscle adaptation | 7 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0086018;SA node cell to atrial cardiac muscle cell signaling | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086045;membrane depolarization during AV node cell action potential | 8 | 6 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086046;membrane depolarization during SA node cell action potential | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060373;regulation of ventricular cardiac muscle cell membrane depolarization | 6 | 4 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000272;negative regulation of signaling receptor activity | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000279;negative regulation of DNA biosynthetic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048145;regulation of fibroblast proliferation | 8 | 5 | 3 | 2 | 0 | 1 | 0 |
| BP | GO:0009987;cellular process | GO:0009913;epidermal cell differentiation | 3 | 0 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0009892;negative regulation of metabolic process | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0030521;androgen receptor signaling pathway | 4 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0050896;response to stimulus | GO:0140467;integrated stress response signaling | 3 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0071391;cellular response to estrogen stimulus | 4 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0042119;neutrophil activation | 3 | 2 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0090023;positive regulation of neutrophil chemotaxis | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0052372;modulation by symbiont of entry into host | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1904375;regulation of protein localization to cell periphery | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0008152;metabolic process | GO:0009435;NAD biosynthetic process | 3 | 2 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1902624;positive regulation of neutrophil migration | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0071624;positive regulation of granulocyte chemotaxis | 2 | 1 | 0 | 0 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0045598;regulation of fat cell differentiation | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051050;positive regulation of transport | 5 | 5 | 1 | 3 | 0 | 0 | 3 |
| MF | GO:0003824;catalytic activity | GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity | 5 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0035256;G protein-coupled glutamate receptor binding | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0098772;molecular function regulator activity | GO:0016004;phospholipase activator activity | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0060229;lipase activator activity | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0043274;phospholipase binding | 4 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0010742;macrophage derived foam cell differentiation | 6 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0035357;peroxisome proliferator activated receptor signaling pathway | 7 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0060331;negative regulation of response to interferon-gamma | 7 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0060336;negative regulation of interferon-gamma-mediated signaling pathway | 7 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0034393;positive regulation of smooth muscle cell apoptotic process | 6 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0042953;lipoprotein transport | 7 | 6 | 0 | 5 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0048384;retinoic acid receptor signaling pathway | 8 | 6 | 0 | 5 | 0 | 0 | 2 |
| BP | GO:0051179;localization | GO:0044872;lipoprotein localization | 7 | 6 | 0 | 5 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0030224;monocyte differentiation | 6 | 5 | 0 | 4 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0001890;placenta development | 5 | 5 | 0 | 4 | 0 | 0 | 2 |
| MF | GO:0060089;molecular transducer activity | GO:0008066;glutamate receptor activity | 5 | 4 | 1 | 3 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0004970;ionotropic glutamate receptor activity | 5 | 4 | 1 | 3 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0015277;kainate selective glutamate receptor activity | 5 | 4 | 1 | 3 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0022834;ligand-gated channel activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0022824;transmitter-gated ion channel activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0001640;adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0098988;G protein-coupled glutamate receptor activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0099094;ligand-gated cation channel activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005216;ion channel activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:1904315;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0000217;DNA secondary structure binding | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005272;sodium channel activity | 5 | 4 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0003680;minor groove of adenine-thymine-rich DNA binding | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005267;potassium channel activity | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0051721;protein phosphatase 2A binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:1902936;phosphatidylinositol bisphosphate binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008172;S-methyltransferase activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0019902;phosphatase binding | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0045322;unmethylated CpG binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0019903;protein phosphatase binding | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0045028;G protein-coupled purinergic nucleotide receptor activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0008353;RNA polymerase II CTD heptapeptide repeat kinase activity | 4 | 3 | 0 | 3 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0034452;dynactin binding | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004707;MAP kinase activity | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0001614;purinergic nucleotide receptor activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0042800;histone methyltransferase activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0016655;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0023026;MHC class II protein complex binding | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0016702;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0060089;molecular transducer activity | GO:0004890;GABA-A receptor activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004745;NAD-retinol dehydrogenase activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:1904813;ficolin-1-rich granule lumen | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0032991;protein-containing complex | GO:0008328;ionotropic glutamate receptor complex | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0101002;ficolin-1-rich granule | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:1901606;alpha-amino acid catabolic process | 3 | 2 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0045670;regulation of osteoclast differentiation | 5 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006270;DNA replication initiation | 5 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0007040;lysosome organization | 6 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0090303;positive regulation of wound healing | 7 | 4 | 0 | 1 | 0 | 1 | 4 |
| BP | GO:0065007;biological regulation | GO:0010718;positive regulation of epithelial to mesenchymal transition | 4 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045724;positive regulation of cilium assembly | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1903146;regulation of autophagy of mitochondrion | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0002673;regulation of acute inflammatory response | 3 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1901021;positive regulation of calcium ion transmembrane transporter activity | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0047496;vesicle transport along microtubule | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0000132;establishment of mitotic spindle orientation | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010921;regulation of phosphatase activity | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0050848;regulation of calcium-mediated signaling | 5 | 3 | 0 | 3 | 0 | 0 | 3 |
| BP | GO:0009987;cellular process | GO:0040001;establishment of mitotic spindle localization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0051294;establishment of spindle orientation | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0072384;organelle transport along microtubule | 3 | 3 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway | 3 | 3 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0099518;vesicle cytoskeletal trafficking | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0008236;serine-type peptidase activity | 3 | 2 | 0 | 3 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0000976;transcription cis-regulatory region binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0051205;protein insertion into membrane | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0014033;neural crest cell differentiation | 7 | 7 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0031644;regulation of nervous system process | 10 | 9 | 1 | 2 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0035690;cellular response to drug | 7 | 7 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046337;phosphatidylethanolamine metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0050853;B cell receptor signaling pathway | 8 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand | 10 | 3 | 1 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0050856;regulation of T cell receptor signaling pathway | 6 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001244;positive regulation of intrinsic apoptotic signaling pathway | 8 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0030217;T cell differentiation | 6 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050871;positive regulation of B cell activation | 7 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001235;positive regulation of apoptotic signaling pathway | 7 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0097191;extrinsic apoptotic signaling pathway | 6 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050671;positive regulation of lymphocyte proliferation | 7 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050870;positive regulation of T cell activation | 6 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903223;positive regulation of oxidative stress-induced neuron death | 6 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1904063;negative regulation of cation transmembrane transport | 4 | 4 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0009083;branched-chain amino acid catabolic process | 9 | 8 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0009081;branched-chain amino acid metabolic process | 9 | 8 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901186;positive regulation of ERBB signaling pathway | 4 | 4 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0042743;hydrogen peroxide metabolic process | 9 | 8 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0060562;epithelial tube morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0048568;embryonic organ development | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007093;mitotic cell cycle checkpoint signaling | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060307;regulation of ventricular cardiac muscle cell membrane repolarization | 3 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0086005;ventricular cardiac muscle cell action potential | 3 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0099623;regulation of cardiac muscle cell membrane repolarization | 3 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1904062;regulation of cation transmembrane transport | 3 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0061041;regulation of wound healing | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0007266;Rho protein signal transduction | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045862;positive regulation of proteolysis | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051055;negative regulation of lipid biosynthetic process | 3 | 1 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:2000378;negative regulation of reactive oxygen species metabolic process | 3 | 1 | 0 | 1 | 0 | 0 | 3 |
| BP | GO:0065007;biological regulation | GO:0032874;positive regulation of stress-activated MAPK cascade | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0036296;response to increased oxygen levels | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0008234;cysteine-type peptidase activity | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0031625;ubiquitin protein ligase binding | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004197;cysteine-type endopeptidase activity | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0044389;ubiquitin-like protein ligase binding | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0032006;regulation of TOR signaling | 6 | 6 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902904;negative regulation of supramolecular fiber organization | 3 | 3 | 1 | 3 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0015864;pyrimidine nucleoside transport | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0015858;nucleoside transport | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0015862;uridine transport | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051349;positive regulation of lyase activity | 4 | 3 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0009065;glutamine family amino acid catabolic process | 4 | 3 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0007263;nitric oxide mediated signal transduction | 4 | 3 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0050896;response to stimulus | GO:0002237;response to molecule of bacterial origin | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0019932;second-messenger-mediated signaling | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0009063;cellular amino acid catabolic process | 5 | 4 | 0 | 3 | 0 | 1 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0003100;regulation of systemic arterial blood pressure by endothelin | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0098735;positive regulation of the force of heart contraction | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0018119;peptidyl-cysteine S-nitrosylation | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0110150;negative regulation of biomineralization | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0018198;peptidyl-cysteine modification | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0019430;removal of superoxide radicals | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071451;cellular response to superoxide | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902514;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902307;positive regulation of sodium ion transmembrane transport | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010765;positive regulation of sodium ion transport | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0048872;homeostasis of number of cells | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043267;negative regulation of potassium ion transport | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050866;negative regulation of cell activation | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048011;neurotrophin TRK receptor signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045618;positive regulation of keratinocyte differentiation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006309;apoptotic DNA fragmentation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003184;pulmonary valve morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0072132;mesenchyme morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003177;pulmonary valve development | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0034311;diol metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003203;endocardial cushion morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000758;positive regulation of peptidyl-lysine acetylation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045606;positive regulation of epidermal cell differentiation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0038179;neurotrophin signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003197;endocardial cushion development | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070168;negative regulation of biomineral tissue development | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010543;regulation of platelet activation | 3 | 3 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:1903169;regulation of calcium ion transmembrane transport | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0035066;positive regulation of histone acetylation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0000737;DNA catabolic process, endonucleolytic | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043484;regulation of RNA splicing | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0035617;stress granule disassembly | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0032988;ribonucleoprotein complex disassembly | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0106057;negative regulation of calcineurin-mediated signaling | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070885;negative regulation of calcineurin-NFAT signaling cascade | 5 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030575;nuclear body organization | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0090312;positive regulation of protein deacetylation | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042987;amyloid precursor protein catabolic process | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator | 4 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045725;positive regulation of glycogen biosynthetic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070875;positive regulation of glycogen metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007064;mitotic sister chromatid cohesion | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0050435;amyloid-beta metabolic process | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901797;negative regulation of signal transduction by p53 class mediator | 4 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1901989;positive regulation of cell cycle phase transition | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033044;regulation of chromosome organization | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1902903;regulation of supramolecular fiber organization | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0005979;regulation of glycogen biosynthetic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0031109;microtubule polymerization or depolymerization | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032272;negative regulation of protein polymerization | 5 | 3 | 1 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070884;regulation of calcineurin-NFAT signaling cascade | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031110;regulation of microtubule polymerization or depolymerization | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0046785;microtubule polymerization | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0007004;telomere maintenance via telomerase | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006278;RNA-dependent DNA biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0010833;telomere maintenance via telomere lengthening | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0051131;chaperone-mediated protein complex assembly | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048675;axon extension | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1990138;neuron projection extension | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901889;negative regulation of cell junction assembly | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031111;negative regulation of microtubule polymerization or depolymerization | 3 | 2 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0034198;cellular response to amino acid starvation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:1990928;response to amino acid starvation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0034374;low-density lipoprotein particle remodeling | 3 | 3 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0042744;hydrogen peroxide catabolic process | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032269;negative regulation of cellular protein metabolic process | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048712;negative regulation of astrocyte differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0035035;histone acetyltransferase binding | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0042162;telomeric DNA binding | 2 | 1 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006003;fructose 2,6-bisphosphate metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070935;3'-UTR-mediated mRNA stabilization | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902373;negative regulation of mRNA catabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043489;RNA stabilization | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048255;mRNA stabilization | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0032868;response to insulin | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0062149;detection of stimulus involved in sensory perception of pain | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0014819;regulation of skeletal muscle contraction | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060371;regulation of atrial cardiac muscle cell membrane depolarization | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060372;regulation of atrial cardiac muscle cell membrane repolarization | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086015;SA node cell action potential | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086016;AV node cell action potential | 6 | 4 | 0 | 4 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0086067;AV node cell to bundle of His cell communication | 5 | 3 | 0 | 3 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0086026;atrial cardiac muscle cell to AV node cell signaling | 4 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902882;regulation of response to oxidative stress | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086014;atrial cardiac muscle cell action potential | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1905897;regulation of response to endoplasmic reticulum stress | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0050974;detection of mechanical stimulus involved in sensory perception | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0018130;heterocycle biosynthetic process | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086012;membrane depolarization during cardiac muscle cell action potential | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0036336;dendritic cell migration | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0003254;regulation of membrane depolarization | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0019370;leukotriene biosynthetic process | 3 | 1 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0032502;developmental process | GO:0003231;cardiac ventricle development | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903035;negative regulation of response to wounding | 4 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0051402;neuron apoptotic process | 6 | 4 | 2 | 3 | 0 | 1 | 0 |
| BP | GO:0009987;cellular process | GO:0071470;cellular response to osmotic stress | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003161;cardiac conduction system development | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0090398;cellular senescence | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1902305;regulation of sodium ion transmembrane transport | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0061045;negative regulation of wound healing | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0060048;cardiac muscle contraction | 3 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0030501;positive regulation of bone mineralization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002028;regulation of sodium ion transport | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0042476;odontogenesis | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0086091;regulation of heart rate by cardiac conduction | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0048546;digestive tract morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000510;positive regulation of dendritic cell chemotaxis | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000508;regulation of dendritic cell chemotaxis | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0002376;immune system process | GO:0045190;isotype switching | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000401;regulation of lymphocyte migration | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0045444;fat cell differentiation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0042592;homeostatic process | GO:0055088;lipid homeostasis | 4 | 3 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0032508;DNA duplex unwinding | 3 | 3 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032682;negative regulation of chemokine production | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:1901687;glutathione derivative biosynthetic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:1901685;glutathione derivative metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046329;negative regulation of JNK cascade | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043506;regulation of JUN kinase activity | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032873;negative regulation of stress-activated MAPK cascade | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006749;glutathione metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043407;negative regulation of MAP kinase activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0061564;axon development | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0000725;recombinational repair | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0000724;double-strand break repair via homologous recombination | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032760;positive regulation of tumor necrosis factor production | 6 | 5 | 1 | 4 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:1903557;positive regulation of tumor necrosis factor superfamily cytokine production | 6 | 5 | 1 | 4 | 0 | 1 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004558;alpha-1,4-glucosidase activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0090599;alpha-glucosidase activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0016323;basolateral plasma membrane | 3 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034163;regulation of toll-like receptor 9 signaling pathway | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048679;regulation of axon regeneration | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0099560;synaptic membrane adhesion | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060998;regulation of dendritic spine development | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032647;regulation of interferon-alpha production | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050771;negative regulation of axonogenesis | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0035335;peptidyl-tyrosine dephosphorylation | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0070933;histone H4 deacetylation | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0070932;histone H3 deacetylation | 3 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0006338;chromatin remodeling | 4 | 2 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0016575;histone deacetylation | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0072330;monocarboxylic acid biosynthetic process | 7 | 5 | 0 | 4 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0070827;chromatin maintenance | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0043116;negative regulation of vascular permeability | 3 | 2 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0043117;positive regulation of vascular permeability | 3 | 2 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0051968;positive regulation of synaptic transmission, glutamatergic | 5 | 4 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1901841;regulation of high voltage-gated calcium channel activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046827;positive regulation of protein export from nucleus | 4 | 3 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032780;negative regulation of ATPase activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900117;regulation of execution phase of apoptosis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0050664;oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0043024;ribosomal small subunit binding | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005730;nucleolus | 5 | 3 | 0 | 2 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0031981;nuclear lumen | 5 | 3 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031452;negative regulation of heterochromatin assembly | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0071557;histone H3-K27 demethylation | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0070544;histone H3-K36 demethylation | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0006356;regulation of transcription by RNA polymerase I | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0033344;cholesterol efflux | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0042472;inner ear morphogenesis | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0061718;glucose catabolic process to pyruvate | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0061621;canonical glycolysis | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0061620;glycolytic process through glucose-6-phosphate | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006096;glycolytic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043087;regulation of GTPase activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0008277;regulation of G protein-coupled receptor signaling pathway | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060079;excitatory postsynaptic potential | 5 | 3 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000300;regulation of synaptic vesicle exocytosis | 4 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0007549;dosage compensation | 3 | 2 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0010826;negative regulation of centrosome duplication | 3 | 2 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045717;negative regulation of fatty acid biosynthetic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051570;regulation of histone H3-K9 methylation | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0009894;regulation of catabolic process | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0060398;regulation of growth hormone receptor signaling pathway | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042976;activation of Janus kinase activity | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0036155;acylglycerol acyl-chain remodeling | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001269;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902253;regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0080164;regulation of nitric oxide metabolic process | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051931;regulation of sensory perception | 2 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045346;regulation of MHC class II biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060306;regulation of membrane repolarization | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0034204;lipid translocation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032414;positive regulation of ion transmembrane transporter activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0045332;phospholipid translocation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0007614;short-term memory | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:1905144;response to acetylcholine | 2 | 2 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0032502;developmental process | GO:0140058;neuron projection arborization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0140059;dendrite arborization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0099173;postsynapse organization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0046218;indolalkylamine catabolic process | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006569;tryptophan catabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006568;tryptophan metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1902991;regulation of amyloid precursor protein catabolic process | 2 | 2 | 0 | 1 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:1900273;positive regulation of long-term synaptic potentiation | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006084;acetyl-CoA metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032077;positive regulation of deoxyribonuclease activity | 4 | 3 | 0 | 3 | 0 | 1 | 2 |
| BP | GO:0050896;response to stimulus | GO:0033194;response to hydroperoxide | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032071;regulation of endodeoxyribonuclease activity | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0016572;histone phosphorylation | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000304;positive regulation of ceramide biosynthetic process | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0090154;positive regulation of sphingolipid biosynthetic process | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000303;regulation of ceramide biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0050996;positive regulation of lipid catabolic process | 2 | 2 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0009987;cellular process | GO:0030837;negative regulation of actin filament polymerization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0120033;negative regulation of plasma membrane bounded cell projection assembly | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0042307;positive regulation of protein import into nucleus | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0035306;positive regulation of dephosphorylation | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1904591;positive regulation of protein import | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051494;negative regulation of cytoskeleton organization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004697;protein kinase C activity | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0140110;transcription regulator activity | GO:0001228;DNA-binding transcription activator activity, RNA polymerase II-specific | 2 | 2 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0051287;NAD binding | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0001046;core promoter sequence-specific DNA binding | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0019900;kinase binding | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0019901;protein kinase binding | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| MF | GO:0005488;binding | GO:0000977;RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045621;positive regulation of lymphocyte differentiation | 2 | 2 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071331;cellular response to hexose stimulus | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0071333;cellular response to glucose stimulus | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0042573;retinoic acid metabolic process | 5 | 5 | 1 | 2 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0010823;negative regulation of mitochondrion organization | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0021953;central nervous system neuron differentiation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032271;regulation of protein polymerization | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0034660;ncRNA metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051881;regulation of mitochondrial membrane potential | 6 | 5 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2001020;regulation of response to DNA damage stimulus | 3 | 2 | 0 | 2 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0050772;positive regulation of axonogenesis | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903827;regulation of cellular protein localization | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032754;positive regulation of interleukin-5 production | 5 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045822;negative regulation of heart contraction | 4 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction | 4 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032674;regulation of interleukin-5 production | 4 | 4 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051252;regulation of RNA metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010677;negative regulation of cellular carbohydrate metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0090307;mitotic spindle assembly | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006511;ubiquitin-dependent protein catabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0016570;histone modification | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0055022;negative regulation of cardiac muscle tissue growth | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903524;positive regulation of blood circulation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046325;negative regulation of glucose import | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033689;negative regulation of osteoblast proliferation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000113;negative regulation of cellular macromolecule biosynthetic process | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030182;neuron differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048489;synaptic vesicle transport | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048313;Golgi inheritance | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010829;negative regulation of glucose transmembrane transport | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0048699;generation of neurons | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0097479;synaptic vesicle localization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045721;negative regulation of gluconeogenesis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048168;regulation of neuronal synaptic plasticity | 3 | 2 | 2 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002689;negative regulation of leukocyte chemotaxis | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002694;regulation of leukocyte activation | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902254;negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 3 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010738;regulation of protein kinase A signaling | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043030;regulation of macrophage activation | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2001021;negative regulation of response to DNA damage stimulus | 2 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0035722;interleukin-12-mediated signaling pathway | 5 | 2 | 2 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071349;cellular response to interleukin-12 | 5 | 2 | 2 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1903206;negative regulation of hydrogen peroxide-induced cell death | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902175;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0001656;metanephros development | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0006073;cellular glucan metabolic process | 4 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:1901028;regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900181;negative regulation of protein localization to nucleus | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006112;energy reserve metabolic process | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity | 2 | 2 | 1 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048172;regulation of short-term neuronal synaptic plasticity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010647;positive regulation of cell communication | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030216;keratinocyte differentiation | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0033293;monocarboxylic acid binding | 3 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006068;ethanol catabolic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0009308;amine metabolic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0051923;sulfation | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0034035;purine ribonucleoside bisphosphate metabolic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006783;heme biosynthetic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0006779;porphyrin-containing compound biosynthetic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0042886;amide transport | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0072348;sulfur compound transport | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0051180;vitamin transport | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048640;negative regulation of developmental growth | 2 | 2 | 1 | 0 | 0 | 0 | 1 |
| MF | GO:0005215;transporter activity | GO:0015378;sodium:chloride symporter activity | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0001755;neural crest cell migration | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032008;positive regulation of TOR signaling | 5 | 5 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0014032;neural crest cell development | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0001667;ameboidal-type cell migration | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0003007;heart morphogenesis | 5 | 5 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903530;regulation of secretion by cell | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0030100;regulation of endocytosis | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000644;regulation of receptor catabolic process | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903898;negative regulation of PERK-mediated unfolded protein response | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903896;positive regulation of IRE1-mediated unfolded protein response | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000646;positive regulation of receptor catabolic process | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070106;interleukin-27-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071350;cellular response to interleukin-15 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0035723;interleukin-15-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0098761;cellular response to interleukin-7 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0038111;interleukin-7-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0007259;receptor signaling pathway via JAK-STAT | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071352;cellular response to interleukin-2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0038110;interleukin-2-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060330;regulation of response to interferon-gamma | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060334;regulation of interferon-gamma-mediated signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032653;regulation of interleukin-10 production | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032731;positive regulation of interleukin-1 beta production | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032732;positive regulation of interleukin-1 production | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071357;cellular response to type I interferon | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060337;type I interferon signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0001959;regulation of cytokine-mediated signaling pathway | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0042129;regulation of T cell proliferation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071346;cellular response to interferon-gamma | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045625;regulation of T-helper 1 cell differentiation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034112;positive regulation of homotypic cell-cell adhesion | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010561;negative regulation of glycoprotein biosynthetic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0042592;homeostatic process | GO:0048878;chemical homeostasis | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0015893;drug transport | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1903793;positive regulation of anion transport | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0009891;positive regulation of biosynthetic process | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0043112;receptor metabolic process | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0048565;digestive tract development | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070098;chemokine-mediated signaling pathway | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0048548;regulation of pinocytosis | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0007183;SMAD protein complex assembly | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0040007;growth | GO:0043403;skeletal muscle tissue regeneration | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0033173;calcineurin-NFAT signaling cascade | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0097720;calcineurin-mediated signaling | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0070262;peptidyl-serine dephosphorylation | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032925;regulation of activin receptor signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0061384;heart trabecula morphogenesis | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0003229;ventricular cardiac muscle tissue development | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0042805;actinin binding | 3 | 2 | 1 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903749;positive regulation of establishment of protein localization to mitochondrion | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006639;acylglycerol metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046434;organophosphate catabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042219;cellular modified amino acid catabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006644;phospholipid metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006650;glycerophospholipid metabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046503;glycerolipid catabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0009395;phospholipid catabolic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0008593;regulation of Notch signaling pathway | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007005;mitochondrion organization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045637;regulation of myeloid cell differentiation | 3 | 3 | 0 | 3 | 0 | 1 | 1 |
| BP | GO:0009987;cellular process | GO:0051259;protein complex oligomerization | 2 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045926;negative regulation of growth | 5 | 4 | 1 | 2 | 0 | 0 | 2 |
| MF | GO:0003824;catalytic activity | GO:0004725;protein tyrosine phosphatase activity | 5 | 3 | 0 | 3 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010649;regulation of cell communication by electrical coupling | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046058;cAMP metabolic process | 3 | 3 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0015143;urate transmembrane transporter activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0032217;riboflavin transmembrane transporter activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0022832;voltage-gated channel activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005244;voltage-gated ion channel activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0008028;monocarboxylic acid transmembrane transporter activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0001222;transcription corepressor binding | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005251;delayed rectifier potassium channel activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0030331;estrogen receptor binding | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0098591;external side of apical plasma membrane | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0015732;prostaglandin transport | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0044419;biological process involved in interspecies interaction between organisms | GO:0051712;positive regulation of killing of cells of other organism | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0001910;regulation of leukocyte mediated cytotoxicity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0034612;response to tumor necrosis factor | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010608;posttranscriptional regulation of gene expression | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030199;collagen fibril organization | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046598;positive regulation of viral entry into host cell | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0034378;chylomicron assembly | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0075294;positive regulation by symbiont of entry into host | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0019511;peptidyl-proline hydroxylation | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0034379;very-low-density lipoprotein particle assembly | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900026;positive regulation of substrate adhesion-dependent cell spreading | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046596;regulation of viral entry into host cell | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010770;positive regulation of cell morphogenesis involved in differentiation | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1900024;regulation of substrate adhesion-dependent cell spreading | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0002495;antigen processing and presentation of peptide antigen via MHC class II | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0002478;antigen processing and presentation of exogenous peptide antigen | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0033631;cell-cell adhesion mediated by integrin | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0010042;response to manganese ion | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0016032;viral process | GO:0019065;receptor-mediated endocytosis of virus by host cell | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0019064;fusion of virus membrane with host plasma membrane | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0016032;viral process | GO:0039663;membrane fusion involved in viral entry into host cell | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042157;lipoprotein metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0042117;monocyte activation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042159;lipoprotein catabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0070201;regulation of establishment of protein localization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060143;positive regulation of syncytium formation by plasma membrane fusion | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0016540;protein autoprocessing | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033630;positive regulation of cell adhesion mediated by integrin | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006509;membrane protein ectodomain proteolysis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045604;regulation of epidermal cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045616;regulation of keratinocyte differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0005080;protein kinase C binding | 2 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0043202;lysosomal lumen | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0042583;chromaffin granule | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0036021;endolysosome lumen | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005775;vacuolar lumen | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0071682;endocytic vesicle lumen | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0031233;intrinsic component of external side of plasma membrane | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0036019;endolysosome | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0031904;endosome lumen | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0062023;collagen-containing extracellular matrix | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0005507;copper ion binding | 2 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0001067;transcription regulatory region nucleic acid binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0030424;axon | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0050896;response to stimulus | GO:0001580;detection of chemical stimulus involved in sensory perception of bitter taste | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0050913;sensory perception of bitter taste | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0050912;detection of chemical stimulus involved in sensory perception of taste | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0070527;platelet aggregation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0034109;homotypic cell-cell adhesion | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0098772;molecular function regulator activity | GO:0019855;calcium channel inhibitor activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0097718;disordered domain specific binding | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0005246;calcium channel regulator activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0098772;molecular function regulator activity | GO:0008200;ion channel inhibitor activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0061629;RNA polymerase II-specific DNA-binding transcription factor binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0033192;calmodulin-dependent protein phosphatase activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0031721;hemoglobin alpha binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0008508;bile acid:sodium symporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0097100;supercoiled DNA binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0035184;histone threonine kinase activity | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1905475;regulation of protein localization to membrane | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0019788;NEDD8 transferase activity | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| CC | GO:0003824;catalytic activity | GO:1905103;integral component of lysosomal membrane | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| CC | GO:0003824;catalytic activity | GO:0031166;integral component of vacuolar membrane | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005640;nuclear outer membrane | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0031333;negative regulation of protein-containing complex assembly | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0046688;response to copper ion | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0072507;divalent inorganic cation homeostasis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0140238;presynaptic endocytosis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0099504;synaptic vesicle cycle | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0051179;localization | GO:0036465;synaptic vesicle recycling | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051049;regulation of transport | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0048488;synaptic vesicle endocytosis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0016079;synaptic vesicle exocytosis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0019319;hexose biosynthetic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0055065;metal ion homeostasis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004712;protein serine/threonine/tyrosine kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0000287;magnesium ion binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0050321;tau-protein kinase activity | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0046872;metal ion binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0048156;tau protein binding | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0005005;transmembrane-ephrin receptor activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0005003;ephrin receptor activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004711;ribosomal protein S6 kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0005004;GPI-linked ephrin receptor activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0001784;phosphotyrosine residue binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0045309;protein phosphorylated amino acid binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0005007;fibroblast growth factor-activated receptor activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004690;cyclic nucleotide-dependent protein kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0030295;protein kinase activator activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0042169;SH2 domain binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004691;cAMP-dependent protein kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0070851;growth factor receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0060089;molecular transducer activity | GO:0038064;collagen receptor activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0043121;neurotrophin binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0043539;protein serine/threonine kinase activator activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0046875;ephrin receptor binding | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0017134;fibroblast growth factor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0005131;growth hormone receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0030145;manganese ion binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0005161;platelet-derived growth factor receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0034236;protein kinase A catalytic subunit binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0017080;sodium channel regulator activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0034987;immunoglobulin receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0008554;P-type sodium transporter activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0005391;P-type sodium:potassium-exchanging transporter activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0051427;hormone receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0051020;GTPase binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0140657;ATP-dependent activity | GO:0008556;P-type potassium transmembrane transporter activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0045296;cadherin binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0097472;cyclin-dependent protein kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0004693;cyclin-dependent protein serine/threonine kinase activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0043015;gamma-tubulin binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0031267;small GTPase binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0003785;actin monomer binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0005154;epidermal growth factor receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0098772;molecular function regulator activity | GO:0015459;potassium channel regulator activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0008140;cAMP response element binding protein binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0051019;mitogen-activated protein kinase binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:1990459;transferrin receptor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0060090;molecular adaptor activity | GO:0005078;MAP-kinase scaffold activity | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0031435;mitogen-activated protein kinase kinase kinase binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0048407;platelet-derived growth factor binding | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005856;cytoskeleton | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0045121;membrane raft | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0032991;protein-containing complex | GO:1902911;protein kinase complex | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0015629;actin cytoskeleton | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005925;focal adhesion | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0030055;cell-substrate junction | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0015630;microtubule cytoskeleton | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| CC | GO:0110165;cellular anatomical entity | GO:0005901;caveola | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0032369;negative regulation of lipid transport | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048550;negative regulation of pinocytosis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0032373;positive regulation of sterol transport | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060457;negative regulation of digestive system process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051006;positive regulation of lipoprotein lipase activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1905953;negative regulation of lipid localization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0061365;positive regulation of triglyceride lipase activity | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034145;positive regulation of toll-like receptor 4 signaling pathway | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0050661;NADP binding | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0052650;NADP-retinol dehydrogenase activity | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0008142;oxysterol binding | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0019439;aromatic compound catabolic process | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045780;positive regulation of bone resorption | 6 | 5 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045651;positive regulation of macrophage differentiation | 6 | 5 | 0 | 5 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900222;negative regulation of amyloid-beta clearance | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006702;androgen biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0035115;embryonic forelimb morphogenesis | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0035136;forelimb morphogenesis | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0098911;regulation of ventricular cardiac muscle cell action potential | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0032526;response to retinoic acid | 5 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010906;regulation of glucose metabolic process | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050861;positive regulation of B cell receptor signaling pathway | 4 | 4 | 0 | 4 | 0 | 1 | 2 |
| BP | GO:0009987;cellular process | GO:0030833;regulation of actin filament polymerization | 3 | 2 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0010827;regulation of glucose transmembrane transport | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0050855;regulation of B cell receptor signaling pathway | 2 | 2 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0009987;cellular process | GO:0030838;positive regulation of actin filament polymerization | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0060326;cell chemotaxis | 2 | 2 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0060252;positive regulation of glial cell proliferation | 2 | 2 | 0 | 2 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0017015;regulation of transforming growth factor beta receptor signaling pathway | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0018394;peptidyl-lysine acetylation | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002053;positive regulation of mesenchymal cell proliferation | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0072075;metanephric mesenchyme development | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048008;platelet-derived growth factor receptor signaling pathway | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000251;positive regulation of actin cytoskeleton reorganization | 2 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0070816;phosphorylation of RNA polymerase II C-terminal domain | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0030851;granulocyte differentiation | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006368;transcription elongation from RNA polymerase II promoter | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006354;DNA-templated transcription, elongation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0042795;snRNA transcription by RNA polymerase II | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:2000045;regulation of G1/S transition of mitotic cell cycle | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0009301;snRNA transcription | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0002573;myeloid leukocyte differentiation | 4 | 2 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2001166;regulation of histone H2B ubiquitination | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033184;positive regulation of histone ubiquitination | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033129;positive regulation of histone phosphorylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0050821;protein stabilization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902416;positive regulation of mRNA binding | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010763;positive regulation of fibroblast migration | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1900364;negative regulation of mRNA polyadenylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031441;negative regulation of mRNA 3'-end processing | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902306;negative regulation of sodium ion transmembrane transport | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:2000650;negative regulation of sodium ion transmembrane transporter activity | 3 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0033127;regulation of histone phosphorylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034763;negative regulation of transmembrane transport | 2 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1903706;regulation of hemopoiesis | 2 | 2 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0051179;localization | GO:0046903;secretion | 2 | 2 | 1 | 1 | 0 | 1 | 1 |
| BP | GO:0065007;biological regulation | GO:0051047;positive regulation of secretion | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1904706;negative regulation of vascular associated smooth muscle cell proliferation | 2 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0014742;positive regulation of muscle hypertrophy | 3 | 2 | 0 | 3 | 0 | 0 | 2 |
| BP | GO:0065007;biological regulation | GO:0010613;positive regulation of cardiac muscle hypertrophy | 2 | 1 | 0 | 2 | 0 | 0 | 2 |
| BP | GO:0032501;multicellular organismal process | GO:0060047;heart contraction | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0032501;multicellular organismal process | GO:0006941;striated muscle contraction | 2 | 1 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0048524;positive regulation of viral process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0002183;cytoplasmic translational initiation | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0000339;RNA cap binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0045182;translation regulator activity | GO:0003743;translation initiation factor activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0097013;phagocytic vesicle lumen | 2 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005766;primary lysosome | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004520;endodeoxyribonuclease activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0007249;I-kappaB kinase/NF-kappaB signaling | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1902915;negative regulation of protein polyubiquitination | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0019885;antigen processing and presentation of endogenous peptide antigen via MHC class I | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0002376;immune system process | GO:0002483;antigen processing and presentation of endogenous peptide antigen | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0032452;histone demethylase activity | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| BP | GO:0050896;response to stimulus | GO:0009416;response to light stimulus | 3 | 1 | 0 | 0 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:0000049;tRNA binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0015631;tubulin binding | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004090;carbonyl reductase | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0008525;phosphatidylcholine transporter activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0016779;nucleotidyltransferase activity | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0097386;glial cell projection | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0097418;neurofibrillary tangle | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0046068;cGMP metabolic process | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0010611;regulation of cardiac muscle hypertrophy | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0003824;catalytic activity | GO:0047555;3',5'-cyclic-GMP phosphodiesterase activity | 2 | 1 | 0 | 2 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0046605;regulation of centrosome cycle | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051785;positive regulation of nuclear division | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045840;positive regulation of mitotic nuclear division | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045663;positive regulation of myoblast differentiation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0033137;negative regulation of peptidyl-serine phosphorylation | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010880;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0061028;establishment of endothelial barrier | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0070647;protein modification by small protein conjugation or removal | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0030517;negative regulation of axon extension | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0034122;negative regulation of toll-like receptor signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0035590;purinergic nucleotide receptor signaling pathway | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0045667;regulation of osteoblast differentiation | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| MF | GO:0005488;binding | GO:1990837;sequence-specific double-stranded DNA binding | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051930;regulation of sensory perception of pain | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006164;purine nucleotide biosynthetic process | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0008152;metabolic process | GO:0043101;purine-containing compound salvage | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0032502;developmental process | GO:0048738;cardiac muscle tissue development | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005215;transporter activity | GO:0005248;voltage-gated sodium channel activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0030553;cGMP binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004114;3',5'-cyclic-nucleotide phosphodiesterase activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0030551;cyclic nucleotide binding | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0004112;cyclic-nucleotide phosphodiesterase activity | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005741;mitochondrial outer membrane | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0031968;organelle outer membrane | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0035881;amacrine cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0046549;retinal cone cell development | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0042670;retinal cone cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0045630;positive regulation of T-helper 2 cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0035116;embryonic hindlimb morphogenesis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0035137;hindlimb morphogenesis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0019198;transmembrane receptor protein phosphatase activity | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0003824;catalytic activity | GO:0005001;transmembrane receptor protein tyrosine phosphatase activity | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| MF | GO:0005488;binding | GO:0030506;ankyrin binding | 3 | 2 | 0 | 1 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0007274;neuromuscular synaptic transmission | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:1905209;positive regulation of cardiocyte differentiation | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0002695;negative regulation of leukocyte activation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0071763;nuclear membrane organization | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0005811;lipid droplet | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
| CC | GO:0110165;cellular anatomical entity | GO:0032059;bleb | 3 | 2 | 0 | 2 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0043388;positive regulation of DNA binding | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0051101;regulation of DNA binding | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0065007;biological regulation | GO:0043392;negative regulation of DNA binding | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| BP | GO:0009987;cellular process | GO:0070199;establishment of protein localization to chromosome | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031061;negative regulation of histone methylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031453;positive regulation of heterochromatin assembly | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0090308;regulation of DNA methylation-dependent heterochromatin assembly | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006312;mitotic recombination | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010959;regulation of metal ion transport | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0016246;RNA interference | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0001836;release of cytochrome c from mitochondria | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0046902;regulation of mitochondrial membrane permeability | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006305;DNA alkylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0044728;DNA methylation or demethylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0070918;production of small RNA involved in gene silencing by RNA | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0042592;homeostatic process | GO:0032469;endoplasmic reticulum calcium ion homeostasis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0046824;positive regulation of nucleocytoplasmic transport | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
| BP | GO:0065007;biological regulation | GO:0090316;positive regulation of intracellular protein transport | 1 | 1 | 0 | 1 | 0 | 1 | 0 |
| BP | GO:0008152;metabolic process | GO:0006107;oxaloacetate metabolic process | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006476;protein deacetylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0035601;protein deacylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010830;regulation of myotube differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0034983;peptidyl-lysine deacetylation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:1903507;negative regulation of nucleic acid-templated transcription | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0010832;negative regulation of myotube differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051154;negative regulation of striated muscle cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0018205;peptidyl-lysine modification | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0051153;regulation of striated muscle cell differentiation | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0008216;spermidine metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0040029;regulation of gene expression, epigenetic | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0008152;metabolic process | GO:0006595;polyamine metabolic process | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0042733;embryonic digit morphogenesis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0060765;regulation of androgen receptor signaling pathway | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0030326;embryonic limb morphogenesis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0043044;ATP-dependent chromatin remodeling | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0030162;regulation of proteolysis | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:1903322;positive regulation of protein modification by small protein conjugation or removal | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0032502;developmental process | GO:0008544;epidermis development | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0065007;biological regulation | GO:0031396;regulation of protein ubiquitination | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| BP | GO:0009987;cellular process | GO:0070842;aggresome assembly | 1 | 0 | 0 | 0 | 0 | 0 | 0 |